rank	score	disease_name	disease_identifier
1	0.8223	Myotonia permanens	ORPHA:99735
2	0.8064	Myotonia congenita, atypical, acetazolamide-responsive	OMIM:608390
3	0.8018	Paramyotonia congenita of Von Eulenburg	ORPHA:684
4	0.7958	Myotonia congenita, dominant	OMIM:160800
5	0.7893	Schwartz-Jampel syndrome, type 1	OMIM:255800
6	0.7854	Myotonia congenita, recessive	OMIM:255700
7	0.7752	Brody myopathy	OMIM:601003
8	0.7727	Autosomal recessive progressive external ophthalmoplegia	ORPHA:254886
8	0.7727	Autosomal recessive progressive external ophthalmoplegia	ORPHA:254886
10	0.7665	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4	OMIM:617070
11	0.7614	Schwartz-Jampel syndrome	ORPHA:800
12	0.7595	Myotonia fluctuans	ORPHA:99734
13	0.7547	Paramyotonia congenita	OMIM:168300
14	0.7511	Autosomal recessive axonal neuropathy with neuromyotonia	ORPHA:324442
15	0.747	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	OMIM:603041
16	0.7464	Progressive external ophthalmoplegia, autosomal recessive 1	OMIM:258450
17	0.7427	Rippling muscle disease 2	OMIM:606072
18	0.739	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3	OMIM:617069
19	0.7379	Autosomal dominant adult-onset proximal spinal muscular atrophy	ORPHA:209335
20	0.7373	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	OMIM:607459
21	0.7372	Mitochondrial myopathy with reversible cytochrome C oxidase deficiency	ORPHA:254864
22	0.7365	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	OMIM:616479
23	0.7288	Myopathy, tubular aggregate, 1	OMIM:160565
24	0.728	Lipodystrophy, congenital generalized, type 4	OMIM:613327
25	0.7272	Progressive external ophthalmoplegia, autosomal dominant 1	OMIM:157640
26	0.7271	Hyperkalemic periodic paralysis	ORPHA:682
27	0.725	Myotonic dystrophy 2	OMIM:602668
28	0.7245	Thyrotoxic periodic paralysis	ORPHA:79102
28	0.7245	Thyrotoxic periodic paralysis	ORPHA:79102
30	0.7244	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	OMIM:609286
31	0.7216	Myhre syndrome	OMIM:139210
32	0.7164	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
32	0.7164	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
32	0.7164	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
32	0.7164	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
32	0.7164	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
37	0.7162	Myopathy, myofibrillar, 3	OMIM:609200
38	0.7156	Distal myotilinopathy	ORPHA:98911
39	0.7152	Marinesco-Sjögren syndrome	ORPHA:559
39	0.7152	Marinesco-Sjögren syndrome	ORPHA:559
41	0.7115	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	OMIM:615418
42	0.7046	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	OMIM:613662
43	0.6984	Myopathy, X-linked, with excessive autophagy	OMIM:310440
44	0.6982	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	OMIM:610131
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
45	0.6954	Childhood-onset nemaline myopathy	ORPHA:171439
52	0.6931	Episodic ataxia type 1	ORPHA:37612
53	0.6924	Autosomal recessive Emery-Dreifuss muscular dystrophy	ORPHA:98855
54	0.6922	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	OMIM:618416
55	0.6875	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
55	0.6875	X-linked Emery-Dreifuss muscular dystrophy	ORPHA:98863
55	0.6875	X-linked Emery-Dreifuss muscular dystrophy	ORPHA:98863
55	0.6875	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
55	0.6875	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
55	0.6875	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
61	0.6817	Combined oxidative phosphorylation deficiency 8	OMIM:614096
62	0.6798	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2	OMIM:609283
63	0.6797	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	OMIM:616539
64	0.6792	Myopathy, lactic acidosis, and sideroblastic anemia 1	OMIM:600462
65	0.6778	Alpha-B crystallin-related late-onset myopathy	ORPHA:399058
66	0.6764	Distal anoctaminopathy	ORPHA:399096
67	0.6725	Myopathy, lactic acidosis, and sideroblastic anemia 2	OMIM:613561
68	0.6702	Glycogen storage disease due to muscle phosphofructokinase deficiency	ORPHA:371
69	0.6675	Hypokalemic periodic paralysis	ORPHA:681
69	0.6675	Hypokalemic periodic paralysis	ORPHA:681
69	0.6675	Hypokalemic periodic paralysis	ORPHA:681
72	0.6661	Mowat-Wilson syndrome	OMIM:235730
73	0.6657	Neuromyotonia and axonal neuropathy, autosomal recessive	OMIM:137200
74	0.6645	Nemaline myopathy 6, autosomal dominant	OMIM:609273
75	0.6644	Leukoencephalopathy, progressive, with ovarian failure	OMIM:615889
76	0.6641	Mitochondrial complex IV deficiency, nuclear type 1	OMIM:220110
77	0.6606	?Combined oxidative phosphorylation deficiency 49	OMIM:619024
78	0.6588	Miyoshi myopathy	ORPHA:45448
79	0.6571	Central core disease	ORPHA:597
80	0.657	Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5	ORPHA:353
80	0.657	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	ORPHA:70472
82	0.6566	Glycogen storage disease due to muscle glycogen phosphorylase deficiency	ORPHA:368
83	0.656	Mitochondrial complex IV deficiency, nuclear type 7	OMIM:619051
84	0.6544	Distal myopathy, Tateyama type	ORPHA:488650
85	0.6541	Mitochondrial complex IV deficiency, nuclear type 3	OMIM:619046
86	0.6503	Muscle glycogenosis	OMIM:300559
87	0.6501	Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis	OMIM:620138
88	0.6484	Myofibrillar myopathy 10	OMIM:619040
89	0.6465	Myopathy with lactic acidosis, hereditary	OMIM:255125
90	0.6365	?Mitochondrial complex IV deficiency, nuclear type 21	OMIM:619065
91	0.6354	Mitochondrial DNA depletion syndrome 11	OMIM:615084
92	0.6345	Hypokalemic periodic paralysis, type 1	OMIM:170400
93	0.6344	VLCAD deficiency	OMIM:201475
94	0.6343	Mitochondrial complex IV deficiency, nuclear type 18	OMIM:619062
95	0.6328	Anoctamin-5-related limb-girdle muscular dystrophy R12	ORPHA:206549
96	0.6326	Autosomal recessive spastic paraplegia type 77	ORPHA:466722
97	0.6317	Spastic paraplegia 7, autosomal recessive	OMIM:607259
98	0.6316	Rigidity and multifocal seizure syndrome, lethal neonatal	OMIM:614498
99	0.6311	Acetazolamide-responsive myotonia	ORPHA:99736
100	0.6307	Episodic ataxia, type 2	OMIM:108500
101	0.6306	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6	OMIM:615156
102	0.6303	Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy	OMIM:251900
103	0.6255	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2	OMIM:613156
104	0.6232	Erythrocyte lactate transporter defect	OMIM:245340
105	0.6223	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	OMIM:611588
106	0.621	Spastic paraplegia 88, autosomal dominant	OMIM:620106
107	0.6207	Hyperkalemic periodic paralysis	OMIM:170500
107	0.6207	Hypokalemic periodic paralysis, type 2	OMIM:613345
109	0.6181	Glycogen storage disease VII	OMIM:232800
110	0.6175	Ethylmalonic encephalopathy	OMIM:602473
111	0.6158	Spastic paraplegia 79B, autosomal recessive	OMIM:615491
112	0.6155	Mitochondrial complex IV deficiency, nuclear type 17	OMIM:619061
113	0.6146	Mitochondrial DNA depletion syndrome 2 (myopathic type)	OMIM:609560
114	0.6123	Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	OMIM:245400
115	0.611	Charcot-Marie-Tooth disease type 1B	ORPHA:101082
116	0.6108	Myotonic dystrophy 1	OMIM:160900
117	0.6105	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	OMIM:601559
118	0.6097	Spinal muscular atrophy, Jokela type	OMIM:615048
119	0.6094	Glycogen storage disease II	OMIM:232300
120	0.6093	Myopathy, myofibrillar, 2	OMIM:608810
121	0.6087	Congenital myopathy 10B, mild variant	OMIM:620249
122	0.6068	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	ORPHA:502423
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
123	0.6067	Walker-Warburg syndrome	ORPHA:899
137	0.6061	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	OMIM:615290
138	0.6056	Duchenne muscular dystrophy	OMIM:310200
139	0.6047	Centronuclear myopathy 1	OMIM:160150
139	0.6047	Centronuclear myopathy, autosomal, modifier of	OMIM:160150
141	0.6041	Myopathy, myofibrillar, 8	OMIM:617258
142	0.6038	Charcot-Marie-Tooth disease, axonal, type 2EE	OMIM:618400
143	0.6022	Nemaline myopathy 2, autosomal recessive	OMIM:256030
143	0.6022	Myopathy, myofibrillar, 6	OMIM:612954
145	0.6016	CPT II deficiency, myopathic, stress-induced	OMIM:255110
146	0.6015	Scapuloperoneal myopathy, X-linked dominant	OMIM:300695
147	0.5994	Plectin-related limb-girdle muscular dystrophy R17	ORPHA:254361
148	0.5988	Muscular dystrophy, limb-girdle, autosomal recessive 8	OMIM:254110
149	0.5985	Spinal and bulbar muscular atrophy of Kennedy	OMIM:313200
150	0.5969	Miyoshi muscular dystrophy 1	OMIM:254130
151	0.5967	Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD	OMIM:617184
152	0.5966	Glycogen storage disease XI	OMIM:612933
152	0.5966	Neuronopathy, distal hereditary motor, type VIII	OMIM:600175
154	0.5963	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6	OMIM:608840
155	0.5961	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
155	0.5961	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
155	0.5961	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
155	0.5961	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
155	0.5961	Congenital muscular dystrophy with intellectual disability	ORPHA:370968
160	0.5959	Choreoacanthocytosis	OMIM:200150
161	0.5952	Malignant hyperthermia of anesthesia	ORPHA:423
161	0.5952	Malignant hyperthermia of anesthesia	ORPHA:423
163	0.594	Myopathy, distal, 4	OMIM:614065
164	0.5932	Sengers syndrome	OMIM:212350
165	0.5928	Laing distal myopathy	OMIM:160500
166	0.5923	Combined oxidative phosphorylation defect type 13	ORPHA:319514
167	0.5921	Autosomal dominant Charcot-Marie-Tooth disease type 2Y	ORPHA:435387
168	0.5908	Charcot-Marie-Tooth disease, dominant intermediate E	OMIM:614455
169	0.5907	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	OMIM:618387
170	0.5906	Combined oxidative phosphorylation deficiency 16	OMIM:615395
171	0.5903	Oculopharyngodistal myopathy 1	OMIM:164310
172	0.5902	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5	OMIM:613077
173	0.5899	Combined oxidative phosphorylation deficiency 23	OMIM:616198
174	0.5886	Muscular dystrophy, limb-girdle, autosomal recessive 23	OMIM:618138
175	0.5885	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
175	0.5885	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
175	0.5885	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
175	0.5885	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
175	0.5885	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
175	0.5885	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
181	0.5881	Neurodegeneration with brain iron accumulation 4	OMIM:614298
182	0.588	Combined oxidative phosphorylation deficiency 24	OMIM:616239
183	0.5878	?Spastic paraplegia 72, autosomal dominant	OMIM:615625
184	0.5874	Spinal muscular atrophy with progressive myoclonic epilepsy	OMIM:159950
184	0.5874	Dysferlin-related limb-girdle muscular dystrophy R2	ORPHA:268
186	0.5869	?Mitochondrial complex IV deficiency, nuclear type 14	OMIM:619058
187	0.5867	Myopathy, myofibrillar, 7	OMIM:617114
188	0.5866	Hyperekplexia 2	OMIM:614619
189	0.5864	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	OMIM:253800
189	0.5864	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	OMIM:614369
191	0.586	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	OMIM:606002
192	0.5851	Infantile-onset X-linked spinal muscular atrophy	ORPHA:1145
193	0.5845	Congenital myopathy 2A, typical, autosomal dominant	OMIM:161800
194	0.5841	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	OMIM:613157
194	0.5841	Mitochondrial complex IV deficiency, nuclear type 23	OMIM:620275
196	0.5838	Hereditary hyperekplexia	ORPHA:3197
196	0.5838	Hereditary hyperekplexia	ORPHA:3197
196	0.5838	Hereditary hyperekplexia	ORPHA:3197
196	0.5838	Hereditary hyperekplexia	ORPHA:3197
196	0.5838	Hereditary hyperekplexia	ORPHA:3197
201	0.5837	Myopathy, X-linked, with postural muscle atrophy	OMIM:300696
202	0.5832	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	OMIM:208920
203	0.5829	Classic glucose transporter type 1 deficiency syndrome	ORPHA:71277
203	0.5829	Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis	OMIM:615704
205	0.5826	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	ORPHA:137898
206	0.5819	Muscular dystrophy, limb-girdle, autosomal recessive 27	OMIM:619566
207	0.5817	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	OMIM:613954
207	0.5817	Classic pantothenate kinase-associated neurodegeneration	ORPHA:216866
209	0.581	Lower motor neuron syndrome with late-adult onset	ORPHA:276435
210	0.5799	DNAJB6-related limb-girdle muscular dystrophy D1	ORPHA:34516
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
211	0.5798	Presynaptic congenital myasthenic syndromes	ORPHA:98914
221	0.5794	Choreoacanthocytosis	ORPHA:2388
222	0.5791	Late-onset distal myopathy, Markesbery-Griggs type	ORPHA:98912
223	0.5786	DPM3-CDG	ORPHA:263494
224	0.5785	TRAPPC11-related limb-girdle muscular dystrophy R18	ORPHA:369840
225	0.5782	Hyperekplexia 3	OMIM:614618
226	0.5776	Progressive external ophthalmoplegia-myopathy-emaciation syndrome	ORPHA:352447
227	0.5775	Myopathy, distal, 5	OMIM:617030
228	0.5766	Muscular dystrophy, limb-girdle, autosomal recessive 7	OMIM:601954
229	0.5762	Charcot-Marie-Tooth disease, axonal, type 2CC	OMIM:616924
230	0.5756	Arthrogryposis multiplex congenita 3, myogenic type	OMIM:618484
231	0.5755	Neuromuscular disease and ocular or auditory anomalies with or without seizures	OMIM:618733
232	0.575	Creatine phosphokinase, elevated serum	OMIM:123320
233	0.5745	Congenital myopathy 10A, severe variant	OMIM:614399
233	0.5745	Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome	ORPHA:397744
235	0.5739	Charcot-Marie-Tooth disease, recessive intermediate C	OMIM:615376
236	0.5737	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
236	0.5737	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
236	0.5737	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
239	0.5734	Myopathy, mitochondrial, and ataxia	OMIM:617675
240	0.5732	Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset	OMIM:300717
241	0.573	Mitochondrial DNA depletion syndrome, myopathic form	ORPHA:254875
241	0.573	Bethlem myopathy	ORPHA:610
241	0.573	Bethlem myopathy	ORPHA:610
241	0.573	Bethlem myopathy	ORPHA:610
241	0.573	Bethlem myopathy	ORPHA:610
246	0.5729	Muscular dystrophy-dystroglycanopathy (congenital with or without impaired intellectual development), type B, 5	OMIM:606612
247	0.5727	Synaptic congenital myasthenic syndromes	ORPHA:98915
247	0.5727	Synaptic congenital myasthenic syndromes	ORPHA:98915
249	0.5725	Ataxia-oculomotor apraxia 3	OMIM:615217
250	0.5723	Muscular dystrophy, limb-girdle, autosomal dominant 3	OMIM:609115
251	0.5719	Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome	ORPHA:496641
252	0.5717	Inclusion body myopathy and brain white matter abnormalities	OMIM:619733
253	0.5707	DNA2-related mitochondrial DNA deletion syndrome	ORPHA:352470
254	0.5706	?Myopathy, scapulohumeroperoneal	OMIM:616852
255	0.5704	Charcot-Marie-Tooth disease, axonal, type 2N	OMIM:613287
255	0.5704	Congenital myopathy 13	OMIM:255995
257	0.5697	Myasthenic syndrome, congenital, 7A, presynaptic, and distal motor neuropathy, autosomal dominant	OMIM:616040
258	0.5695	Myopathy, distal, with rimmed vacuoles	OMIM:617158
259	0.5694	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	OMIM:613158
259	0.5694	Hereditary myopathy with early respiratory failure	ORPHA:178464
261	0.5691	Hypomyelinating neuropathy, congenital, 2	OMIM:618184
262	0.569	Myopathy, myofibrillar, 4	OMIM:609452
263	0.5689	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	OMIM:617193
263	0.5689	Myopathy with extrapyramidal signs	OMIM:615673
265	0.5688	Autosomal dominant centronuclear myopathy	ORPHA:169189
265	0.5688	Autosomal dominant centronuclear myopathy	ORPHA:169189
265	0.5688	Autosomal dominant centronuclear myopathy	ORPHA:169189
265	0.5688	Charcot-Marie-Tooth disease, axonal, type 2Z	OMIM:616688
265	0.5688	Autosomal dominant centronuclear myopathy	ORPHA:169189
265	0.5688	Autosomal dominant centronuclear myopathy	ORPHA:169189
271	0.5686	Myasthenic syndrome, congenital, 23, presynaptic	OMIM:618197
272	0.5682	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	OMIM:612073
273	0.5681	Charcot-Marie-Tooth disease, axonal, type 2A2A	OMIM:609260
274	0.5678	Scapuloperoneal spinal muscular atrophy	OMIM:181405
275	0.5677	Charcot-Marie-Tooth disease, type 2B1	OMIM:605588
276	0.5675	Charcot-Marie-Tooth disease, type 2B	OMIM:600882
277	0.5667	Mitochondrial complex IV deficiency, nuclear type 8	OMIM:619052
278	0.5665	Spinal muscular atrophy-3	OMIM:253400
278	0.5665	Spinal muscular atrophy, type III, modifier of	OMIM:253400
278	0.5665	Medium chain acyl-CoA dehydrogenase deficiency	ORPHA:42
281	0.5664	Congenital myopathy 7B, myosin storage, autosomal recessive	OMIM:255160
282	0.5662	Charcot-Marie-Tooth disease, type 1E	OMIM:118300
283	0.5661	POMT1-related limb-girdle muscular dystrophy R11	ORPHA:86812
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
284	0.5659	Amyotrophic lateral sclerosis 27, juvenile	OMIM:620285
292	0.5658	?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12	OMIM:616094
293	0.5656	Myopathy, tubular aggregate, 2	OMIM:615883
294	0.5643	Neuroectodermal melanolysosomal disease	ORPHA:33445
295	0.5634	Becker muscular dystrophy	OMIM:300376
296	0.5633	Typical nemaline myopathy	ORPHA:171436
296	0.5633	Typical nemaline myopathy	ORPHA:171436
296	0.5633	Typical nemaline myopathy	ORPHA:171436
296	0.5633	Typical nemaline myopathy	ORPHA:171436
296	0.5633	Typical nemaline myopathy	ORPHA:171436
296	0.5633	Typical nemaline myopathy	ORPHA:171436
296	0.5633	Myoglobinuria, acute recurrent, autosomal recessive	OMIM:268200
303	0.563	Neutral lipid storage myopathy	ORPHA:98908
304	0.5629	Glycogen storage disease IV	OMIM:232500
304	0.5629	Vocal cord and pharyngeal distal myopathy	ORPHA:600
306	0.5627	Charcot-Marie-Tooth disease type 1A	ORPHA:101081
306	0.5627	Muscular dystrophy, limb-girdle, autosomal recessive 18	OMIM:615356
306	0.5627	Hereditary motor and sensory neuropathy VIA	OMIM:601152
309	0.5626	Myopathy, myofibrillar, 9, with early respiratory failure	OMIM:603689
310	0.5622	Hereditary motor and sensory neuropathy, Okinawa type	OMIM:604484
311	0.562	Charcot-Marie-Tooth disease, type 1B	OMIM:118200
312	0.5619	Charcot-Marie-Tooth disease, axonal, type 2II	OMIM:620068
313	0.5618	Charcot-Marie-Tooth disease, type 1A	OMIM:118220
314	0.5616	Spinal muscular atrophy, distal, autosomal recessive, 6	OMIM:620011
314	0.5616	Pontocerebellar hypoplasia, type 1D	OMIM:618065
316	0.5614	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	OMIM:613153
316	0.5614	PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation	ORPHA:438216
318	0.5613	Danon disease	OMIM:300257
319	0.5612	Charcot-Marie-Tooth disease, type 2A1	OMIM:118210
320	0.5611	GNE myopathy	ORPHA:602
321	0.5607	Charcot-Marie-Tooth disease, recessive intermediate, A	OMIM:608340
322	0.5601	Spinal muscular atrophy, X-linked 2, infantile	OMIM:301830
322	0.5601	Developmental and epileptic encephalopathy 51	OMIM:617339
324	0.5599	X-linked Charcot-Marie-Tooth disease type 5	ORPHA:99014
324	0.5599	Autosomal recessive spastic paraplegia type 26	ORPHA:101006
326	0.5598	McLeod syndrome with or without chronic granulomatous disease	OMIM:300842
327	0.5595	Muscular dystrophy, limb-girdle, autosomal recessive 3	OMIM:608099
328	0.5594	Congenital myopathy 1B, autosomal recessive	OMIM:255320
329	0.5592	Charcot-Marie-Tooth disease, type 4D	OMIM:601455
330	0.5588	Combined oxidative phosphorylation deficiency 6	OMIM:300816
331	0.558	Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria	ORPHA:1933
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
332	0.5579	Frontotemporal dementia with motor neuron disease	ORPHA:275872
339	0.5577	Congenital myopathy 7A, myosin storage, autosomal dominant	OMIM:608358
340	0.5576	Duchenne muscular dystrophy	ORPHA:98896
340	0.5576	Duchenne muscular dystrophy	ORPHA:98896
340	0.5576	Charcot-Marie-Tooth disease, axonal, type 2DD	OMIM:618036
340	0.5576	Charcot-Marie-Tooth disease, axonal, type 2P	OMIM:614436
344	0.5575	Bethlem myopathy 1	OMIM:158810
344	0.5575	Bethlem myopathy 1	OMIM:158810
344	0.5575	Bethlem myopathy 1	OMIM:158810
347	0.5574	Mucolipidosis II alpha/beta	OMIM:252500
347	0.5574	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
347	0.5574	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
347	0.5574	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
347	0.5574	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
347	0.5574	Congenital myasthenic syndromes with glycosylation defect	ORPHA:353327
353	0.5573	LIPE-related familial partial lipodystrophy	ORPHA:435660
354	0.5572	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	OMIM:167320
354	0.5572	Laminin subunit alpha 2-related congenital muscular dystrophy	ORPHA:258
356	0.557	Muscular dystrophy, congenital, with or without seizures	OMIM:620166
356	0.557	Muscular dystrophy, congenital, with or without seizures	OMIM:620166
356	0.557	Neuropathy, hereditary motor and sensory, type VIB	OMIM:616505
359	0.5568	Charcot-Marie-Tooth disease, type 2J	OMIM:607736
360	0.5567	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	OMIM:617519
361	0.5566	Dejerine-Sottas disease	OMIM:145900
361	0.5566	Dejerine-Sottas disease	OMIM:145900
361	0.5566	Charcot-Marie-Tooth disease, type 4B2	OMIM:604563
361	0.5566	Dejerine-Sottas disease	OMIM:145900
361	0.5566	Dejerine-Sottas disease	OMIM:145900
366	0.5563	Neutral lipid storage disease with myopathy	OMIM:610717
366	0.5563	Hemolytic anemia due to triosephosphate isomerase deficiency	OMIM:615512
366	0.5563	Polyglucosan body myopathy 1 with or without immunodeficiency	OMIM:615895
369	0.5562	Reducing body myopathy, X-linked 1b, with late childhood or adult onset	OMIM:300718
370	0.5561	Spinal muscular atrophy, late-onset, Finkel type	OMIM:182980
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Desmosterolosis	ORPHA:35107
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
370	0.5561	Aicardi-Goutières syndrome	ORPHA:51
380	0.556	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	OMIM:181350
380	0.556	Charcot-Marie-Tooth disease, type 2I	OMIM:607677
382	0.5558	Muscular dystrophy, limb-girdle, autosomal recessive 6	OMIM:601287
382	0.5558	Muscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8	OMIM:618135
382	0.5558	Amyotrophic lateral sclerosis 21	OMIM:606070
385	0.5555	Calpain-3-related limb-girdle muscular dystrophy R1	ORPHA:267
385	0.5555	Congenital myopathy 1A, autosomal dominant, with susceptibility to malignant hyperthermia	OMIM:117000
385	0.5555	Spinocerebellar ataxia type 43	ORPHA:497764
388	0.5554	Muscular dystrophy, limb-girdle, autosomal recessive 17	OMIM:613723
388	0.5554	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	OMIM:616827
390	0.5552	Charcot-Marie-Tooth disease, dominant intermediate D	OMIM:607791
391	0.5551	Marinesco-Sjogren syndrome	OMIM:248800
392	0.555	Neuronopathy, distal hereditary motor, type VI	OMIM:604320
393	0.5549	Rigid spine syndrome	ORPHA:97244
393	0.5549	Rigid spine syndrome	ORPHA:97244
393	0.5549	Autosomal recessive myogenic arthrogryposis multiplex congenita	ORPHA:319332
396	0.5542	BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy	ORPHA:363454
396	0.5542	GMPPB-related limb-girdle muscular dystrophy R19	ORPHA:363623
398	0.5541	Intermediate nemaline myopathy	ORPHA:171433
398	0.5541	Intermediate nemaline myopathy	ORPHA:171433
398	0.5541	Intermediate nemaline myopathy	ORPHA:171433
398	0.5541	Intermediate nemaline myopathy	ORPHA:171433
398	0.5541	Muscular dystrophy, congenital, merosin deficient or partially deficient	OMIM:607855
403	0.554	Neuropathy, hereditary sensory and autonomic, type IA	OMIM:162400
404	0.5536	Congenital myopathy 23	OMIM:609285
405	0.5535	Congenital disorder of glycosylation, type IIe	OMIM:608779
405	0.5535	X-linked Charcot-Marie-Tooth disease type 6	ORPHA:352675
405	0.5535	?Mitochondrial myopathy with lactic acidosis	OMIM:251950
408	0.5531	Autosomal dominant optic atrophy plus syndrome	ORPHA:1215
409	0.553	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	OMIM:616437
409	0.553	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	OMIM:616439
411	0.5524	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
411	0.5524	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
411	0.5524	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
411	0.5524	Congenital muscular dystrophy, Ullrich type	ORPHA:75840
415	0.5522	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	OMIM:607155
416	0.5521	Hereditary motor and sensory neuropathy, type IIc	OMIM:606071
416	0.5521	Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	OMIM:613710
418	0.5518	Muscular dystrophy, limb-girdle, autosomal recessive 25	OMIM:616812
419	0.5517	Roussy-Levy syndrome	OMIM:180800
419	0.5517	Roussy-Levy syndrome	OMIM:180800
419	0.5517	?Giant axonal neuropathy 2, autosomal dominant	OMIM:610100
419	0.5517	Charcot-Marie-Tooth disease, axonal, type 2L	OMIM:608673
419	0.5517	?Charcot-Marie-Tooth disease, type 2B2	OMIM:605589
424	0.5516	Myasthenic syndrome, congenital, 10	OMIM:254300
425	0.5513	Myopathy, distal, 6, adult onset	OMIM:618655
426	0.5512	Charcot-Marie-Tooth disease, type 4A	OMIM:214400
427	0.551	Giant axonal neuropathy-1	OMIM:256850
428	0.5509	CPT deficiency, hepatic, type IA	OMIM:255120
429	0.5505	Combined oxidative phosphorylation deficiency 13	OMIM:614932
430	0.5503	Carey-Fineman-Ziter syndrome	OMIM:254940
431	0.55	Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	OMIM:256810
431	0.55	Charcot-Marie-Tooth disease, type 2Y	OMIM:616687
433	0.5499	Neuropathy, hereditary motor and sensory, Russe type	OMIM:605285
434	0.5497	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	OMIM:611105
435	0.5496	?Spastic paraplegia 43, autosomal recessive	OMIM:615043
436	0.5495	PCWH syndrome	OMIM:609136
437	0.5492	Cardiomyopathy, dilated, 1X	OMIM:611615
437	0.5492	Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency	ORPHA:300179
439	0.5491	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14	OMIM:615351
440	0.549	Mitochondrial complex I deficiency, nuclear type 1	OMIM:252010
441	0.5489	Thomsen and Becker disease	ORPHA:614
441	0.5489	Proximal myotonic myopathy	ORPHA:606
441	0.5489	Arthrogryposis, distal, with impaired proprioception and touch	OMIM:617146
441	0.5489	Spinocerebellar ataxia, autosomal recessive 21	OMIM:616719
441	0.5489	Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome	ORPHA:391307
446	0.5486	Hereditary motor and sensory neuropathy, Okinawa type	ORPHA:90117
447	0.5485	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7	OMIM:616052
447	0.5485	Charcot-Marie-Tooth disease type 4A	ORPHA:99948
449	0.5484	Muscular dystrophy, congenital, due to ITGA7 deficiency	OMIM:613204
449	0.5484	Pontocerebellar hypoplasia type 1	ORPHA:2254
449	0.5484	Pontocerebellar hypoplasia type 1	ORPHA:2254
449	0.5484	Pontocerebellar hypoplasia type 1	ORPHA:2254
449	0.5484	Pontocerebellar hypoplasia type 1	ORPHA:2254
449	0.5484	Pontocerebellar hypoplasia type 1	ORPHA:2254
449	0.5484	Pontocerebellar hypoplasia type 1	ORPHA:2254
456	0.548	Congenital myopathy 14	OMIM:618414
457	0.5477	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	OMIM:302800
458	0.5475	Oculopharyngodistal myopathy 4	OMIM:619790
459	0.5474	Muscular dystrophy, limb-girdle, autosomal recessive 10	OMIM:608807
460	0.5473	Combined oxidative phosphorylation deficiency 55	OMIM:619743
461	0.5472	Charcot-Marie-Tooth disease, dominant intermediate F	OMIM:615185
462	0.5471	Congenital myopathy 22A, classic	OMIM:620351
462	0.5471	Muscular dystrophy, limb-girdle, autosomal recessive 12	OMIM:611307
462	0.5471	Lipodystrophy, familial partial, type 6	OMIM:615980
462	0.5471	Neuronopathy, distal hereditary motor, type IX	OMIM:617721
466	0.5463	?Myosclerosis, congenital	OMIM:255600
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15	OMIM:612937
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
467	0.5462	Isolated complex I deficiency	ORPHA:2609
497	0.5458	Charcot-Marie-Tooth disease, axonal, type 2GG	OMIM:606483
498	0.5452	Pierson syndrome	OMIM:609049
499	0.545	Charcot-Marie-Tooth disease, axonal, type 2S	OMIM:616155
500	0.5448	Charcot-Marie-Tooth disease, type 2D	OMIM:601472
501	0.5444	Muscular dystrophy, congenital	OMIM:613205
502	0.5443	Muscular dystrophy, congenital, with cataracts and intellectual disability	OMIM:617404
503	0.5435	Neuropathy, hereditary motor, with myopathic features	OMIM:619216
504	0.5433	Spastic paraplegia 26, autosomal recessive	OMIM:609195
505	0.5432	Multiple congenital anomalies-hypotonia-seizures syndrome	ORPHA:280633
506	0.543	Centronuclear myopathy 5	OMIM:615959
507	0.5429	Myasthenia, congenital, 12, with tubular aggregates	OMIM:610542
508	0.5428	X-linked intellectual disability due to GRIA3 mutations	ORPHA:364028
509	0.5426	?Uruguay faciocardiomusculoskeletal syndrome	OMIM:300280
510	0.5423	Charcot-Marie-Tooth disease, axonal type 2M	OMIM:606482
511	0.5421	Muscular dystrophy, limb-girdle, autosomal dominant 4	OMIM:618129
512	0.5419	Amyotrophy, hereditary neuralgic	OMIM:162100
512	0.5419	Niemann-Pick disease, type A	OMIM:257200
514	0.5415	Miyoshi muscular dystrophy 3	OMIM:613319
514	0.5415	Emery-Dreifuss muscular dystrophy 4, autosomal dominant	OMIM:612998
516	0.5414	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
516	0.5414	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
516	0.5414	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
519	0.5409	Charcot-Marie-Tooth disease, axonal, type 2A2B	OMIM:617087
520	0.5406	Spinocerebellar ataxia type 18	ORPHA:98771
521	0.5405	FKRP-related limb-girdle muscular dystrophy R9	ORPHA:34515
521	0.5405	POMT2-related limb-girdle muscular dystrophy R14	ORPHA:206559
523	0.5404	Distal myopathy with anterior tibial onset	ORPHA:178400
523	0.5404	Spinal muscular atrophy, distal, X-linked 3	OMIM:300489
525	0.5403	Nonaka myopathy	OMIM:605820
525	0.5403	Charcot-Marie-Tooth disease, type 1C	OMIM:601098
527	0.5401	Congenital disorder of glycosylation, type Ia	OMIM:212065
527	0.5401	Autosomal recessive spastic paraplegia type 15	ORPHA:100996
529	0.5398	Congenital myopathy 5 with cardiomyopathy	OMIM:611705
530	0.5393	Autosomal dominant limb-girdle muscular dystrophy type 1A	ORPHA:266
530	0.5393	Beta-sarcoglycan-related limb-girdle muscular dystrophy R4	ORPHA:119
532	0.5392	Rhizomelic chondrodysplasia punctata, type 5	OMIM:616716
533	0.5378	Myopathy, sarcoplasmic body	OMIM:620286
534	0.5377	Charcot-Marie-Tooth disease, axonal, type 2T	OMIM:617017
534	0.5377	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	OMIM:617156
536	0.5372	Autosomal dominant spastic paraplegia type 4	ORPHA:100985
536	0.5372	Tangier disease	OMIM:205400
538	0.5369	Muscular dystrophy, limb-girdle, autosomal recessive 2	OMIM:253601
539	0.5367	?Mitochondrial DNA depletion syndrome 16 (hepatic type)	OMIM:618528
539	0.5367	Genetic recurrent myoglobinuria	ORPHA:99845
539	0.5367	?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	OMIM:615422
539	0.5367	Genetic recurrent myoglobinuria	ORPHA:99845
539	0.5367	Genetic recurrent myoglobinuria	ORPHA:99845
539	0.5367	Genetic recurrent myoglobinuria	ORPHA:99845
545	0.5366	Charcot-Marie-Tooth disease type 1E	ORPHA:90658
546	0.5365	Alpha-dystroglycan-related limb-girdle muscular dystrophy R16	ORPHA:280333
546	0.5365	Muscular dystrophy, limb-girdle, autosomal recessive 26	OMIM:618848
548	0.5362	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
548	0.5362	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
548	0.5362	Neuronopathy, distal hereditary motor, type VIIA	OMIM:158580
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
551	0.5358	Congenital fiber-type disproportion myopathy	ORPHA:2020
559	0.5355	?Myopathy, distal, 3	OMIM:610099
560	0.535	Muscular dystrophy, limb-girdle, autosomal recessive 5	OMIM:253700
561	0.5348	Sandhoff disease, adult form	ORPHA:309169
562	0.5347	Becker muscular dystrophy	ORPHA:98895
563	0.5345	Charcot-Marie-Tooth disease, type 4H	OMIM:609311
564	0.5344	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	OMIM:612999
565	0.5342	Distal myopathy with posterior leg and anterior hand involvement	ORPHA:63273
566	0.5337	Peripheral primitive neuroectodermal tumor	ORPHA:370348
567	0.5336	Peroxisome biogenesis disorder 6B	OMIM:614871
568	0.5328	Boucher-Neuhauser syndrome	OMIM:215470
569	0.5324	COG7-CDG	ORPHA:79333
570	0.5322	Tibial muscular dystrophy	ORPHA:609
570	0.5322	Muscular dystrophy, limb-girdle, autosomal recessive 4	OMIM:604286
572	0.5319	Hypermethioninemia due to adenosine kinase deficiency	OMIM:614300
573	0.5318	Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome	ORPHA:466794
574	0.5317	Neuropathy, hereditary sensory, type IIC	OMIM:614213
574	0.5317	Mitochondrial trifunctional protein deficiency 1	OMIM:609015
576	0.5316	?Congenital myopathy 12	OMIM:612540
577	0.5311	Glycogen storage disease IIIa	OMIM:232400
577	0.5311	Porphyria variegata	ORPHA:79473
579	0.5308	Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency	ORPHA:79240
580	0.5307	Adenylosuccinate synthetase-like 1-related distal myopathy	ORPHA:482601
581	0.5306	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	OMIM:616516
582	0.5305	Mitochondrial trifunctional protein deficiency	ORPHA:746
582	0.5305	Polyglucosan body myopathy 2	OMIM:616199
582	0.5305	Mitochondrial trifunctional protein deficiency	ORPHA:746
585	0.5303	Autosomal recessive spastic paraplegia type 48	ORPHA:306511
586	0.5301	Myopathy, distal, Tateyama type	OMIM:614321
587	0.53	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	OMIM:609308
588	0.5294	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	OMIM:616878
589	0.5293	?Charcot-Marie-Tooth disease, axonal, type 2Q	OMIM:615025
589	0.5293	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	OMIM:613150
589	0.5293	ISPD-related limb-girdle muscular dystrophy R20	ORPHA:352479
592	0.5292	Mitochondrial complex IV deficiency, nuclear type 12	OMIM:619055
593	0.529	Lowe syndrome	OMIM:309000
593	0.529	Autosomal dominant spastic paraplegia type 10	ORPHA:100991
595	0.5288	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	OMIM:615911
596	0.5285	Ataxia-telangiectasia-like disorder 1	OMIM:604391
597	0.5284	Muscular dystrophy, limb-girdle, autosomal recessive 1	OMIM:253600
598	0.5283	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	OMIM:253280
598	0.5283	Amyloidosis, hereditary, transthyretin-related	OMIM:105210
600	0.5281	Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy	OMIM:619424
600	0.5281	S-adenosylhomocysteine hydrolase deficiency	ORPHA:88618
602	0.5279	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	OMIM:615350
602	0.5279	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	OMIM:617072
604	0.5278	Developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy	OMIM:619090
605	0.5274	Charcot-Marie-Tooth disease, axonal, type 2F	OMIM:606595
606	0.5273	Ullrich congenital muscular dystrophy 1	OMIM:254090
606	0.5273	Ullrich congenital muscular dystrophy 1	OMIM:254090
606	0.5273	Ullrich congenital muscular dystrophy 1	OMIM:254090
609	0.5272	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	OMIM:618098
610	0.5263	Alacrimia-choreoathetosis-liver dysfunction syndrome	ORPHA:404454
611	0.5261	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
611	0.5261	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
611	0.5261	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
611	0.5261	Congenital muscular dystrophy without intellectual disability	ORPHA:370980
611	0.5261	?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3	OMIM:615424
616	0.5258	Oculopharyngeal muscular dystrophy	OMIM:164300
617	0.5254	Welander distal myopathy	OMIM:604454
618	0.5253	Dystonia 31	OMIM:619565
618	0.5253	X-linked spasticity-intellectual disability-epilepsy syndrome	ORPHA:3175
618	0.5253	Encephalocraniocutaneous lipomatosis	ORPHA:2396
618	0.5253	Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome	ORPHA:457193
618	0.5253	Microcephaly-lymphedema-chorioretinopathy syndrome	ORPHA:2526
618	0.5253	Encephalocraniocutaneous lipomatosis	ORPHA:2396
618	0.5253	Periodic fever, familial	OMIM:142680
625	0.5233	Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development	OMIM:618124
626	0.5227	Nemaline myopathy 5C, autosomal dominant	OMIM:620389
627	0.5226	Congenital myopathy 11	OMIM:619967
628	0.5224	Glycogen storage disease due to liver phosphorylase kinase deficiency	ORPHA:264580
628	0.5224	Glycogen storage disease due to liver phosphorylase kinase deficiency	ORPHA:264580
630	0.5222	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1	OMIM:613155
631	0.5221	Autosomal dominant Charcot-Marie-Tooth disease type 2Z	ORPHA:466768
632	0.5211	Cowchock syndrome	OMIM:310490
633	0.521	Laing early-onset distal myopathy	ORPHA:59135
634	0.5208	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	OMIM:615352
635	0.5207	Spinocerebellar ataxia with axonal neuropathy type 2	ORPHA:64753
635	0.5207	Spinocerebellar ataxia with axonal neuropathy type 2	ORPHA:64753
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
637	0.5205	Williams syndrome	ORPHA:904
657	0.5203	Congenital disorder of deglycosylation 1	OMIM:615273
658	0.5195	Myopathy with rimmed ubiquitin-positive autophagic vacuolation, autosomal dominant	OMIM:601846
659	0.5194	Muscular dystrophy, limb-girdle, autosomal dominant 1	OMIM:603511
660	0.519	Neutral lipid storage disease with ichthyosis	ORPHA:98907
661	0.5187	Autosomal recessive spastic paraplegia type 74	ORPHA:468661
662	0.5185	Nemaline myopathy 5B, autosomal recessive, childhood-onset	OMIM:620386
663	0.5183	Moderate multiminicore disease with hand involvement	ORPHA:178145
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
664	0.5177	Trichohepatoneurodevelopmental syndrome	OMIM:618268
714	0.5174	Amyotrophic lateral sclerosis 8	OMIM:608627
715	0.5173	Metachromatic leukodystrophy due to SAP-b deficiency	OMIM:249900
716	0.5172	Metachromatic leukodystrophy	OMIM:250100
717	0.5169	Neuronopathy, distal hereditary motor, type IID	OMIM:615575
718	0.5164	Kufor-Rakeb syndrome	ORPHA:306674
719	0.5162	Coenzyme Q10 deficiency, primary, 1	OMIM:607426
720	0.5158	Spinocerebellar ataxia type 1	ORPHA:98755
721	0.5157	Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome	ORPHA:95433
722	0.5153	Myopathy, myofibrillar, 1	OMIM:601419
723	0.5152	Distal myopathy, Welander type	ORPHA:603
723	0.5152	Distal myopathy, Welander type	ORPHA:603
723	0.5152	Spinocerebellar ataxia 1	OMIM:164400
723	0.5152	Mucopolysaccharidosis-plus syndrome	OMIM:617303
727	0.515	?Combined oxidative phosphorylation deficiency 22	OMIM:616045
728	0.5149	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	OMIM:612674
729	0.5148	Epiphyseal dysplasia, multiple, 3, with or without myopathy	OMIM:600969
730	0.5143	Neurodegeneration with brain iron accumulation 6	OMIM:615643
731	0.5138	Familial thyroid dyshormonogenesis	ORPHA:95716
731	0.5138	Familial thyroid dyshormonogenesis	ORPHA:95716
731	0.5138	Familial thyroid dyshormonogenesis	ORPHA:95716
731	0.5138	Familial thyroid dyshormonogenesis	ORPHA:95716
731	0.5138	Familial thyroid dyshormonogenesis	ORPHA:95716
731	0.5138	Familial thyroid dyshormonogenesis	ORPHA:95716
737	0.5136	Oculopharyngodistal myopathy	ORPHA:98897
737	0.5136	Oculopharyngodistal myopathy	ORPHA:98897
737	0.5136	Mitochondrial complex I deficiency, nuclear type 12	OMIM:301020
737	0.5136	Oculopharyngodistal myopathy	ORPHA:98897
741	0.5133	Muscular dystrophy, limb-girdle, autosomal recessive 21	OMIM:617232
742	0.5132	Charcot-Marie-Tooth disease, type 4J	OMIM:611228
743	0.5129	Hypothyroidism due to TSH receptor mutations	ORPHA:90673
744	0.5128	Amyotrophic lateral sclerosis, susceptibility to, 13	OMIM:183090
744	0.5128	Spinocerebellar ataxia 2	OMIM:183090
746	0.5125	Macular degeneration, age-related, 3	OMIM:608895
747	0.5121	Centronuclear myopathy 2	OMIM:255200
747	0.5121	Ververi-Brady syndrome	OMIM:617982
747	0.5121	Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome	ORPHA:486815
750	0.512	Charcot-Marie-Tooth disease type 2B1	ORPHA:98856
750	0.512	?Mitochondrial DNA depletion syndrome 19	OMIM:618972
752	0.5119	Peroxisome biogenesis disorder 1A (Zellweger)	OMIM:214100
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Atypical juvenile parkinsonism	ORPHA:391411
753	0.5117	Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders	ORPHA:505248
753	0.5117	Atypical juvenile parkinsonism	ORPHA:391411
753	0.5117	Atypical juvenile parkinsonism	ORPHA:391411
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
753	0.5117	Postsynaptic congenital myasthenic syndromes	ORPHA:98913
769	0.5112	?Spinocerebellar ataxia 43	OMIM:617018
769	0.5112	Combined oxidative phosphorylation deficiency 3	OMIM:610505
771	0.5107	Fragile X-associated tremor/ataxia syndrome	ORPHA:93256
772	0.5106	Perrault syndrome 5	OMIM:616138
773	0.5104	Hypermanganesemia with dystonia 2	OMIM:617013
774	0.5089	Proximal myopathy with extrapyramidal signs	ORPHA:401768
775	0.5088	Hypomyelinating neuropathy, congenital, 3	OMIM:618186
776	0.5086	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	OMIM:617913
777	0.5084	Mitochondrial complex IV deficiency, nuclear type 11	OMIM:619054
778	0.5083	Autosomal recessive Charcot-Marie-Tooth disease with hoarseness	ORPHA:101097
779	0.5082	Bethlem myopathy 2	OMIM:616471
779	0.5082	Charcot-Marie-Tooth disease, axonal, type 2FF	OMIM:619519
779	0.5082	Isolated thyroid-stimulating hormone deficiency	ORPHA:90674
782	0.508	Chediak-Higashi syndrome	OMIM:214500
783	0.5077	Refsum disease	OMIM:266500
784	0.5076	Spinal muscular atrophy, distal, autosomal recessive, 4	OMIM:611067
785	0.5075	Parkinson disease 14, autosomal recessive	OMIM:612953
785	0.5075	Muscular dystrophy, congenital, megaconial type	OMIM:602541
787	0.5072	Intellectual developmental disorder, X-linked syndromic, Wu type	OMIM:300699
788	0.5066	Charcot-Marie-Tooth disease, recessive intermediate D	OMIM:616039
788	0.5066	?Charcot-Marie-Tooth disease, recessive intermediate, B	OMIM:613641
790	0.5065	Kennedy disease	ORPHA:481
790	0.5065	Charcot-Marie-Tooth disease, axonal, type 2O	OMIM:614228
792	0.5061	Stormorken syndrome	OMIM:185070
792	0.5061	Neuropathy, hereditary sensory and autonomic, type IC	OMIM:613640
794	0.506	Adrenomyeloneuropathy	ORPHA:139399
795	0.5055	Mitochondrial complex III deficiency, nuclear type 8	OMIM:615838
796	0.5054	Congenital generalized lipodystrophy	ORPHA:528
796	0.5054	Congenital generalized lipodystrophy	ORPHA:528
796	0.5054	Congenital generalized lipodystrophy	ORPHA:528
796	0.5054	Congenital generalized lipodystrophy	ORPHA:528
796	0.5054	Congenital generalized lipodystrophy	ORPHA:528
796	0.5054	Congenital generalized lipodystrophy	ORPHA:528
802	0.5053	Muscle filaminopathy	ORPHA:171445
802	0.5053	Carnitine deficiency, systemic primary	OMIM:212140
804	0.5052	Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3	ORPHA:62
805	0.5051	?Optic atrophy 11	OMIM:617302
805	0.5051	Combined oxidative phosphorylation defect type 7	ORPHA:254930
807	0.5048	Mitochondrial complex I deficiency, nuclear type 26	OMIM:618247
808	0.5041	Cap myopathy	ORPHA:171881
808	0.5041	Cap myopathy	ORPHA:171881
808	0.5041	Cap myopathy	ORPHA:171881
811	0.504	Autosomal dominant spastic ataxia type 1	ORPHA:251282
811	0.504	Pontocerebellar hypoplasia, type 11	OMIM:617695
813	0.5038	?Mitochondrial DNA depletion syndrome 18	OMIM:618811
814	0.5037	Epilepsy, progressive myoclonic 6	OMIM:614018
814	0.5037	Epilepsy, progressive myoclonic 6	OMIM:614018
816	0.5036	Oculopharyngodistal myopathy 2	OMIM:618940
816	0.5036	Myopathy, vacuolar, with CASQ1 aggregates	OMIM:616231
818	0.5032	Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome	ORPHA:480864
818	0.5032	CIDEC-related familial partial lipodystrophy	ORPHA:435651
820	0.5031	Neuropathy, hereditary sensory, type IE	OMIM:614116
820	0.5031	Spastic paraplegia 84, autosomal recessive	OMIM:619621
822	0.5027	Spinal muscular atrophy, infantile, James type	OMIM:619042
823	0.5026	Glycogen storage disease XII	OMIM:611881
823	0.5026	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease	OMIM:616263
825	0.5024	Autosomal spastic paraplegia type 30	ORPHA:101010
826	0.5019	TBCK-related intellectual disability syndrome	ORPHA:488632
827	0.501	Neuronopathy, distal hereditary motor, type IIA	OMIM:158590
828	0.5009	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	OMIM:615249
828	0.5009	Charcot-Marie-Tooth disease type 4G	ORPHA:99953
830	0.5004	Charcot-Marie-Tooth disease, type 4F	OMIM:614895
831	0.5003	Mitchell syndrome	OMIM:618960
832	0.5002	Neuropathy, recurrent, with pressure palsies	OMIM:162500
833	0.5001	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	OMIM:613818
834	0.5	Mitochondrial DNA depletion syndrome 20 (MNGIE type)	OMIM:619780
835	0.4998	Carnitine-acylcarnitine translocase deficiency	ORPHA:159
836	0.4997	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures	OMIM:614501
837	0.4994	Spinocerebellar ataxia with axonal neuropathy type 1	ORPHA:94124
838	0.499	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	OMIM:613154
838	0.499	Lethal congenital contracture syndrome 5	OMIM:615368
838	0.499	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	OMIM:614643
841	0.4989	Cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism	OMIM:619761
842	0.4984	?Charcot-Marie-Tooth disease, axonal, type 2V	OMIM:616491
843	0.4982	Congenital disorder of glycosylation, type IIo	OMIM:616828
844	0.4981	Myopathy due to myoadenylate deaminase deficiency	OMIM:615511
845	0.4979	Episodic ataxia/myokymia syndrome	OMIM:160120
845	0.4979	Autosomal dominant mitochondrial myopathy with exercise intolerance	ORPHA:457050
847	0.497	Wiedemann-Rautenstrauch syndrome	ORPHA:3455
848	0.4969	Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation	ORPHA:453504
849	0.4968	?Neuronopathy, distal hereditary motor, type VB	OMIM:614751
850	0.4964	PRUNE1-related neurological syndrome	ORPHA:544469
851	0.4963	Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency	ORPHA:263297
852	0.4961	Myasthenic syndrome, congenital, 14, with tubular aggregates	OMIM:616228
853	0.496	Microcephaly, seizures, and developmental delay	OMIM:613402
854	0.4959	McArdle disease	OMIM:232600
854	0.4959	Spinocerebellar ataxia type 10	ORPHA:98761
856	0.4958	Spinocerebellar ataxia, autosomal recessive 30	OMIM:619405
857	0.4957	?Muscle hypertrophy	OMIM:614160
858	0.4956	Mitochondrial complex I deficiency, nuclear type 10	OMIM:618233
859	0.4952	Spastic paraplegia 75, autosomal recessive	OMIM:616680
859	0.4952	?Myasthenic syndrome, congenital, 17	OMIM:616304
861	0.4949	Dysautonomia, familial	OMIM:223900
862	0.4948	Spinocerebellar ataxia, autosomal recessive 20	OMIM:616354
862	0.4948	Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome	ORPHA:397709
864	0.4947	Carnitine-acylcarnitine translocase deficiency	OMIM:212138
865	0.4943	PMM2-CDG	ORPHA:79318
866	0.494	Charcot-Marie-Tooth disease, axonal, type 2K	OMIM:607831
866	0.494	?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K	OMIM:607831
866	0.494	Brown-Vialetto-Van Laere syndrome 2	OMIM:614707
869	0.4939	Dimethylglycine dehydrogenase deficiency	OMIM:605850
870	0.4938	Congenital disorder of glycosylation, type Ie	OMIM:608799
870	0.4938	Mitochondrial complex V (ATP synthase) deficiency	OMIM:618120
872	0.4936	Striatonigral degeneration, childhood-onset	OMIM:617054
873	0.4933	?Myopathy, isolated mitochondrial, autosomal dominant	OMIM:616209
874	0.4932	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	OMIM:607706
875	0.493	Autosomal recessive centronuclear myopathy	ORPHA:169186
875	0.493	Autosomal recessive centronuclear myopathy	ORPHA:169186
875	0.493	Autosomal recessive centronuclear myopathy	ORPHA:169186
875	0.493	Autosomal recessive centronuclear myopathy	ORPHA:169186
879	0.4929	Agenesis of the corpus callosum with peripheral neuropathy	OMIM:218000
879	0.4929	Deafness-enamel hypoplasia-nail defects syndrome	ORPHA:3220
879	0.4929	Deafness-enamel hypoplasia-nail defects syndrome	ORPHA:3220
879	0.4929	Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation	ORPHA:289266
883	0.4928	Congenital myopathy 2B, severe infantile, autosomal recessive	OMIM:620265
884	0.4927	Adenosine monophosphate deaminase deficiency	ORPHA:45
884	0.4927	Congenital disorder of glycosylation, type It	OMIM:614921
884	0.4927	Adenosine monophosphate deaminase deficiency	ORPHA:45
887	0.4925	Spinal muscular atrophy, lower extremity-predominant 1, AD	OMIM:158600
888	0.4924	Spinal muscular atrophy-1	OMIM:253300
888	0.4924	Perrault syndrome 1	OMIM:233400
888	0.4924	Brown-Vialetto-Van Laere syndrome 1	OMIM:211530
891	0.4922	Roussy-Lévy syndrome	ORPHA:3115
891	0.4922	Roussy-Lévy syndrome	ORPHA:3115
891	0.4922	Carnitine palmitoyl transferase II deficiency, severe infantile form	ORPHA:228305
894	0.4921	Congenital myopathy 19	OMIM:618578
894	0.4921	Mitochondrial complex III deficiency, nuclear type 10	OMIM:618775
894	0.4921	Congenital disorder of glycosylation, type IIk	OMIM:614727
897	0.4916	Nemaline myopathy 7, autosomal recessive	OMIM:610687
897	0.4916	Charcot-Marie-Tooth disease, type 4B3	OMIM:615284
899	0.4915	Charcot-Marie-Tooth disease type 4C	ORPHA:99949
900	0.4912	Dentatorubral pallidoluysian atrophy	ORPHA:101
901	0.4911	Mitochondrial myopathy and sideroblastic anemia	ORPHA:2598
901	0.4911	Mitochondrial myopathy and sideroblastic anemia	ORPHA:2598
903	0.4908	Charcot-Marie-Tooth disease, axonal, type 2U	OMIM:616280
904	0.4906	Congenital myopathy 2C, severe infantile, autosomal dominant	OMIM:620278
904	0.4906	?De Sanctis-Cacchione syndrome	OMIM:278800
904	0.4906	?De Sanctis-Cacchione syndrome	OMIM:278800
907	0.4905	Spinal muscular atrophy with congenital bone fractures 2	OMIM:616867
908	0.4904	Carnitine palmitoyl transferase II deficiency, myopathic form	ORPHA:228302
909	0.4901	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	OMIM:271245
910	0.4899	Myopathy, distal, with anterior tibial onset	OMIM:606768
910	0.4899	King-Denborough syndrome	OMIM:619542
910	0.4899	Muscular dystrophy-dystroglycanopathy (congenital without impaired intellectual development), type B, 4	OMIM:613152
910	0.4899	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9	OMIM:616538
910	0.4899	Rhabdomyolysis, susceptibility to, 1	OMIM:620235
910	0.4899	Congenital muscular dystrophy with intellectual disability and severe epilepsy	ORPHA:329178
910	0.4899	Ataxia with vitamin E deficiency	ORPHA:96
910	0.4899	Dimethylglycine dehydrogenase deficiency	ORPHA:243343
918	0.4898	Autosomal recessive ataxia, Beauce type	ORPHA:88644
919	0.4896	Spastic paraplegia-optic atrophy-neuropathy syndrome	ORPHA:320406
919	0.4896	Spastic paraplegia-optic atrophy-neuropathy syndrome	ORPHA:320406
921	0.4895	Autosomal recessive spastic paraplegia type 75	ORPHA:459056
922	0.4894	Intellectual developmental disorder, autosomal recessive 5	OMIM:611091
922	0.4894	Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	OMIM:612300
924	0.4893	Muscle-eye-brain disease with bilateral multicystic leucodystrophy	ORPHA:370997
925	0.4892	Hypomyelinating neuropathy, congenital, 1	OMIM:605253
925	0.4892	Charcot-Marie-Tooth disease, dominant intermediate C	OMIM:608323
925	0.4892	Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome	OMIM:619518
928	0.489	Adult-onset autosomal recessive cerebellar ataxia	ORPHA:284289
929	0.4889	Acute inflammatory demyelinating polyradiculoneuropathy	ORPHA:98916
929	0.4889	Spinocerebellar ataxia, autosomal recessive 2	OMIM:213200
931	0.4888	Combined oxidative phosphorylation deficiency 7	OMIM:613559
932	0.4887	Progressive supranuclear palsy-parkinsonism syndrome	ORPHA:240085
933	0.4886	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	OMIM:255100
933	0.4886	Dworschak-Punetha neurodevelopmental syndrome	OMIM:619955
935	0.4885	Spinocerebellar ataxia 19	OMIM:607346
936	0.4883	Acyl-CoA dehydrogenase 9 deficiency	ORPHA:99901
937	0.4882	Spinal muscular atrophy with congenital bone fractures 1	OMIM:616866
938	0.488	Ataxia, posterior column, with retinitis pigmentosa	OMIM:609033
939	0.4879	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	OMIM:256040
940	0.4878	Severe X-linked mitochondrial encephalomyopathy	ORPHA:238329
941	0.4876	Peroxisome biogenesis disorder 3B	OMIM:266510
942	0.4875	Lipodystrophy, familial partial, type 2	OMIM:151660
942	0.4875	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	OMIM:608030
944	0.4872	Emery-Dreifuss muscular dystrophy 1, X-linked	OMIM:310300
944	0.4872	Facioscapulohumeral dystrophy	ORPHA:269
944	0.4872	Facioscapulohumeral dystrophy	ORPHA:269
944	0.4872	Facioscapulohumeral dystrophy	ORPHA:269
948	0.487	Multiple mitochondrial dysfunctions syndrome 5	OMIM:617613
949	0.4869	Short stature-micrognathia syndrome	OMIM:617164
950	0.4867	Myopathy, myofibrillar, 5	OMIM:609524
950	0.4867	Mevalonic aciduria	OMIM:610377
952	0.4865	X-linked Charcot-Marie-Tooth disease type 4	ORPHA:101078
952	0.4865	Beta-ketothiolase deficiency	ORPHA:134
952	0.4865	Charcot-Marie-Tooth disease, axonal, type 2X	OMIM:616668
955	0.4863	Spinocerebellar ataxia 34	OMIM:133190
956	0.4862	Classic progressive supranuclear palsy syndrome	ORPHA:240071
957	0.4861	3-hydroxy-3-methylglutaric aciduria	ORPHA:20
958	0.4859	Congenital myopathy 18 due to dihydropyridine receptor defect	OMIM:620246
959	0.4856	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
959	0.4856	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
959	0.4856	Developmental and epileptic encephalopathy 80	OMIM:618580
959	0.4856	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
959	0.4856	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
959	0.4856	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
965	0.4851	Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	ORPHA:329336
965	0.4851	Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	ORPHA:329336
965	0.4851	Wieacker-Wolff syndrome	OMIM:314580
968	0.4847	Neuropathy, hereditary sensory and autonomic, type II	OMIM:201300
969	0.4844	Microcephaly, growth restriction, and increased sister chromatid exchange 2	OMIM:618097
970	0.4842	Kufor-Rakeb syndrome	OMIM:606693
971	0.4838	Pseudohypoparathyroidism type 1A	ORPHA:79443
972	0.4837	Neuronopathy, distal hereditary motor, type IIB	OMIM:608634
972	0.4837	Glycogen storage disease due to aldolase A deficiency	ORPHA:57
972	0.4837	Neurodevelopmental disorder with central and peripheral motor dysfunction	OMIM:618356
975	0.4835	Spinocerebellar ataxia type 31	ORPHA:217012
976	0.4832	Smith-Magenis syndrome	OMIM:182290
977	0.4831	Congenital myopathy 24	OMIM:617336
978	0.483	Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome	ORPHA:254343
979	0.4829	Amyotrophic lateral sclerosis 2, juvenile	OMIM:205100
980	0.4827	Spinal muscular atrophy, distal, autosomal recessive, 5	OMIM:614881
981	0.4826	Combined oxidative phosphorylation deficiency 11	OMIM:614922
982	0.4822	Myasthenic syndrome, congenital, 25	OMIM:618323
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Trichothiodystrophy	ORPHA:33364
983	0.4819	Lissencephaly 8	OMIM:617255
993	0.4818	Spinocerebellar ataxia 21	OMIM:607454
994	0.4815	Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome	OMIM:614575
995	0.4812	Succinic semialdehyde dehydrogenase deficiency	OMIM:271980
996	0.4811	Spinocerebellar ataxia type 2	ORPHA:98756
997	0.481	Congenital myopathy 21 with early respiratory failure	OMIM:620326
997	0.481	Autosomal dominant Charcot-Marie-Tooth disease type 2A2	ORPHA:99947
999	0.4808	Spinocerebellar ataxia type 19/22	ORPHA:98772
1000	0.4804	46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome	ORPHA:168563
1001	0.4802	Autosomal recessive spastic paraplegia type 9B	ORPHA:447760
1002	0.48	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
1002	0.48	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
1002	0.48	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
1002	0.48	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
1006	0.4797	Neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities	OMIM:619383
1007	0.4795	Native American myopathy	ORPHA:168572
1008	0.4793	Glycine encephalopathy1	OMIM:605899
1009	0.479	Abetalipoproteinemia	ORPHA:14
1010	0.4789	Pseudohypoparathyroidism type 1B	ORPHA:94089
1010	0.4789	Pseudohypoparathyroidism type 1B	ORPHA:94089
1010	0.4789	Pseudohypoparathyroidism type 1C	ORPHA:79444
1013	0.4786	CNTNAP2-related developmental and epileptic encephalopathy	ORPHA:163681
1014	0.4783	Spinal muscular atrophy-4	OMIM:271150
1015	0.4782	TRIM32-related limb-girdle muscular dystrophy R8	ORPHA:1878
1015	0.4782	X-linked intellectual disability, Hedera type	ORPHA:93952
1017	0.4781	Charcot-Marie-Tooth disease, demyelinating, type 1G	OMIM:618279
1018	0.478	PPARG-related familial partial lipodystrophy	ORPHA:79083
1019	0.4778	Spinocerebellar ataxia, autosomal recessive 15	OMIM:615705
1020	0.4775	3-methylglutaconic aciduria, type IX	OMIM:617698
1021	0.4774	Hypotonia, infantile, with psychomotor retardation and characteristic facies 3	OMIM:616900
1022	0.4773	Neurodevelopmental disorder with poor growth and behavioral abnormalities	OMIM:620242
1023	0.4768	Developmental delay with hypotonia, myopathy, and brain abnormalities	OMIM:620240
1024	0.4767	Congenital disorder of glycosylation, type Iu	OMIM:615042
1025	0.4763	Spinocerebellar ataxia, autosomal recessive 12	OMIM:614322
1026	0.4761	Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2	OMIM:610185
1027	0.4757	Krabbe disease, atypical	OMIM:611722
1028	0.4747	Infantile cerebellar-retinal degeneration	OMIM:614559
1029	0.474	Orthostatic hypotension 1, due to DBH deficiency	OMIM:223360
1030	0.4739	Pitt-Hopkins like syndrome 1	OMIM:610042
1031	0.4738	?Spinal muscular atrophy, distal, autosomal recessive, 2	OMIM:605726
1032	0.4736	Spastic ataxia, Charlevoix-Saguenay type	OMIM:270550
1032	0.4736	Desminopathy	ORPHA:98909
1034	0.4735	Peroxisome biogenesis disorder 5B	OMIM:614867
1035	0.4732	Fragile X tremor/ataxia syndrome	OMIM:300623
1036	0.4731	Intellectual disability, Birk-Barel type	ORPHA:166108
1037	0.4727	Charcot-Marie-Tooth disease, demyelinating, type 1I	OMIM:619742
1037	0.4727	?Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1	OMIM:607250
1039	0.4725	Charcot-Marie-Tooth disease, axonal, type 2HH	OMIM:619574
1040	0.4724	Giant axonal neuropathy	ORPHA:643
1041	0.4722	Autosomal recessive spastic paraplegia type 43	ORPHA:320370
1042	0.472	DPM1-CDG	ORPHA:79322
1042	0.472	Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome	ORPHA:370022
1044	0.4719	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant	OMIM:619092
1045	0.4717	Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome	ORPHA:330054
1046	0.4713	Sulfite oxidase deficiency	OMIM:272300
1046	0.4713	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	OMIM:617710
1046	0.4713	Neuropathy, hereditary motor and sensory, type VIC, with optic atrophy	OMIM:618511
1049	0.4712	Ataxia, sensory, 1, autosomal dominant	OMIM:608984
1050	0.4711	WARS2-related combined oxidative phosphorylation defect	ORPHA:572798
1051	0.4708	Neurodevelopmental disorder with or without hypotonia, seizures, and cerebellar atrophy	OMIM:616917
1052	0.4707	Prader-Willi syndrome due to translocation	ORPHA:177907
1053	0.4704	Developmental and epileptic encephalopathy 100	OMIM:619777
1054	0.4702	Brain small vessel disease with or without ocular anomalies	OMIM:175780
1055	0.4698	Mitochondrial complex III deficiency, nuclear type 2	OMIM:615157
1056	0.4696	Autosomal recessive spastic ataxia of Charlevoix-Saguenay	ORPHA:98
1056	0.4696	Neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia	OMIM:618292
1058	0.4695	Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	OMIM:613752
1059	0.4691	?Charcot-Marie-Tooth disease, X-linked dominant, 6	OMIM:300905
1060	0.4686	?Centronuclear myopathy 4	OMIM:614807
1061	0.4685	Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency	ORPHA:71212
1061	0.4685	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	OMIM:616007
1063	0.4683	Pontocerebellar hypoplasia type 1A	OMIM:607596
1064	0.4679	Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency	ORPHA:1900
1065	0.4678	Smith-Magenis syndrome	ORPHA:819
1065	0.4678	Smith-Magenis syndrome	ORPHA:819
1065	0.4678	Smith-Magenis syndrome	ORPHA:819
1065	0.4678	Smith-Magenis syndrome	ORPHA:819
1069	0.4673	Familial partial lipodystrophy, Dunnigan type	ORPHA:2348
1069	0.4673	Lipodystrophy, familial partial, type 4	OMIM:613877
1071	0.4672	Congenital disorder of glycosylation, type IIf	OMIM:603585
1072	0.467	?Mitochondrial complex IV deficiency, nuclear type 15	OMIM:619059
1072	0.467	Familial dysautonomia	ORPHA:1764
1074	0.4668	X-linked progressive cerebellar ataxia	ORPHA:1175
1075	0.4666	Bartter syndrome, type 4b, digenic	OMIM:613090
1075	0.4666	Bartter syndrome, type 4b, digenic	OMIM:613090
1075	0.4666	Sensorineural deafness with mild renal dysfunction	OMIM:602522
1078	0.4665	Allan-Herndon-Dudley syndrome	ORPHA:59
1079	0.4662	Lethal ataxia with deafness and optic atrophy	ORPHA:1187
1080	0.4661	Hereditary continuous muscle fiber activity	ORPHA:972
1080	0.4661	Mitochondrial trifunctional protein deficiency 2	OMIM:620300
1080	0.4661	Congenital disorder of glycosylation, type IIh	OMIM:611182
1080	0.4661	Congenital bile acid synthesis defect type 4	ORPHA:79095
1084	0.4659	PMP22-RAI1 contiguous gene duplication syndrome	ORPHA:477817
1085	0.4655	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked	OMIM:301056
1086	0.4653	Pelizaeus-Merzbacher disease	OMIM:312080
1087	0.4652	Pontocerebellar hypoplasia, type 2F	OMIM:617026
1088	0.4649	Congenital arthrogryposis with anterior horn cell disease	OMIM:611890
1089	0.4647	Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome	ORPHA:504476
1090	0.4643	Developmental and epileptic encephalopathy 109	OMIM:620145
1091	0.4642	Combined oxidative phosphorylation deficiency 52	OMIM:619386
1092	0.464	Charcot-Marie-Tooth disease, type 2R	OMIM:615490
1093	0.4637	CAPOS syndrome	OMIM:601338
1093	0.4637	Parkes Weber syndrome	ORPHA:90307
1095	0.4636	Charcot-Marie-Tooth disease, X-linked recessive, 5	OMIM:311070
1096	0.4635	Pontocerebellar hypoplasia, type 1B	OMIM:614678
1097	0.4633	CPT II deficiency, lethal neonatal	OMIM:608836
1097	0.4633	?Spastic ataxia 4, autosomal recessive	OMIM:613672
1099	0.4631	Carnitine palmitoyl transferase II deficiency, neonatal form	ORPHA:228308
1100	0.463	Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome	ORPHA:2072
1101	0.4629	Pyruvate dehydrogenase E1-beta deficiency	OMIM:614111
1102	0.4628	Friedreich ataxia	ORPHA:95
1103	0.4626	Charcot-Marie-Tooth disease type 4B2	ORPHA:99956
1104	0.4625	Xeroderma pigmentosum, group D	OMIM:278730
1104	0.4625	Spinocerebellar ataxia 36	OMIM:614153
1104	0.4625	Xeroderma pigmentosum, group A	OMIM:278700
1107	0.4623	Pancreatic and cerebellar agenesis	OMIM:609069
1108	0.4622	Osteosclerotic metaphyseal dysplasia	OMIM:615198
1109	0.4621	Adult-onset dystonia-parkinsonism	ORPHA:199351
1109	0.4621	Immunodeficiency 23	OMIM:615816
1111	0.462	Dopamine beta-hydroxylase deficiency	ORPHA:230
1112	0.4618	Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency	ORPHA:284282
1112	0.4618	Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency	ORPHA:404499
1114	0.4617	Very long chain acyl-CoA dehydrogenase deficiency	ORPHA:26793
1114	0.4617	Vici syndrome	OMIM:242840
1116	0.4615	Charcot-Marie-Tooth disease, axonal, type 2W	OMIM:616625
1117	0.4613	Multiple congenital anomalies-hypotonia-seizures syndrome 1	OMIM:614080
1117	0.4613	?Neuronopathy, distal hereditary motor, type IIC	OMIM:613376
1119	0.4609	Arnold-Chiari malformation type I	ORPHA:268882
1120	0.4607	Lethal congenital contracture syndrome 7	OMIM:616286
1120	0.4607	Spinocerebellar ataxia type 34	ORPHA:1955
1120	0.4607	Neuropathy, hereditary sensory and autonomic, type IIB	OMIM:613115
1123	0.4598	Autosomal dominant Charcot-Marie-Tooth disease type 2F	ORPHA:99940
1124	0.4596	Myasthenic syndrome, congenital, 20, presynaptic	OMIM:617143
1125	0.4593	Congenital multicore myopathy with external ophthalmoplegia	ORPHA:98905
1125	0.4593	Gerstmann-Straussler disease	OMIM:137440
1127	0.4592	?Spinocerebellar ataxia, autosomal recessive 26	OMIM:617633
1128	0.4591	Infantile neuroaxonal dystrophy 1	OMIM:256600
1129	0.459	Autosomal recessive spastic paraplegia type 62	ORPHA:401785
1130	0.4588	Spastic ataxia 1, autosomal dominant	OMIM:108600
1131	0.4587	Arts syndrome	OMIM:301835
1132	0.4582	Developmental delay with or without intellectual impairment or behavioral abnormalities	OMIM:619575
1133	0.4581	Lethal congenital contracture syndrome 8	OMIM:616287
1134	0.4574	Sandhoff disease, infantile, juvenile, and adult forms	OMIM:268800
1135	0.457	Mitochondrial complex IV deficiency, nuclear type 22	OMIM:619355
1136	0.4567	Silver spastic paraplegia syndrome	OMIM:270685
1137	0.4565	Gerstmann-Straussler-Scheinker syndrome	ORPHA:356
1138	0.4561	Pontocerebellar hypoplasia, type 1C	OMIM:616081
1139	0.4558	Spinocerebellar ataxia, autosomal recessive 4	OMIM:607317
1140	0.4555	Neuronopathy, distal hereditary motor, type VA	OMIM:600794
1141	0.4554	Charcot-Marie-Tooth disease, type 4K	OMIM:616684
1141	0.4554	Spastic paraplegia 9A, autosomal dominant	OMIM:601162
1143	0.4553	Early-onset epilepsy-intellectual disability-brain anomalies syndrome	ORPHA:488635
1144	0.4548	Spastic paraplegia 42, autosomal dominant	OMIM:612539
1145	0.4546	Pontocerebellar hypoplasia, type 7	OMIM:614969
1146	0.4543	Sialidosis, type II	OMIM:256550
1147	0.4542	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	OMIM:213980
1148	0.454	Myopathy, centronuclear, X-linked	OMIM:310400
1149	0.4539	Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities, autosomal recessive	OMIM:619091
1150	0.4537	Oculocerebrorenal syndrome of Lowe	ORPHA:534
1151	0.4529	Autosomal dominant spastic paraplegia type 17	ORPHA:100998
1152	0.4528	Cockayne syndrome type 3	ORPHA:90324
1152	0.4528	Cockayne syndrome type 3	ORPHA:90324
1152	0.4528	Cockayne syndrome type 3	ORPHA:90324
1155	0.4525	DPAGT1-CDG	ORPHA:86309
1156	0.4524	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects	OMIM:620007
1157	0.4519	Focal segmental glomerulosclerosis and neurodevelopmental syndrome	OMIM:619428
1158	0.4516	Microhydranencephaly	OMIM:605013
1158	0.4516	Autosomal dominant optic atrophy and cataract	ORPHA:67036
1160	0.4513	Amyotrophic lateral sclerosis 1	OMIM:105400
1160	0.4513	?Amyotrophic lateral sclerosis, susceptibility to	OMIM:105400
1160	0.4513	Amyotrophic lateral sclerosis, susceptibility to	OMIM:105400
1160	0.4513	Juvenile primary lateral sclerosis	ORPHA:247604
1160	0.4513	Amyotrophic lateral sclerosis, susceptibility to	OMIM:105400
1160	0.4513	Juvenile primary lateral sclerosis	ORPHA:247604
1166	0.451	Nemaline myopathy 10	OMIM:616165
1167	0.4509	Autosomal recessive spastic paraplegia type 55	ORPHA:320375
1167	0.4509	Amyotrophic lateral sclerosis 5, juvenile	OMIM:602099
1169	0.4504	Combined oxidative phosphorylation deficiency 54	OMIM:619737
1170	0.4503	Amyotrophic lateral sclerosis 4, juvenile	OMIM:602433
1171	0.4502	Spinocerebellar ataxia type 14	ORPHA:98763
1172	0.4501	Myofibrillar myopathy 11	OMIM:619178
1173	0.4499	Combined oxidative phosphorylation deficiency 40	OMIM:618835
1173	0.4499	Combined oxidative phosphorylation deficiency 42	OMIM:618839
1175	0.4495	Congenital disorder of glycosylation, type IIl	OMIM:614576
1176	0.4494	Charcot-Marie-Tooth disease, demyelinating, type 1H	OMIM:619764
1176	0.4494	Adult-onset autosomal dominant leukodystrophy	ORPHA:99027
1178	0.4493	Autosomal spastic paraplegia type 18	ORPHA:209951
1179	0.4489	Frontotemporal lobar degeneration, TARDBP-related	OMIM:612069
1179	0.4489	Carnitine palmitoyl transferase 1A deficiency	ORPHA:156
1181	0.4481	?Spastic ataxia 9, autosomal recessive	OMIM:618438
1182	0.4478	Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome	ORPHA:313772
1182	0.4478	Combined oxidative phosphorylation deficiency 33	OMIM:617713
1182	0.4478	?Combined oxidative phosphorylation deficiency 43	OMIM:618851
1185	0.4476	Spastic paraplegia 11, autosomal recessive	OMIM:604360
1186	0.4475	Autosomal recessive spastic paraplegia type 76	ORPHA:488594
1187	0.4474	Mitochondrial complex I deficiency, nuclear type 17	OMIM:618239
1188	0.4472	Autosomal dominant Charcot-Marie-Tooth disease type 2W	ORPHA:488333
1189	0.4471	Spastic paraplegia 76, autosomal recessive	OMIM:616907
1190	0.447	Malignant hyperthermia susceptibility 1	OMIM:145600
1191	0.4469	Combined oxidative phosphorylation defect type 39	ORPHA:565624
1192	0.4467	Combined oxidative phosphorylation deficiency 44	OMIM:618855
1193	0.4462	Intellectual developmental disorder, X-linked syndromic, Hedera type	OMIM:300423
1194	0.4461	?Spastic paraplegia 73, autosomal dominant	OMIM:616282
1195	0.4455	Wiedemann-Rautenstrauch syndrome	OMIM:264090
1196	0.4454	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
1196	0.4454	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
1196	0.4454	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
1196	0.4454	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
1196	0.4454	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
1196	0.4454	Hoyeraal-Hreidarsson syndrome	ORPHA:3322
1202	0.4453	Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome	ORPHA:1171
1203	0.4452	Neurodegeneration, childhood-onset, with cerebellar atrophy	OMIM:618276
1204	0.4449	Autosomal dominant optic atrophy, classic form	ORPHA:98673
1204	0.4449	Autosomal dominant optic atrophy, classic form	ORPHA:98673
1204	0.4449	Lysinuric protein intolerance	OMIM:222700
1207	0.4446	Ataxia-oculomotor apraxia 4	OMIM:616267
1208	0.4442	Spastic paraplegia 31, autosomal dominant	OMIM:610250
1208	0.4442	Neurodevelopmental disorder with variable motor and speech impairment	OMIM:617804
1208	0.4442	Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features	OMIM:617865
1211	0.4441	Charcot-Marie-Tooth disease, type 4C	OMIM:601596
1212	0.4439	Dilated cardiomyopathy with ataxia	ORPHA:66634
1213	0.4436	CPT II deficiency, infantile	OMIM:600649
1214	0.4435	?Spastic paraplegia 57, autosomal recessive	OMIM:615658
1214	0.4435	Spastic paraplegia 18, autosomal recessive	OMIM:611225
1216	0.4433	CEDNIK syndrome	ORPHA:66631
1216	0.4433	Peroxisome biogenesis disorder 14B	OMIM:614920
1218	0.4426	Deafness, X-linked 5	OMIM:300614
1219	0.4421	Ataxia-telangiectasia-like disorder	ORPHA:251347
1220	0.442	Gitelman syndrome	OMIM:263800
1220	0.442	Pontocerebellar hypoplasia, type 17	OMIM:619909
1222	0.4418	DOORS syndrome	ORPHA:79500
1222	0.4418	DOORS syndrome	ORPHA:79500
1224	0.4413	Phelan-McDermid syndrome	OMIM:606232
1224	0.4413	Developmental and epileptic encephalopathy 48	OMIM:617276
1226	0.4412	?Neurodevelopmental disorder with midbrain and hindbrain malformations	OMIM:617523
1226	0.4412	Autosomal recessive spastic paraplegia type 20	ORPHA:101000
1228	0.4411	?Myasthenic syndrome, congenital, 18	OMIM:616330
1229	0.4409	Osteopetrosis with renal tubular acidosis	ORPHA:2785
1230	0.4404	Peripheral motor neuropathy, childhood-onset, biotin-responsive	OMIM:619903
1231	0.44	COG8-CDG	ORPHA:95428
1231	0.44	?Combined oxidative phosphorylation deficiency 41	OMIM:618838
1233	0.4397	Myhre syndrome	ORPHA:2588
1233	0.4397	Leri-Weill dyschondrosteosis	OMIM:127300
1233	0.4397	SHOX-related short stature	ORPHA:314795
1233	0.4397	Spastic paraplegia 62	OMIM:615681
1233	0.4397	Congenital disorder of glycosylation, type Iw, autosomal dominant	OMIM:619714
1238	0.4388	Fucosidosis	OMIM:230000
1239	0.4385	Charcot-Marie-Tooth disease, demyelinating, type 1J	OMIM:620111
1240	0.4382	Sandhoff disease, juvenile form	ORPHA:309162
1241	0.4378	Hyperphosphatasia with impaired intellectual development syndrome 6	OMIM:616809
1242	0.4372	Spastic paraplegia, optic atrophy, and neuropathy	OMIM:609541
1243	0.437	Camurati-Engelmann disease	ORPHA:1328
1243	0.437	Birk-Landau-Perez syndrome	OMIM:617595
1245	0.4365	Dent disease 2	OMIM:300555
1245	0.4365	Mitochondrial complex II deficiency, nuclear type 1	OMIM:252011
1245	0.4365	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	OMIM:609528
1245	0.4365	Congenital myopathy 9B, proximal, with minicore lesions	OMIM:618823
1245	0.4365	Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect	OMIM:617468
1250	0.4364	B4GALT1-CDG	ORPHA:79332
1251	0.4362	Sialidosis type 1	ORPHA:812
1251	0.4362	Ataxia-telangiectasia	OMIM:208900
1253	0.4361	Developmental and epileptic encephalopathy 53	OMIM:617389
1253	0.4361	MPDU1-CDG	ORPHA:79323
1255	0.436	Ataxia with isolated vitamin E deficiency	OMIM:277460
1256	0.4359	Bannayan-Riley-Ruvalcaba syndrome	ORPHA:109
1257	0.4356	Cushing disease	ORPHA:96253
1257	0.4356	Cushing disease	ORPHA:96253
1257	0.4356	Cushing disease	ORPHA:96253
1257	0.4356	Cushing disease	ORPHA:96253
1257	0.4356	Troyer syndrome	OMIM:275900
1257	0.4356	Cushing disease	ORPHA:96253
1257	0.4356	Cushing disease	ORPHA:96253
1257	0.4356	Cushing disease	ORPHA:96253
1265	0.4353	Glycogen storage disease X	OMIM:261670
1266	0.4352	Congenital myopathy 3 with rigid spine	OMIM:602771
1267	0.4348	Chédiak-Higashi syndrome	ORPHA:167
1268	0.4345	Spastic paraplegia 2, X-linked	OMIM:312920
1269	0.434	Spastic paraplegia 5A, autosomal recessive	OMIM:270800
1270	0.4339	Salt and pepper developmental regression syndrome	OMIM:609056
1271	0.4338	Myasthenic syndrome, congenital, 1A, slow-channel	OMIM:601462
1271	0.4338	Combined oxidative phosphorylation deficiency 37	OMIM:618329
1273	0.4337	Kearns-Sayre syndrome	ORPHA:480
1273	0.4337	Kearns-Sayre syndrome	ORPHA:480
1275	0.4332	Familial or sporadic hemiplegic migraine	ORPHA:569
1275	0.4332	Familial or sporadic hemiplegic migraine	ORPHA:569
1275	0.4332	Familial or sporadic hemiplegic migraine	ORPHA:569
1275	0.4332	Familial or sporadic hemiplegic migraine	ORPHA:569
1279	0.4329	Congenital myopathy 4B, autosomal recessive	OMIM:609284
1279	0.4329	Spastic paraplegia 15, autosomal recessive	OMIM:270700
1279	0.4329	Inherited Creutzfeldt-Jakob disease	ORPHA:282166
1282	0.4322	Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency	ORPHA:284426
1282	0.4322	Myasthenic syndrome, congenital, 2A, slow-channel	OMIM:616313
1284	0.4318	Hereditary sensory and autonomic neuropathy type 1	ORPHA:36386
1284	0.4318	Hereditary sensory and autonomic neuropathy type 1	ORPHA:36386
1284	0.4318	Hereditary sensory and autonomic neuropathy type 1	ORPHA:36386
1284	0.4318	Hereditary sensory and autonomic neuropathy type 1	ORPHA:36386
1288	0.4316	Distal hereditary motor neuropathy type 5	ORPHA:139536
1288	0.4316	Distal hereditary motor neuropathy type 5	ORPHA:139536
1288	0.4316	Machado-Joseph disease	OMIM:109150
1288	0.4316	Distal hereditary motor neuropathy type 5	ORPHA:139536
1292	0.4315	Classic multiminicore myopathy	ORPHA:324604
1292	0.4315	Classic multiminicore myopathy	ORPHA:324604
1292	0.4315	Classic multiminicore myopathy	ORPHA:324604
1292	0.4315	3-methylglutaconic aciduria type 9	ORPHA:505216
1296	0.4313	Hereditary neuropathy with liability to pressure palsies	ORPHA:640
1296	0.4313	Arthrogryposis, distal, type 5	OMIM:108145
1296	0.4313	Cortical dysplasia, complex, with other brain malformations 13	OMIM:614563
1296	0.4313	Developmental and epileptic encephalopathy 18	OMIM:615476
1296	0.4313	DOORS syndrome	OMIM:220500
1296	0.4313	46XY gonadal dysgenesis with minifascicular neuropathy	OMIM:607080
1296	0.4313	?Pontocerebellar hypoplasia, type 1F	OMIM:619304
1296	0.4313	Sudden infant death-dysgenesis of the testes syndrome	ORPHA:168593
1296	0.4313	Cerebellar atrophy, visual impairment, and psychomotor retardation	OMIM:616875
1296	0.4313	Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome	ORPHA:480898
1296	0.4313	Short-rib thoracic dysplasia 14 with polydactyly	OMIM:616546
1296	0.4313	Neuropathy, hereditary sensory and autonomic, type VIII	OMIM:616488
1296	0.4313	Insensitivity to pain, congenital	OMIM:243000
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	X-linked Charcot-Marie-Tooth disease type 1	ORPHA:101075
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Centronuclear myopathy 6 with fiber-type disproportion	OMIM:617760
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Spastic paraplegia 9B, autosomal recessive	OMIM:616586
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1309	0.4311	Amyotrophic lateral sclerosis	ORPHA:803
1349	0.4307	Frontotemporal dementia and/or amyotrophic lateral sclerosis 1	OMIM:105550
1349	0.4307	Pontocerebellar hypoplasia type 7	ORPHA:284339
1349	0.4307	Pontocerebellar hypoplasia type 7	ORPHA:284339
1352	0.4306	Oculodentodigital dysplasia	ORPHA:2710
1352	0.4306	Mitochondrial complex III deficiency, nuclear type 1	OMIM:124000
1352	0.4306	Dihydropyrimidine dehydrogenase deficiency	ORPHA:1675
1355	0.4304	Autosomal dominant spastic paraplegia type 12	ORPHA:100993
1355	0.4304	Autosomal dominant spastic paraplegia type 12	ORPHA:100993
1355	0.4304	Jaberi-Elahi syndrome	OMIM:617988
1358	0.4301	Spinocerebellar ataxia 5	OMIM:600224
1359	0.43	Autosomal recessive ataxia due to ubiquinone deficiency	ORPHA:139485
1360	0.4297	Leukodystrophy, hypomyelinating, 9	OMIM:616140
1361	0.4296	Spinocerebellar ataxia type 7	ORPHA:94147
1361	0.4296	Nijmegen breakage syndrome	ORPHA:647
1361	0.4296	Intellectual developmental disorder, X-linked 108	OMIM:301024
1364	0.4292	Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus	OMIM:619653
1364	0.4292	Osteopetrosis, autosomal recessive 5	OMIM:259720
1366	0.429	Infantile multisystem neurologic-endocrine-pancreatic disease	ORPHA:456312
1366	0.429	Huntington disease	ORPHA:399
1366	0.429	Achalasia-addisonianism-alacrimia syndrome	OMIM:231550
1366	0.429	Huntington disease	ORPHA:399
1370	0.4289	Spastic paraplegia 55, autosomal recessive	OMIM:615035
1371	0.4285	Neurodevelopmental disorder with spasticity and poor growth	OMIM:618076
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Oculopharyngeal muscular dystrophy	ORPHA:270
1372	0.4282	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	OMIM:611773
1372	0.4282	Cardiomyopathy, dilated, 1L	OMIM:606685
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Myopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related	OMIM:613869
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Cardiomyopathy, dilated, 1II	OMIM:615184
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Cardiomyopathy, dilated, 1I	OMIM:604765
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11	OMIM:615181
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	OMIM:615287
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3	OMIM:613151
1372	0.4282	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	OMIM:236670
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Epidermolysis bullosa simplex with pyloric atresia	ORPHA:158684
1372	0.4282	Muscle-eye-brain disease	ORPHA:588
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Sulfide:quinone oxidoreductase deficiency	OMIM:619221
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Epidermolysis bullosa simplex with pyloric atresia	ORPHA:158684
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Vacuolar myopathy with sarcoplasmic reticulum protein aggregates	ORPHA:88635
1372	0.4282	Glycogen storage disease XIII	OMIM:612932
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Nivelon-Nivelon-Mabille syndrome	OMIM:600092
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Poikiloderma with neutropenia	OMIM:604173
1372	0.4282	Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis	OMIM:618331
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Congenital disorder of glycosylation, type IId	OMIM:607091
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1372	0.4282	Familial isolated dilated cardiomyopathy	ORPHA:154
1451	0.4277	Amyotrophic lateral sclerosis type 4	ORPHA:357043
1452	0.4275	2,4-dienoyl-CoA reductase deficiency	OMIM:616034
1453	0.4274	Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction	OMIM:620089
1454	0.4273	Alpha-N-acetylgalactosaminidase deficiency type 1	ORPHA:79279
1455	0.4272	Autosomal dominant spastic paraplegia type 9A	ORPHA:447753
1455	0.4272	Autosomal dominant spastic paraplegia type 9A	ORPHA:447753
1457	0.4269	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
1457	0.4269	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
1459	0.4265	Neuropathy, hereditary sensory, type IF	OMIM:615632
1460	0.4262	Charcot-Marie-Tooth disease type 4D	ORPHA:99950
1461	0.426	Molybdenum cofactor deficiency C	OMIM:615501
1461	0.426	Chylomicron retention disease	OMIM:246700
1463	0.4258	Neuropathy, hereditary sensory, with spastic paraplegia	OMIM:256840
1464	0.4253	Myasthenic syndrome, congenital, 1B, fast-channel	OMIM:608930
1465	0.4249	Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive	OMIM:619461
1466	0.4247	Autosomal recessive spastic paraplegia type 11	ORPHA:2822
1467	0.4244	Autosomal recessive cerebelloparenchymal disorder type 3	ORPHA:1170
1468	0.4242	Oliver-McFarlane syndrome	OMIM:275400
1469	0.424	Congenital myopathy 22B, severe fetal	OMIM:620369
1470	0.4232	Leukodystrophy, hypomyelinating, 4	OMIM:612233
1471	0.4231	Glycogen storage disease due to phosphoglycerate kinase 1 deficiency	ORPHA:713
1472	0.423	Spastic paraplegia 39, autosomal recessive	OMIM:612020
1473	0.4229	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	OMIM:112250
1474	0.4228	Spastic paraplegia 30, autosomal dominant	OMIM:610357
1475	0.4226	RARS-related autosomal recessive hypomyelinating leukodystrophy	ORPHA:438114
1476	0.4223	Norrie disease	ORPHA:649
1477	0.4222	6-pyruvoyl-tetrahydropterin synthase deficiency	ORPHA:13
1478	0.4221	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	OMIM:614557
1478	0.4221	Lichtenstein-Knorr syndrome	OMIM:616291
1478	0.4221	Classical-like Ehlers-Danlos syndrome type 1	ORPHA:230839
1481	0.4218	Emery-Dreifuss muscular dystrophy 7, AD	OMIM:614302
1482	0.4217	Hyperprolinemia type 2	ORPHA:79101
1483	0.4216	Spastic paraplegia type 2	ORPHA:99015
1484	0.4214	Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency	OMIM:608931
1485	0.4212	Autosomal dominant Charcot-Marie-Tooth disease type 2K	ORPHA:99944
1486	0.4211	Congenital myopathy 20	OMIM:620310
1486	0.4211	Spinocerebellar ataxia type 4	ORPHA:98765
1488	0.421	3-methylglutaconic aciduria, type VIIB, autosomal recessive	OMIM:616271
1489	0.4206	Autosomal spastic paraplegia type 58	ORPHA:397946
1490	0.4204	Alternating hemiplegia of childhood	ORPHA:2131
1490	0.4204	Menkes disease	OMIM:309400
1490	0.4204	Alternating hemiplegia of childhood	ORPHA:2131
1490	0.4204	Alternating hemiplegia of childhood	ORPHA:2131
1490	0.4204	Alternating hemiplegia of childhood	ORPHA:2131
1495	0.4203	MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect	ORPHA:485421
1495	0.4203	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	OMIM:614299
1497	0.4202	Pelizaeus-Merzbacher disease, connatal form	ORPHA:280210
1498	0.4201	Lesch-Nyhan syndrome	OMIM:300322
1498	0.4201	Autosomal dominant spastic paraplegia type 8	ORPHA:100989
1500	0.4198	Neurodevelopmental disorder with epilepsy and hemochromatosis	OMIM:301072
1501	0.4196	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects	OMIM:619576
1502	0.4194	Autosomal dominant spastic paraplegia type 42	ORPHA:171863
1503	0.4193	Peroxisome biogenesis disorder 5A (Zellweger)	OMIM:614866
1503	0.4193	Primrose syndrome	OMIM:259050
1505	0.4191	Lipodystrophy, familial partial, type 7	OMIM:606721
1506	0.4189	Spastic paraplegia 85, autosomal recessive	OMIM:619686
1507	0.4188	Coenzyme Q10 deficiency, primary, 4	OMIM:612016
1508	0.4187	?Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15	OMIM:618992
1508	0.4187	Mitochondrial complex II deficiency, nuclear type 4	OMIM:619224
1510	0.4186	Combined oxidative phosphorylation deficiency 27	OMIM:616672
1511	0.4185	Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome	ORPHA:457279
1512	0.4184	HSD10 disease, infantile type	ORPHA:391428
1512	0.4184	SLC39A8-CDG	ORPHA:468699
1514	0.418	Combined oxidative phosphorylation deficiency 12	OMIM:614924
1515	0.4176	Charcot-Marie-Tooth disease, type 1D	OMIM:607678
1515	0.4176	Intellectual developmental disorder, autosomal recessive 61	OMIM:617773
1517	0.4172	Spastic paraplegia 46, autosomal recessive	OMIM:614409
1518	0.4166	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	OMIM:614388
1518	0.4166	Hypobetalipoproteinemia	OMIM:615558
1520	0.4164	Porphyria due to ALA dehydratase deficiency	ORPHA:100924
1521	0.4161	Short-rib thoracic dysplasia 9 with or without polydactyly	OMIM:266920
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1522	0.416	Isolated ATP synthase deficiency	ORPHA:254913
1530	0.4159	Peroxisome biogenesis disorder 9B	OMIM:614879
1531	0.4155	Spastic paraplegia 77, autosomal recessive	OMIM:617046
1532	0.4154	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant	OMIM:614162
1533	0.4153	Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency	ORPHA:329314
1534	0.4152	Friedreich ataxia with retained reflexes	OMIM:229300
1534	0.4152	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	OMIM:617862
1536	0.415	Myasthenic syndrome, congenital, 19	OMIM:616720
1536	0.415	Autosomal dominant spastic paraplegia type 31	ORPHA:101011
1536	0.415	Congenital glucokinase-related hyperinsulinism	ORPHA:79299
1539	0.4149	Mitochondrial complex I deficiency, nuclear type 29	OMIM:618250
1539	0.4149	Short stature-delayed bone age due to thyroid hormone metabolism deficiency	ORPHA:171706
1541	0.4148	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
1541	0.4148	Allan-Herndon-Dudley syndrome	OMIM:300523
1541	0.4148	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
1544	0.4146	Charcot-Marie-Tooth disease, type 4B1	OMIM:601382
1545	0.4145	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	ORPHA:276580
1545	0.4145	Mitochondrial complex I deficiency, nuclear type 37	OMIM:619272
1547	0.4137	Spinal muscular atrophy-2	OMIM:253550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	MELAS	ORPHA:550
1548	0.4132	Spinocerebellar ataxia type 36	ORPHA:276198
1556	0.413	Acute intermittent porphyria	ORPHA:79276
1557	0.4129	ALG11-CDG	ORPHA:280071
1558	0.4128	Pontocerebellar hypoplasia, type 6	OMIM:611523
1559	0.4126	NARP syndrome	ORPHA:644
1560	0.4124	Joubert syndrome 1	OMIM:213300
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Mitochondrial complex I deficiency, nuclear type 6	OMIM:618228
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1560	0.4124	Kallmann syndrome	ORPHA:478
1583	0.4122	Autosomal recessive spastic paraplegia type 35	ORPHA:171629
1584	0.4121	Aicardi-Goutieres syndrome 7	OMIM:615846
1584	0.4121	Autosomal recessive cerebellar ataxia due to STUB1 deficiency	ORPHA:412057
1586	0.4117	Spastic paralysis, infantile onset ascending	OMIM:607225
1587	0.4116	Autosomal recessive spastic paraplegia type 78	ORPHA:513436
1587	0.4116	?Combined oxidative phosphorylation deficiency 45	OMIM:618951
1589	0.4114	Leukodystrophy, hypomyelinating, 5	OMIM:610532
1590	0.4113	Cutis laxa, autosomal recessive, type IIIA	OMIM:219150
1591	0.4112	Neuronopathy, distal hereditary motor, type VIIB	OMIM:607641
1592	0.4111	GM2-gangliosidosis, AB variant	OMIM:272750
1592	0.4111	Mast syndrome	OMIM:248900
1592	0.4111	Developmental and epileptic encephalopathy 39	OMIM:612949
1595	0.411	3-Methylcrotonyl-CoA carboxylase 2 deficiency	OMIM:210210
1596	0.4107	Mitochondrial membrane protein-associated neurodegeneration	ORPHA:289560
1597	0.4106	Congenital muscular dystrophy due to LMNA mutation	ORPHA:157973
1598	0.4103	?Ullrich congenital muscular dystrophy 2	OMIM:616470
1599	0.4102	Autosomal recessive spastic paraplegia type 5A	ORPHA:100986
1600	0.4101	?Spastic paraplegia 74, autosomal recessive	OMIM:616451
1600	0.4101	Developmental and epileptic encephalopathy 84	OMIM:618792
1602	0.4099	Mitochondrial complex IV deficiency, nuclear type 16	OMIM:619060
1603	0.4096	Basal ganglia calcification, idiopathic, 7, autosomal recessive	OMIM:618317
1604	0.4095	Spastic paraplegia 3A, autosomal dominant	OMIM:182600
1605	0.4094	Developmental and epileptic encephalopathy 31B, autosomal recessive	OMIM:620352
1606	0.4093	Spastic ataxia 5, autosomal recessive	OMIM:614487
1607	0.4092	MEPAN syndrome	ORPHA:508093
1608	0.4091	?Combined oxidative phosphorylation deficiency 19	OMIM:615595
1608	0.4091	Cerebrotendinous xanthomatosis	ORPHA:909
1608	0.4091	?Combined oxidative phosphorylation deficiency 50	OMIM:619025
1611	0.409	Transcobalamin II deficiency	OMIM:275350
1612	0.4088	Developmental and epileptic encephalopathy 55	OMIM:617599
1613	0.4087	Bartter syndrome type 4	ORPHA:89938
1613	0.4087	Bartter syndrome type 4	ORPHA:89938
1613	0.4087	Bartter syndrome type 4	ORPHA:89938
1616	0.4085	Combined oxidative phosphorylation deficiency 20	OMIM:615917
1616	0.4085	Spastic paraplegia 86, autosomal recessive	OMIM:619735
1618	0.4083	Multiple congenital anomalies-hypotonia-seizures syndrome 4	OMIM:618548
1619	0.4082	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	OMIM:618170
1620	0.4081	Intellectual developmental disorder with poor growth and with or without seizures or ataxia	OMIM:618808
1620	0.4081	Spastic ataxia 2, autosomal recessive	OMIM:611302
1622	0.408	Myasthenic syndrome, congenital, 5	OMIM:603034
1623	0.4079	Intellectual developmental disorder and microcephaly with pontine and cerebellar hypoplasia	OMIM:300749
1624	0.4078	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction	OMIM:619333
1624	0.4078	Familial hyperaldosteronism type I	ORPHA:403
1624	0.4078	Familial hyperaldosteronism type I	ORPHA:403
1627	0.4077	Spastic paraplegia type 7	ORPHA:99013
1627	0.4077	Autosomal dominant spastic paraplegia type 3	ORPHA:100984
1629	0.4076	Dystonia-1, torsion	OMIM:128100
1630	0.4073	Spastic paraplegia 8, autosomal dominant	OMIM:603563
1631	0.4071	Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome	ORPHA:391408
1631	0.4071	Wolcott-Rallison syndrome	ORPHA:1667
1631	0.4071	Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome	ORPHA:391408
1631	0.4071	Leukodystrophy, hypomyelinating, 10	OMIM:616420
1635	0.407	Neuropathy, hereditary sensory and autonomic, type VI	OMIM:614653
1635	0.407	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	OMIM:613470
1635	0.407	Hereditary spherocytosis	ORPHA:822
1635	0.407	Hereditary spherocytosis	ORPHA:822
1635	0.407	Hereditary spherocytosis	ORPHA:822
1635	0.407	Hereditary spherocytosis	ORPHA:822
1635	0.407	Hereditary spherocytosis	ORPHA:822
1642	0.4069	Congenital myopathy 6 with ophthalmoplegia	OMIM:605637
1642	0.4069	Dyskinesia with orofacial involvement, autosomal dominant	OMIM:606703
1644	0.4068	Familial hyperaldosteronism type II	ORPHA:404
1644	0.4068	Alagille syndrome 1	OMIM:118450
1644	0.4068	Chylomicron retention disease	ORPHA:71
1644	0.4068	Familial hyperaldosteronism type III	ORPHA:251274
1648	0.4065	?Parkinsonism-dystonia, infantile, 2	OMIM:618049
1648	0.4065	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits	OMIM:618087
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1648	0.4065	Saccharopinuria	ORPHA:3124
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1648	0.4065	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1658	0.4061	Stüve-Wiedemann syndrome	ORPHA:3206
1658	0.4061	Stüve-Wiedemann syndrome	ORPHA:3206
1658	0.4061	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	OMIM:618451
1658	0.4061	Peroxisome biogenesis disorder 13A (Zellweger)	OMIM:614887
1662	0.406	Autosomal dominant spastic paraplegia type 73	ORPHA:444099
1663	0.4058	Familial infantile bilateral striatal necrosis	ORPHA:225154
1663	0.4058	Familial infantile bilateral striatal necrosis	ORPHA:225154
1663	0.4058	Familial infantile bilateral striatal necrosis	ORPHA:225154
1663	0.4058	Familial infantile bilateral striatal necrosis	ORPHA:225154
1663	0.4058	Spastic paraplegia 54, autosomal recessive	OMIM:615033
1668	0.4055	Intellectual developmental disorder, autosomal dominant 54	OMIM:617799
1669	0.4054	Leukodystrophy, hypomyelinating, 2	OMIM:608804
1669	0.4054	Combined oxidative phosphorylation deficiency 48	OMIM:619012
1671	0.405	DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect	ORPHA:330050
1672	0.4047	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1672	0.4047	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1672	0.4047	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1675	0.4046	Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency	OMIM:616325
1675	0.4046	Amish nemaline myopathy	ORPHA:98902
1675	0.4046	Xq21 microdeletion syndrome	ORPHA:1435
1675	0.4046	Spinocerebellar ataxia type 35	ORPHA:276193
1679	0.4044	Autosomal dominant spastic paraplegia type 37	ORPHA:171612
1680	0.4042	Hypocalcemic vitamin D-dependent rickets	ORPHA:289157
1680	0.4042	Hypocalcemic vitamin D-dependent rickets	ORPHA:289157
1682	0.4041	HJV or HAMP-related hemochromatosis	ORPHA:79230
1682	0.4041	HJV or HAMP-related hemochromatosis	ORPHA:79230
1684	0.4039	Encephalopathy, progressive, with amyotrophy and optic atrophy	OMIM:617207
1685	0.4037	Phosphoglycerate kinase 1 deficiency	OMIM:300653
1685	0.4037	?Mitochondrial complex I deficiency, nuclear type 28	OMIM:618249
1687	0.4036	Nemaline myopathy 5A, autosomal recessive, severe infantile	OMIM:605355
1687	0.4036	Camurati-Engelmann disease	OMIM:131300
1687	0.4036	Amyotrophic lateral sclerosis 18	OMIM:614808
1687	0.4036	Coffin-Lowry syndrome	ORPHA:192
1691	0.4034	Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome	ORPHA:496756
1691	0.4034	Trichothiodystrophy 8, nonphotosensitive	OMIM:619691
1693	0.4033	Severe congenital nemaline myopathy	ORPHA:171430
1693	0.4033	Severe congenital nemaline myopathy	ORPHA:171430
1693	0.4033	Severe congenital nemaline myopathy	ORPHA:171430
1693	0.4033	Severe congenital nemaline myopathy	ORPHA:171430
1693	0.4033	Severe congenital nemaline myopathy	ORPHA:171430
1693	0.4033	Fatal infantile lactic acidosis with methylmalonic aciduria	ORPHA:17
1699	0.403	?Ataxia-telangiectasia-like disorder 2	OMIM:615919
1700	0.4028	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities	OMIM:615802
1701	0.4027	Adenylosuccinase deficiency	OMIM:103050
1702	0.4026	?Lissencephaly 7 with cerebellar hypoplasia	OMIM:616342
1702	0.4026	Multiple mitochondrial dysfunctions syndrome 6	OMIM:617954
1702	0.4026	Coenzyme Q10 deficiency, primary, 2	OMIM:614651
1705	0.4024	Primary Fanconi renotubular syndrome	ORPHA:3337
1705	0.4024	Primary Fanconi renotubular syndrome	ORPHA:3337
1705	0.4024	Primary Fanconi renotubular syndrome	ORPHA:3337
1705	0.4024	Primary Fanconi renotubular syndrome	ORPHA:3337
1709	0.4022	Mannosidosis, alpha-, types I and II	OMIM:248500
1709	0.4022	Neuroferritinopathy	ORPHA:157846
1711	0.402	Severe Canavan disease	ORPHA:314911
1711	0.402	Mild Canavan disease	ORPHA:314918
1711	0.402	?Neurodevelopmental disorder with microcephaly, seizures, and brain atrophy	OMIM:619076
1711	0.402	Encephalopathy due to defective mitochondrial and peroxisomal fission 2	OMIM:617086
1711	0.402	Dopa-responsive dystonia due to sepiapterin reductase deficiency	ORPHA:70594
1716	0.4019	Immunodeficiency, developmental delay, and hypohomocysteinemia	OMIM:617744
1717	0.4018	Immunodeficiency 9	OMIM:612782
1718	0.4017	?Spastic paraplegia 63	OMIM:615686
1719	0.4011	Multiple system atrophy, susceptibility to	OMIM:146500
1720	0.4007	Mutilating hereditary sensory neuropathy with spastic paraplegia	ORPHA:139578
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Infantile Refsum disease	ORPHA:772
1721	0.4005	Posterior column ataxia-retinitis pigmentosa syndrome	ORPHA:88628
1721	0.4005	Infantile Refsum disease	ORPHA:772
1735	0.4003	Hereditary sensory and autonomic neuropathy type 4	ORPHA:642
1736	0.4002	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain abnormalities	OMIM:616486
1736	0.4002	Hereditary sensory and autonomic neuropathy due to TECPR2 mutation	ORPHA:320385
1736	0.4002	Neuropathy, hereditary sensory and autonomic, type IX, with developmental delay	OMIM:615031
1739	0.3999	Muscular dystrophy, limb-girdle, autosomal dominant 2	OMIM:608423
1740	0.3997	Scapuloperoneal syndrome, neurogenic, Kaeser type	OMIM:181400
1740	0.3997	Bartter syndrome, type 1	OMIM:601678
1742	0.3995	PYCR2-related microcephaly-progressive leukoencephalopathy	ORPHA:481152
1743	0.3993	Spastic paraplegia 12, autosomal dominant	OMIM:604805
1744	0.3991	Wieacker-Wolff syndrome, female-restricted	OMIM:301041
1745	0.399	Myasthenic syndrome, congenital, 3B, fast-channel	OMIM:616322
1746	0.3988	Hypotonia, ataxia, and delayed development syndrome	OMIM:617330
1747	0.3987	Leukodystrophy, hypomyelinating, 19, transient infantile	OMIM:618688
1748	0.3984	Congenital myopathy 4A, autosomal dominant	OMIM:255310
1749	0.3983	Cockayne syndrome, type B	OMIM:133540
1749	0.3983	Cockayne syndrome, type B	OMIM:133540
1749	0.3983	Cockayne syndrome, type A	OMIM:216400
1752	0.3982	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	OMIM:615471
1752	0.3982	Congenital disorder of glycosylation, type IIn	OMIM:616721
1752	0.3982	Intellectual developmental disorder, X-linked syndromic 33	OMIM:300966
1755	0.3981	Cutis laxa, autosomal recessive, type IIC	OMIM:617402
1756	0.3976	Congenital myopathy 8	OMIM:618654
1757	0.3975	Developmental and epileptic encephalopathy 1	OMIM:308350
1758	0.3974	Macrocephaly-intellectual disability-left ventricular non compaction syndrome	ORPHA:466791
1758	0.3974	Spinocerebellar ataxia 38	OMIM:615957
1760	0.3973	Bartter syndrome, type 2	OMIM:241200
1761	0.3972	Spinocerebellar ataxia type 25	ORPHA:101111
1761	0.3972	Retinal dystrophy with leukodystrophy	OMIM:618863
1763	0.3968	Progressive pseudorheumatoid arthropathy of childhood	ORPHA:1159
1764	0.3967	Megaloblastic anemia due to dihydrofolate reductase deficiency	OMIM:613839
1765	0.3964	Paget disease of bone 5, juvenile-onset	OMIM:239000
1766	0.396	Peroxisome biogenesis disorder 2A (Zellweger)	OMIM:214110
1766	0.396	Pontocerebellar hypoplasia, type 9	OMIM:615809
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Peroxisome biogenesis disorder 3A (Zellweger)	OMIM:614859
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1768	0.3957	Noonan syndrome	ORPHA:648
1783	0.3955	Spastic paraplegia 45, autosomal recessive	OMIM:613162
1784	0.3952	Hypophosphatemic rickets with hypercalciuria	OMIM:241530
1785	0.3951	Cardiomyopathy, dilated, 3B	OMIM:302045
1785	0.3951	Arrhythmogenic right ventricular dysplasia 10	OMIM:610193
1785	0.3951	Autosomal dominant spastic paraplegia type 13	ORPHA:100994
1788	0.395	PGM3-CDG	ORPHA:443811
1789	0.3945	Spastic paraplegia 4, autosomal dominant	OMIM:182601
1790	0.394	Parkinson disease 20, early-onset	OMIM:615530
1790	0.394	Hereditary folate malabsorption	ORPHA:90045
1790	0.394	Distal renal tubular acidosis 1	OMIM:179800
1793	0.3939	Mitochondrial complex I deficiency, nuclear type 2	OMIM:618222
1794	0.3938	Multiple mitochondrial dysfunctions syndrome 3	OMIM:615330
1795	0.3937	Autosomal dominant hypophosphatemic rickets	ORPHA:89937
1795	0.3937	Fanconi renotubular syndrome 1	OMIM:134600
1797	0.3936	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	OMIM:617481
1798	0.3935	Leprechaunism	ORPHA:508
1799	0.3934	Autosomal recessive hypophosphatemic rickets	ORPHA:289176
1799	0.3934	Autosomal recessive hypophosphatemic rickets	ORPHA:289176
1799	0.3934	Alexander disease type II	ORPHA:363722
1802	0.3932	Hyperparathyroidism-jaw tumor syndrome	ORPHA:99880
1802	0.3932	Parathyroid carcinoma	ORPHA:143
1804	0.3931	Neurodevelopmental disorder with hypotonia and dysmorphic facies	OMIM:619503
1805	0.3929	Congenital disorder of glycosylation, type IIm	OMIM:300896
1806	0.3927	Dystonia, DOPA-responsive	OMIM:128230
1807	0.3926	Hereditary coproporphyria	ORPHA:79273
1807	0.3926	Multiple myeloma	ORPHA:29073
1809	0.3925	Helsmoortel-van der Aa syndrome	OMIM:615873
1810	0.3924	Spinocerebellar ataxia 35	OMIM:613908
1811	0.3923	Spastic paraplegia 6, autosomal dominant	OMIM:600363
1811	0.3923	Bartter syndrome, type 3	OMIM:607364
1813	0.3921	Intellectual developmental disorder, X-linked syndromic, Christianson type	OMIM:300243
1814	0.392	Pontocerebellar hypoplasia type 10	ORPHA:411493
1814	0.392	Intellectual developmental disorder, autosomal recessive 58	OMIM:617270
1814	0.392	3-methylglutaconic aciduria, type V	OMIM:610198
1814	0.392	?Pontocerebellar hypoplasia, type 3	OMIM:608027
1818	0.3918	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	OMIM:251880
1819	0.3915	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1	OMIM:615419
1820	0.3913	Myasthenic syndrome, congenital, 4B, fast-channel	OMIM:616324
1821	0.3912	Hypocalciuric hypercalcemia, type III	OMIM:600740
1821	0.3912	Severe neurodegenerative syndrome with lipodystrophy	ORPHA:363400
1823	0.3911	Neurodegeneration with brain iron accumulation 3	OMIM:606159
1824	0.3909	Adrenocortical carcinoma	ORPHA:1501
1824	0.3909	Adrenocortical carcinoma	ORPHA:1501
1824	0.3909	Spastic paraplegia 70, autosomal recessive	OMIM:620323
1824	0.3909	Adrenocortical carcinoma	ORPHA:1501
1824	0.3909	Adrenocortical carcinoma	ORPHA:1501
1824	0.3909	Adrenocortical carcinoma	ORPHA:1501
1824	0.3909	Amyotrophic lateral sclerosis 9	OMIM:611895
1824	0.3909	Ehlers-Danlos syndrome, classic-like, 1	OMIM:606408
1824	0.3909	Adrenocortical carcinoma	ORPHA:1501
1833	0.3908	Atypical teratoid rhabdoid tumor	ORPHA:99966
1834	0.3907	Athyreosis	ORPHA:95713
1834	0.3907	Athyreosis	ORPHA:95713
1834	0.3907	Thyroid ectopia	ORPHA:95712
1834	0.3907	Athyreosis	ORPHA:95713
1834	0.3907	Athyreosis	ORPHA:95713
1834	0.3907	Wilson disease	OMIM:277900
1834	0.3907	Thyroid ectopia	ORPHA:95712
1834	0.3907	Athyreosis	ORPHA:95713
1834	0.3907	Athyreosis	ORPHA:95713
1834	0.3907	Mucopolysaccharidosis type 2, severe form	ORPHA:217085
1844	0.3906	Fontaine progeroid syndrome	OMIM:612289
1845	0.3903	Chanarin-Dorfman syndrome	OMIM:275630
1845	0.3903	Giant cell arteritis	ORPHA:397
1845	0.3903	Giant cell arteritis	ORPHA:397
1845	0.3903	Giant cell arteritis	ORPHA:397
1845	0.3903	Giant cell arteritis	ORPHA:397
1850	0.3902	Linear nevus sebaceus syndrome	ORPHA:2612
1850	0.3902	Linear nevus sebaceus syndrome	ORPHA:2612
1850	0.3902	Linear nevus sebaceus syndrome	ORPHA:2612
1853	0.3901	Leukodystrophy, hypomyelinating, 16	OMIM:617964
1854	0.3899	Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities	OMIM:619121
1854	0.3899	Peroxisome biogenesis disorder 8B	OMIM:614877
1856	0.3898	Neurodegeneration with ataxia and late-onset optic atrophy	OMIM:619259
1856	0.3898	Spastic paraplegia 33, autosomal dominant	OMIM:610244
1858	0.3897	Autosomal dominant spastic paraplegia type 6	ORPHA:100988
1859	0.3894	Spinocerebellar ataxia, autosomal recessive 10	OMIM:613728
1860	0.3892	Schimke immuno-osseous dysplasia	ORPHA:1830
1861	0.3891	Adrenoleukodystrophy	OMIM:300100
1862	0.3889	Visceral neuropathy, familial, 1, autosomal recessive	OMIM:243180
1863	0.3888	GM1-gangliosidosis, type III	OMIM:230650
1863	0.3888	Dysequilibrium syndrome	ORPHA:1766
1863	0.3888	Dysequilibrium syndrome	ORPHA:1766
1863	0.3888	Dysequilibrium syndrome	ORPHA:1766
1863	0.3888	Dysequilibrium syndrome	ORPHA:1766
1863	0.3888	Dysequilibrium syndrome	ORPHA:1766
1869	0.3887	Rickets due to defect in vitamin D 25-hydroxylation deficiency	OMIM:600081
1870	0.3886	EAST syndrome	ORPHA:199343
1871	0.3884	Spinocerebellar ataxia 25	OMIM:608703
1872	0.3881	Neurodevelopmental disorder with involuntary movements	OMIM:617493
1872	0.3881	Paroxysmal non-kinesigenic dyskinesia	ORPHA:98810
1872	0.3881	Paroxysmal non-kinesigenic dyskinesia	ORPHA:98810
1875	0.388	?Fazio-Londe disease	OMIM:211500
1876	0.3878	Alpers-Huttenlocher syndrome	ORPHA:726
1876	0.3878	Congenital disorder of glycosylation, type Ic	OMIM:603147
1878	0.3875	Spastic paraplegia 10, autosomal dominant	OMIM:604187
1879	0.3872	Glutaric acidemia type 3	ORPHA:35706
1880	0.3871	Gitelman syndrome	ORPHA:358
1880	0.3871	Gitelman syndrome	ORPHA:358
1882	0.3869	Multiple mitochondrial dysfunctions syndrome 1	OMIM:605711
1882	0.3869	PLIN1-related familial partial lipodystrophy	ORPHA:280356
1882	0.3869	Combined oxidative phosphorylation deficiency 18	OMIM:615578
1885	0.3868	Ataxia-oculomotor apraxia type 4	ORPHA:459033
1885	0.3868	Intellectual developmental disorder, X-linked syndromic, Turner type	OMIM:309590
1887	0.3865	ATP13A2-related juvenile neuronal ceroid lipofuscinosis	ORPHA:314632
1888	0.3864	Mitochondrial complex I deficiency, nuclear type 31	OMIM:618251
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	OMIM:238970
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1889	0.3863	Meningioma	ORPHA:2495
1901	0.3859	Dyggve-Melchior-Clausen disease	ORPHA:239
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Young-onset Parkinson disease	ORPHA:2828
1902	0.3858	Martsolf syndrome 1	OMIM:212720
1914	0.3856	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1914	0.3856	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1914	0.3856	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1914	0.3856	Developmental and epileptic encephalopathy 29	OMIM:616339
1914	0.3856	Andersen-Tawil syndrome	ORPHA:37553
1914	0.3856	Andersen-Tawil syndrome	ORPHA:37553
1914	0.3856	Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1	OMIM:224050
1914	0.3856	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
1922	0.3854	Microcephaly, developmental delay, and brittle hair syndrome	OMIM:618891
1922	0.3854	Sodium-dependent multivitamin transporter deficiency	OMIM:618973
1924	0.3851	Angelman syndrome	OMIM:105830
1925	0.385	Combined oxidative phosphorylation deficiency 28	OMIM:616794
1926	0.3849	Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	OMIM:261750
1927	0.3842	Spinocerebellar ataxia, autosomal recessive 18	OMIM:616204
1928	0.3839	Monomelic amyotrophy	ORPHA:65684
1928	0.3839	Monomelic amyotrophy	ORPHA:65684
1930	0.3838	Autosomal recessive spastic paraplegia type 21	ORPHA:101001
1931	0.3832	?Congenital disorder of glycosylation, type IIz	OMIM:620201
1931	0.3832	Intellectual developmental disorder, X-linked syndromic, Claes-Jensen type	OMIM:300534
1933	0.3828	Hypophosphatemic rickets, autosomal dominant	OMIM:193100
1934	0.3826	Ataxia-telangiectasia	ORPHA:100
1934	0.3826	Myopathy, distal, 7, adult-onset, X-linked	OMIM:301075
1934	0.3826	Spinocerebellar ataxia type 38	ORPHA:423296
1937	0.3825	Aceruloplasminemia	ORPHA:48818
1937	0.3825	Intellectual developmental disorder, autosomal dominant 42	OMIM:616973
1939	0.3824	Adult polyglucosan body disease	ORPHA:206583
1939	0.3824	Neurodevelopmental disorder with microcephaly, ataxia, and seizures	OMIM:617709
1939	0.3824	Spinocerebellar ataxia, autosomal recessive 31	OMIM:619422
1939	0.3824	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities	OMIM:620191
1943	0.3823	Myasthenic syndrome, congenital, 22	OMIM:616224
1943	0.3823	Brain dopamine-serotonin vesicular transport disease	ORPHA:352649
1945	0.382	Autosomal recessive spastic paraplegia type 39	ORPHA:139480
1946	0.3819	?Mitochondrial complex III deficiency, nuclear type 9	OMIM:616111
1947	0.3816	Oxoglutarate dehydrogenase deficiency	OMIM:203740
1947	0.3816	Galloway-Mowat syndrome 1	OMIM:251300
1949	0.3814	Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome	ORPHA:445062
1949	0.3814	Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	OMIM:616192
1951	0.3813	Developmental delay, impaired speech, and behavioral abnormalities	OMIM:619475
1952	0.3812	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy	OMIM:300232
1953	0.3808	Spastic paraplegia 13, autosomal dominant	OMIM:605280
1953	0.3808	Spastic paraplegia 28, autosomal recessive	OMIM:609340
1953	0.3808	Autosomal recessive spastic paraplegia type 28	ORPHA:101008
1953	0.3808	Spastic paraplegia 23	OMIM:270750
1957	0.3805	Spinocerebellar ataxia 10	OMIM:603516
1958	0.3804	Infantile-onset spinocerebellar ataxia	ORPHA:1186
1958	0.3804	Optic atrophy 1	OMIM:165500
1958	0.3804	?Trichothiodystrophy 9, nonphotosensitive	OMIM:619692
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Pyruvate dehydrogenase E1-beta deficiency	ORPHA:255138
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Autosomal recessive spastic paraplegia type 63	ORPHA:401805
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Xeroderma pigmentosum	ORPHA:910
1958	0.3804	Amyotrophic lateral sclerosis, susceptibility to, 24	OMIM:617892
1971	0.38	Rett syndrome	ORPHA:778
1971	0.38	Neuronopathy, distal hereditary motor, type X	OMIM:620080
1973	0.3799	Oxoglutaric aciduria	ORPHA:31
1973	0.3799	Intellectual developmental disorder, autosomal dominant 43	OMIM:616977
1975	0.3798	Congenital myopathy 16	OMIM:618524
1975	0.3798	Childhood-onset spasticity with hyperglycinemia	ORPHA:401866
1977	0.3791	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	ORPHA:415
1978	0.3789	Cerebrotendinous xanthomatosis	OMIM:213700
1979	0.3788	Schindler disease, type I	OMIM:609241
1980	0.3786	Aicardi-Goutieres syndrome 1, dominant and recessive	OMIM:225750
1981	0.3783	Spastic tetraplegia and axial hypotonia, progressive	OMIM:618598
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	Harel-Yoon syndrome	OMIM:617183
1982	0.3782	Zellweger syndrome	ORPHA:912
1982	0.3782	?Marsili syndrome	OMIM:147430
1997	0.3781	Cystinosis, nephropathic	OMIM:219800
1998	0.378	Myasthenic syndrome, congenital, 24, presynaptic	OMIM:618198
1998	0.378	Spondyloocular syndrome	OMIM:605822
1998	0.378	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	OMIM:618718
2001	0.3776	Spectrin-associated autosomal recessive cerebellar ataxia	ORPHA:352403
2002	0.3775	MAGEL2-related Prader-Willi-like syndrome	ORPHA:398069
2002	0.3775	Caudal regression syndrome	ORPHA:3027
2002	0.3775	Caudal regression syndrome	ORPHA:3027
2005	0.3766	Marden-Walker syndrome	ORPHA:2461
2006	0.3764	Urocanic aciduria	ORPHA:210128
2006	0.3764	Liver disease, severe congenital	OMIM:619991
2008	0.3763	Mitochondrial complex I deficiency, nuclear type 20	OMIM:611126
2009	0.3762	Sarcoidosis	ORPHA:797
2009	0.3762	Sarcoidosis	ORPHA:797
2011	0.3761	Spastic paraplegia 35, autosomal recessive	OMIM:612319
2011	0.3761	Coenzyme Q10 deficiency, primary, 8	OMIM:616733
2013	0.376	Glutaric acidemia IIA	OMIM:231680
2013	0.376	GNB5-related intellectual disability-cardiac arrhythmia syndrome	ORPHA:542306
2013	0.376	Glutaric acidemia IIB	OMIM:231680
2013	0.376	Glutaric acidemia IIC	OMIM:231680
2013	0.376	ALG13-CDG	ORPHA:324422
2018	0.3759	Tangier disease	ORPHA:31150
2019	0.3758	Behr syndrome	OMIM:210000
2019	0.3758	Neurodegeneration and seizures due to copper transport defect	OMIM:620306
2021	0.3757	Donohue syndrome	OMIM:246200
2021	0.3757	Spinocerebellar ataxia 49	OMIM:619806
2023	0.3756	?Myasthenic syndrome, congenital, 3A, slow-channel	OMIM:616321
2023	0.3756	Hyperphosphatasia with impaired intellectual development syndrome 3	OMIM:614207
2025	0.3754	Spinocerebellar ataxia, autosomal recessive 7	OMIM:609270
2025	0.3754	Carney complex	ORPHA:1359
2025	0.3754	Carney complex	ORPHA:1359
2028	0.3751	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	OMIM:201750
2028	0.3751	STING-associated vasculopathy, infantile-onset	OMIM:615934
2030	0.3749	GM2-gangliosidosis, several forms	OMIM:272800
2030	0.3749	Neurodegeneration, childhood-onset, with progressive microcephaly	OMIM:619847
2032	0.3748	Biotinidase deficiency	ORPHA:79241
2032	0.3748	Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia	ORPHA:284324
2034	0.3746	Homocystinuria due to methylene tetrahydrofolate reductase deficiency	ORPHA:395
2034	0.3746	Spastic paraplegia 87, autosomal recessive	OMIM:619966
2036	0.3745	Spasticity, childhood-onset, with hyperglycinemia	OMIM:616859
2037	0.374	Mitochondrial complex I deficiency, nuclear type 5	OMIM:618226
2038	0.3739	Congenital disorder of glycosylation, type Ij	OMIM:608093
2038	0.3739	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	OMIM:614381
2038	0.3739	X-linked sideroblastic anemia	ORPHA:75563
2041	0.3738	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	OMIM:617145
2042	0.3737	Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome	ORPHA:529665
2043	0.3733	Nemaline myopathy 8, autosomal recessive	OMIM:615348
2043	0.3733	Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum	OMIM:618766
2043	0.3733	Pontocerebellar hypoplasia, type 1E	OMIM:619303
2043	0.3733	Congenital disorder of glycosylation, type Ik	OMIM:608540
2043	0.3733	?Leukodystrophy, progressive, early childhood-onset	OMIM:617762
2043	0.3733	Peroxisome biogenesis disorder 10A (Zellweger)	OMIM:614882
2043	0.3733	?Congenital myopathy 9A with respiratory insufficiency and bone fractures	OMIM:618822
2043	0.3733	?Central hypoventilation syndrome, congenital, 2, and autonomic dysfunction	OMIM:619482
2043	0.3733	?Leukodystrophy, hypomyelinating, 24	OMIM:619851
2043	0.3733	Autosomal recessive spastic paraplegia type 64	ORPHA:401810
2053	0.3732	Anemia, sideroblastic, with ataxia	OMIM:301310
2054	0.3731	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	OMIM:618291
2055	0.3729	Rett syndrome, atypical	OMIM:312750
2055	0.3729	Spinocerebellar ataxia, autosomal recessive 27	OMIM:618369
2057	0.3728	Herpes simplex virus encephalitis	ORPHA:1930
2057	0.3728	Herpes simplex virus encephalitis	ORPHA:1930
2057	0.3728	Herpes simplex virus encephalitis	ORPHA:1930
2057	0.3728	Herpes simplex virus encephalitis	ORPHA:1930
2057	0.3728	Herpes simplex virus encephalitis	ORPHA:1930
2062	0.3725	Developmental and epileptic encephalopathy 59	OMIM:617904
2062	0.3725	Developmental and epileptic encephalopathy 103	OMIM:619913
2064	0.3724	?Facioscapulohumeral muscular dystrophy 3, digenic	OMIM:619477
2065	0.3723	Coenzyme Q10 deficiency, primary, 7	OMIM:616276
2066	0.3722	Spinocerebellar ataxia type 6	ORPHA:98758
2067	0.3721	Spinocerebellar ataxia, autosomal recessive 13	OMIM:614831
2067	0.3721	ALG9-CDG	ORPHA:79328
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2069	0.3719	Early infantile epileptic encephalopathy	ORPHA:1934
2087	0.3716	DEND syndrome	ORPHA:79134
2087	0.3716	DEND syndrome	ORPHA:79134
2087	0.3716	Menkes disease	ORPHA:565
2087	0.3716	DEND syndrome	ORPHA:79134
2087	0.3716	Diabetes mellitus, permanent neonatal 3, with or without neurologic features	OMIM:618857
2092	0.3715	Homocystinuria due to MTHFR deficiency	OMIM:236250
2093	0.3714	Thyrotoxic periodic paralysis, susceptibility to, 1	OMIM:188580
2093	0.3714	Myasthenic syndrome, congenital, 4A, slow-channel	OMIM:605809
2093	0.3714	Liddle syndrome	ORPHA:526
2093	0.3714	Liddle syndrome	ORPHA:526
2093	0.3714	Liddle syndrome	ORPHA:526
2093	0.3714	Hypomagnesemia 6, renal	OMIM:613882
2099	0.3712	Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency	OMIM:614736
2100	0.3709	Polyglucosan body disease, adult form	OMIM:263570
2100	0.3709	Atelis syndrome 2	OMIM:620185
2102	0.3708	Cockayne syndrome type 1	ORPHA:90321
2102	0.3708	Cockayne syndrome type 1	ORPHA:90321
2102	0.3708	Cockayne syndrome type 1	ORPHA:90321
2102	0.3708	Cockayne syndrome type 1	ORPHA:90321
2106	0.3707	Spinocerebellar ataxia type 26	ORPHA:101112
2106	0.3707	?Spinocerebellar ataxia 40	OMIM:616053
2108	0.3705	Spinocerebellar ataxia 23	OMIM:610245
2109	0.3703	Spinocerebellar ataxia type 23	ORPHA:101108
2110	0.3702	Mucolipidosis IV	OMIM:252650
2110	0.3702	Dystonia, early-onset, and/or spastic paraplegia	OMIM:619681
2110	0.3702	?Amyotrophic lateral sclerosis 16, juvenile	OMIM:614373
2113	0.3699	Combined oxidative phosphorylation deficiency 1	OMIM:609060
2114	0.3698	Spinocerebellar ataxia, autosomal recessive 16	OMIM:615768
2114	0.3698	Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal)	OMIM:606854
2116	0.3697	ALG6-CDG	ORPHA:79320
2117	0.3695	?Hermansky-Pudlak syndrome 10	OMIM:617050
2117	0.3695	Peroxisome biogenesis disorder 11B	OMIM:614885
2119	0.3694	Mitochondrial complex I deficiency, nuclear type 21	OMIM:618242
2120	0.3693	Dystonia-parkinsonism-hypermanganesemia syndrome	ORPHA:521406
2121	0.3692	Stiff skin syndrome	ORPHA:2833
2121	0.3692	Refsum disease	ORPHA:773
2121	0.3692	Refsum disease	ORPHA:773
2124	0.369	Phenylketonuria	OMIM:261600
2125	0.3688	X-linked cerebral adrenoleukodystrophy	ORPHA:139396
2125	0.3688	Spinocerebellar ataxia, autosomal recessive 17	OMIM:616127
2127	0.3687	Hyperlysinemia	ORPHA:2203
2128	0.3686	Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis	OMIM:619685
2129	0.3685	Myasthenic syndrome, congenital, 13, with tubular aggregates	OMIM:614750
2129	0.3685	Triose phosphate-isomerase deficiency	ORPHA:868
2129	0.3685	Cerebral creatine deficiency syndrome 2	OMIM:612736
2132	0.3683	Bilateral perisylvian polymicrogyria	ORPHA:98889
2132	0.3683	CARASIL syndrome	OMIM:600142
2132	0.3683	Bilateral perisylvian polymicrogyria	ORPHA:98889
2132	0.3683	Bilateral perisylvian polymicrogyria	ORPHA:98889
2136	0.3681	Developmental and epileptic encephalopathy 110	OMIM:620149
2136	0.3681	Developmental and epileptic encephalopathy 97	OMIM:619561
2136	0.3681	COG4-CDG	ORPHA:263501
2136	0.3681	Oculocerebrofacial syndrome, Kaufman type	ORPHA:2707
2140	0.3679	Hypoglycemia of infancy, leucine-sensitive	OMIM:240800
2141	0.3678	Infantile neuroaxonal dystrophy	ORPHA:35069
2142	0.3676	Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency	ORPHA:90793
2142	0.3676	Hypomagnesemia 2, renal	OMIM:154020
2142	0.3676	Ceroid lipofuscinosis, neuronal, 13 (Kufs type)	OMIM:615362
2145	0.3674	Stomatin-deficient cryohydrocytosis with neurologic defects	OMIM:608885
2145	0.3674	Spastic ataxia 3, autosomal recessive	OMIM:611390
2147	0.3673	Spinocerebellar ataxia 11	OMIM:604432
2148	0.3672	Carey-Fineman-Ziter syndrome	ORPHA:1358
2148	0.3672	Moebius syndrome	ORPHA:570
2148	0.3672	Autosomal recessive spastic ataxia with leukoencephalopathy	ORPHA:314603
2148	0.3672	Moebius syndrome	ORPHA:570
2152	0.3671	Spinocerebellar ataxia type 13	ORPHA:98768
2153	0.3669	Spinocerebellar ataxia 13	OMIM:605259
2154	0.3667	CDKL5-deficiency disorder	ORPHA:505652
2154	0.3667	DK1-CDG	ORPHA:91131
2154	0.3667	Neurodevelopmental disorder with hyperkinetic movements and dyskinesia	OMIM:619651
2157	0.3666	Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to	OMIM:105500
2157	0.3666	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	OMIM:619141
2157	0.3666	Primary sclerosing cholangitis	ORPHA:171
2157	0.3666	Primary sclerosing cholangitis	ORPHA:171
2157	0.3666	Primary sclerosing cholangitis	ORPHA:171
2157	0.3666	Primary sclerosing cholangitis	ORPHA:171
2163	0.3665	Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency	ORPHA:324262
2163	0.3665	CLN5 disease	ORPHA:228360
2163	0.3665	D-glyceric aciduria	OMIM:220120
2163	0.3665	Onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome	OMIM:619356
2167	0.3664	Multiple congenital anomalies-hypotonia-seizures syndrome 2	OMIM:300868
2168	0.3662	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
2168	0.3662	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
2168	0.3662	Polyendocrine-polyneuropathy syndrome	ORPHA:453533
2171	0.3661	Hemophagocytic lymphohistiocytosis, familial, 2	OMIM:603553
2172	0.366	Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency	ORPHA:90795
2173	0.3659	Spinocerebellar ataxia 14	OMIM:605361
2173	0.3659	Corticosteroid-binding globulin deficiency	OMIM:611489
2175	0.3657	Multiple symmetric lipomatosis	ORPHA:2398
2175	0.3657	Hypomyelination neuropathy-arthrogryposis syndrome	ORPHA:2680
2175	0.3657	COFS syndrome	ORPHA:1466
2175	0.3657	COFS syndrome	ORPHA:1466
2175	0.3657	COFS syndrome	ORPHA:1466
2175	0.3657	COFS syndrome	ORPHA:1466
2175	0.3657	Cataract 11, multiple types	OMIM:610623
2175	0.3657	COFS syndrome	ORPHA:1466
2175	0.3657	Hypomyelination neuropathy-arthrogryposis syndrome	ORPHA:2680
2175	0.3657	Kuskokwim syndrome	ORPHA:1149
2175	0.3657	Hypomyelination neuropathy-arthrogryposis syndrome	ORPHA:2680
2175	0.3657	Mulibrey nanism	ORPHA:2576
2175	0.3657	Ataxia-pancytopenia syndrome	OMIM:159550
2175	0.3657	Basel-Vanagaite-Smirin-Yosef syndrome	ORPHA:464738
2189	0.3656	MEHMO syndrome	OMIM:300148
2190	0.3655	Pelger-Huet anomaly	OMIM:169400
2190	0.3655	Asparagine synthetase deficiency	OMIM:615574
2192	0.3654	Congenital disorder of glycosylation, type IIj	OMIM:613489
2193	0.3653	?Spastic paraplegia 61, autosomal recessive	OMIM:615685
2194	0.3651	Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome	ORPHA:314404
2195	0.365	Systemic primary carnitine deficiency	ORPHA:158
2195	0.365	Neonatal intrahepatic cholestasis due to citrin deficiency	ORPHA:247598
2197	0.3647	Epidermolysis bullosa simplex with muscular dystrophy	ORPHA:257
2197	0.3647	Pyruvate dehydrogenase E2 deficiency	OMIM:245348
2197	0.3647	Sorbitol dehydrogenase deficiency with peripheral neuropathy	OMIM:618912
2200	0.3643	Mohr-Tranebjaerg syndrome	ORPHA:52368
2200	0.3643	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 3	OMIM:619950
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Basal ganglia calcification, idiopathic, 1	OMIM:213600
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	?Neurodegeneration with brain iron accumulation 8	OMIM:617917
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2202	0.3642	Retinitis pigmentosa	ORPHA:791
2289	0.364	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	OMIM:614052
2290	0.3639	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies	OMIM:617527
2290	0.3639	Neuropathy, distal hereditary motor, type VC	OMIM:619112
2292	0.3637	?Spinocerebellar ataxia, autosomal recessive 25	OMIM:617584
2293	0.3636	Neurodevelopmental disorder with visual defects and brain anomalies	OMIM:618547
2293	0.3636	Methylmalonic aciduria, vitamin B12-responsive, cblA type	OMIM:251100
2295	0.3635	Lissencephaly due to LIS1 mutation	ORPHA:95232
2295	0.3635	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	OMIM:616657
2297	0.3634	Spinocerebellar ataxia 48	OMIM:618093
2298	0.3629	Spastic paraplegia 80, autosomal dominant	OMIM:618418
2299	0.3627	Immunodeficiency, X-linked, with hyper-IgM	OMIM:308230
2299	0.3627	Nephrogenic syndrome of inappropriate antidiuresis	OMIM:300539
2301	0.3626	Vitamin D-dependent rickets, type I	OMIM:264700
2302	0.3625	Nemaline myopathy 9	OMIM:615731
2303	0.3624	Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency	ORPHA:88639
2303	0.3624	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies	OMIM:618527
2303	0.3624	Porphyria, acute intermittent, nonerythroid variant	OMIM:176000
2306	0.3621	Glucocorticoid deficiency, due to ACTH unresponsiveness	OMIM:202200
2306	0.3621	Glucocorticoid deficiency 2	OMIM:607398
2308	0.362	Mitochondrial complex I deficiency, nuclear type 15	OMIM:618237
2308	0.362	Spastic paraplegia 78, autosomal recessive	OMIM:617225
2308	0.362	Intellectual disability-hypotonic facies syndrome, X-linked	OMIM:309580
2311	0.3619	Brain abnormalities, neurodegeneration, and dysosteosclerosis	OMIM:618476
2312	0.3617	Spastic paraplegia 50, autosomal recessive	OMIM:612936
2313	0.3616	Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome	ORPHA:309854
2314	0.3614	Familial acute necrotizing encephalopathy	ORPHA:88619
2314	0.3614	Pseudohyperkalemia, familial, 2, due to red cell leak	OMIM:609153
2316	0.3613	ACTH-independent macronodular adrenal hyperplasia	OMIM:219080
2317	0.3612	Mitochondrial complex I deficiency, nuclear type 32	OMIM:618252
2317	0.3612	Gyrate atrophy of choroid and retina with or without ornithinemia	OMIM:258870
2319	0.361	Leukodystrophy, adult-onset, autosomal dominant	OMIM:169500
2320	0.3609	Autosomal recessive spastic paraplegia type 46	ORPHA:320391
2320	0.3609	?Spastic paraplegia 44, autosomal recessive	OMIM:613206
2320	0.3609	Tremor-ataxia-central hypomyelination syndrome	ORPHA:447896
2320	0.3609	?Neurodegeneration with brain iron accumulation 7	OMIM:617916
2320	0.3609	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	OMIM:618088
2325	0.3608	Spinocerebellar ataxia 42	OMIM:616795
2325	0.3608	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	OMIM:607694
2327	0.3607	Spinocerebellar ataxia 7	OMIM:164500
2328	0.3604	Combined oxidative phosphorylation deficiency 53	OMIM:619423
2329	0.36	Spinocerebellar ataxia, autosomal recessive 14	OMIM:615386
2329	0.36	Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities	OMIM:620330
2331	0.3599	Intellectual developmental disorder, autosomal recessive 1	OMIM:249500
2332	0.3597	SESAME syndrome	OMIM:612780
2332	0.3597	Sotos syndrome	OMIM:117550
2332	0.3597	Leukodystrophy, hypomyelinating, 13	OMIM:616881
2335	0.3596	Pituitary adenoma 4, ACTH-secreting, somatic	OMIM:219090
2335	0.3596	?Coenzyme Q10 deficiency, primary, 9	OMIM:619028
2335	0.3596	Microcephaly, short stature, and impaired glucose metabolism 2	OMIM:616817
2338	0.3595	Spinocerebellar ataxia 15	OMIM:606658
2338	0.3595	Ataxia-pancytopenia syndrome	ORPHA:2585
2338	0.3595	Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome	ORPHA:280679
2341	0.3592	Encephalopathy, acute, infection-induced, susceptibility to, 9	OMIM:618426
2341	0.3592	Hypoxanthine guanine phosphoribosyltransferase partial deficiency	ORPHA:79233
2343	0.3591	Developmental and epileptic encephalopathy 6B, non-Dravet	OMIM:619317
2343	0.3591	?Spinocerebellar ataxia, autosomal recessive 22	OMIM:616948
2345	0.359	Cushing syndrome, ACTH-independent adrenal, somatic	OMIM:615830
2346	0.3588	Mitochondrial complex III deficiency, nuclear type 4	OMIM:615159
2347	0.3587	Mitochondrial complex I deficiency, nuclear type 22	OMIM:618243
2348	0.3585	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency	OMIM:616326
2349	0.3584	Rickets, vitamin D-resistant, type IIA	OMIM:277440
2350	0.358	3-methylglutaconic aciduria type 7	ORPHA:445038
2351	0.3578	Myasthenic syndrome, congenital, 6, presynaptic	OMIM:254210
2352	0.3576	Multiple sclerosis, susceptibility to, 1	OMIM:126200
2352	0.3576	Keppen-Lubinsky syndrome	OMIM:614098
2352	0.3576	Multiple sclerosis, susceptibility to, 1	OMIM:126200
2352	0.3576	Multiple sclerosis, disease progression, modifier of	OMIM:126200
2356	0.3574	Spinocerebellar ataxia type 28	ORPHA:101109
2356	0.3574	Mucopolysaccharidosis type IIID	OMIM:252940
2356	0.3574	Pentosuria	ORPHA:2843
2359	0.3572	Spinocerebellar ataxia 28	OMIM:610246
2359	0.3572	Spinocerebellar ataxia 44	OMIM:617691
2361	0.3565	Farber disease	ORPHA:333
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	GM2 gangliosidosis, AB variant	ORPHA:309246
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Pontocerebellar hypoplasia, type 16	OMIM:619527
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Duane retraction syndrome	ORPHA:233
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Duane retraction syndrome	ORPHA:233
2361	0.3565	Duane retraction syndrome	ORPHA:233
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Borjeson-Forssman-Lehmann syndrome	ORPHA:127
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2361	0.3565	Bardet-Biedl syndrome	ORPHA:110
2395	0.3561	Autosomal dominant generalized epidermolysis bullosa simplex, severe form	ORPHA:79396
2395	0.3561	Autosomal dominant generalized epidermolysis bullosa simplex, severe form	ORPHA:79396
2397	0.356	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	OMIM:618056
2398	0.3559	Mitochondrial complex I deficiency, nuclear type 23	OMIM:618244
2398	0.3559	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	OMIM:202010
2400	0.3556	Spinocerebellar ataxia, autosomal recessive 8	OMIM:610743
2401	0.3554	?Mitochondrial complex IV deficiency, nuclear type 20	OMIM:619064
2402	0.3553	?Muscular dystrophy, congenital, Davignon-Chauveau type	OMIM:617066
2402	0.3553	Encephalopathy, progressive, with or without lipodystrophy	OMIM:615924
2404	0.3552	Neuropathy, hereditary sensory, type ID	OMIM:613708
2405	0.3547	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
2405	0.3547	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
2407	0.3544	Rabson-Mendenhall syndrome	ORPHA:769
2408	0.354	?Hypervalinemia or hyperleucine-isoleucinemia	OMIM:618850
2409	0.3538	Alpha-methylacyl-CoA racemase deficiency	OMIM:614307
2410	0.3537	Homocystinuria-megaloblastic anemia, cbl E type	OMIM:236270
2411	0.3536	Hyperphenylalaninemia, BH4-deficient, A	OMIM:261640
2412	0.3532	3-Methylcrotonyl-CoA carboxylase 1 deficiency	OMIM:210200
2413	0.3531	Juvenile Huntington disease	ORPHA:248111
2413	0.3531	Combined oxidative phosphorylation deficiency 32	OMIM:617664
2415	0.3528	Spinocerebellar ataxia type 40	ORPHA:423275
2416	0.3523	NESCAV syndrome	OMIM:614255
2416	0.3523	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	OMIM:617282
2418	0.3522	Pseudo-TORCH syndrome 1	OMIM:251290
2419	0.3519	Primary hyperaldosteronism-seizures-neurological abnormalities syndrome	ORPHA:369929
2419	0.3519	?Epilepsy, progressive myoclonic, 10	OMIM:616640
2421	0.3517	Cerebellar ataxia	OMIM:604290
2421	0.3517	Lysinuric protein intolerance	ORPHA:470
2423	0.3516	Spinocerebellar ataxia 12	OMIM:604326
2424	0.3515	Coenzyme Q10 deficiency, primary, 5	OMIM:614654
2425	0.3514	Pulmonary alveolar microlithiasis	ORPHA:60025
2426	0.3513	Glycosylphosphatidylinositol biosynthesis defect 15	OMIM:617810
2427	0.3511	Pontocerebellar hypoplasia, type 8	OMIM:614961
2428	0.3509	?Epilepsy, progressive myoclonic, 9	OMIM:616540
2429	0.3508	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	OMIM:600795
2429	0.3508	Barth syndrome	OMIM:302060
2431	0.3507	Spastic paraplegia 48, autosomal recessive	OMIM:613647
2432	0.3506	Hyperinsulinemic hypoglycemia, familial, 8	OMIM:620211
2433	0.3503	Joubert syndrome 24	OMIM:616654
2434	0.3501	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	OMIM:617560
2435	0.3497	Multiple mitochondrial dysfunctions syndrome 4	OMIM:616370
2436	0.3496	Mohr-Tranebjaerg syndrome	OMIM:304700
2436	0.3496	Short stature, oligodontia, dysmorphic facies, and motor delay	OMIM:619234
2438	0.3495	Phosphoserine aminotransferase deficiency, infantile/juvenile form	ORPHA:284417
2438	0.3495	Fascioscapulohumeral muscular dystrophy 2, digenic	OMIM:158901
2440	0.3494	Glutamine deficiency, congenital	OMIM:610015
2441	0.3493	PLAA-associated neurodevelopmental disorder	ORPHA:521426
2442	0.3492	Primary hyperoxaluria type 1	ORPHA:93598
2443	0.3491	Mitochondrial complex I deficiency, nuclear type 18	OMIM:618240
2443	0.3491	Apparent mineralocorticoid excess	ORPHA:320
2445	0.3487	Intellectual developmental disorder with speech delay and axonal peripheral neuropathy	OMIM:619099
2446	0.3486	Alacrima, achalasia, and impaired intellectual development syndrome	OMIM:615510
2446	0.3486	Multiple sulfatase deficiency	OMIM:272200
2448	0.3482	Intellectual developmental disorder, X-linked 104	OMIM:300983
2449	0.3481	Cerebrooculofacioskeletal syndrome 4	OMIM:610758
2449	0.3481	46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency	ORPHA:168558
2449	0.3481	Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency	ORPHA:90791
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Hypomyelination with brainstem and spinal cord involvement and leg spasticity	OMIM:615281
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2452	0.3478	Behavioral variant of frontotemporal dementia	ORPHA:275864
2462	0.3476	Basal ganglia calcification, idiopathic, 8, autosomal recessive	OMIM:618824
2463	0.3475	Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	OMIM:604317
2464	0.3472	Hereditary hypophosphatemic rickets with hypercalciuria	ORPHA:157215
2464	0.3472	Immunodeficiency 82 with systemic inflammation	OMIM:619381
2464	0.3472	Hereditary hypophosphatemic rickets with hypercalciuria	ORPHA:157215
2467	0.347	Krabbe disease	OMIM:245200
2467	0.347	Spastic paraplegia 56, autosomal recessive	OMIM:615030
2469	0.3468	Huntington disease-like 1	ORPHA:157941
2469	0.3468	Developmental and epileptic encephalopathy 69	OMIM:618285
2471	0.3467	Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome	ORPHA:447997
2472	0.3466	Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	OMIM:604121
2473	0.3465	Neurodevelopmental disorder with seizures, hypotonia, and brain abnormalities	OMIM:618922
2474	0.3464	?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency	OMIM:616323
2474	0.3464	?Birk-Aharoni syndrome	OMIM:620071
2474	0.3464	Leukocyte adhesion deficiency type II	ORPHA:99843
2477	0.3462	Pseudohypoaldosteronism, type IIC	OMIM:614492
2478	0.346	Biliary, renal, neurologic, and skeletal syndrome	OMIM:619534
2479	0.3459	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	OMIM:218700
2480	0.3458	Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome	ORPHA:500150
2481	0.3457	Spastic paraplegia 81, autosomal recessive	OMIM:618768
2482	0.3453	Striatal degeneration, autosomal dominant	OMIM:609161
2483	0.3452	Frontometaphyseal dysplasia 1	OMIM:305620
2483	0.3452	Lethal congenital contracture syndrome 1	OMIM:253310
2483	0.3452	Ogden syndrome	OMIM:300855
2486	0.3451	Cerebellar, ocular, craniofacial, and genital syndrome	OMIM:618479
2487	0.345	?Hemochromatosis, type 5	OMIM:615517
2488	0.3445	Sandhoff disease, infantile form	ORPHA:309155
2489	0.3444	Peroxisome biogenesis disorder 12A (Zellweger)	OMIM:614886
2490	0.3443	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	OMIM:618425
2491	0.344	ANE syndrome	ORPHA:157954
2491	0.344	Developmental and epileptic encephalopathy 14	OMIM:614959
2493	0.3438	Combined oxidative phosphorylation deficiency 36	OMIM:617950
2493	0.3438	H syndrome	ORPHA:168569
2495	0.3436	Intellectual developmental disorder, X-linked syndromic 13	OMIM:300055
2495	0.3436	GLUT1 deficiency syndrome 1, infantile onset, severe	OMIM:606777
2495	0.3436	Neurodegeneration with brain iron accumulation 1	OMIM:234200
2495	0.3436	3-methylglutaconic aciduria, type III	OMIM:258501
2499	0.3433	Hypokalemic tubulopathy and deafness	OMIM:619406
2500	0.3431	Liddle syndrome 2	OMIM:618114
2500	0.3431	?Liddle syndrome 3	OMIM:618126
2500	0.3431	Liddle syndrome 1	OMIM:177200
2500	0.3431	Apparent mineralocorticoid excess	OMIM:218030
2504	0.3429	MGAT2-CDG	ORPHA:79329
2505	0.3428	Spinocerebellar ataxia type 15/16	ORPHA:98769
2505	0.3428	Developmental and epileptic encephalopathy 95	OMIM:618143
2507	0.3427	Intellectual disability and myopathy syndrome	OMIM:619719
2508	0.3425	Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	OMIM:250850
2509	0.3422	Osteogenesis imperfecta, type XVII	OMIM:616507
2509	0.3422	Stiff skin syndrome	OMIM:184900
2509	0.3422	Singleton-Merten syndrome 1	OMIM:182250
2509	0.3422	Neuralgic amyotrophy	ORPHA:2901
2509	0.3422	Lymphedema-distichiasis syndrome	ORPHA:33001
2509	0.3422	?Glycogen storage disease XV	OMIM:613507
2509	0.3422	Intellectual developmental disorder, autosomal recessive 68	OMIM:618302
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Multiple epiphyseal dysplasia due to collagen 9 anomaly	ORPHA:166002
2509	0.3422	Neurofibromatosis-Noonan syndrome	OMIM:601321
2509	0.3422	?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency	OMIM:616314
2509	0.3422	Full schwannomatosis	ORPHA:93921
2509	0.3422	Congenital myopathy 15	OMIM:620161
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Arthrogryposis, distal, type 2A (Freeman-Sheldon)	OMIM:193700
2509	0.3422	Aminoacylase 1 deficiency	OMIM:609924
2509	0.3422	Neuropathy, hereditary sensory and autonomic, type VII	OMIM:615548
2509	0.3422	Classical Ehlers-Danlos syndrome	ORPHA:287
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Multiple epiphyseal dysplasia due to collagen 9 anomaly	ORPHA:166002
2509	0.3422	Angioedema, hereditary, 1 and 2	OMIM:106100
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Takayasu arteritis	ORPHA:3287
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Marbach-Rustad progeroid syndrome	OMIM:619322
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	X-linked complicated corpus callosum dysgenesis	ORPHA:1497
2509	0.3422	Thyrotropin-releasing hormone deficiency	OMIM:275120
2509	0.3422	Takayasu arteritis	ORPHA:3287
2509	0.3422	Musculocontractural Ehlers-Danlos syndrome	ORPHA:2953
2509	0.3422	Musculocontractural Ehlers-Danlos syndrome	ORPHA:2953
2509	0.3422	Sneddon syndrome	ORPHA:820
2509	0.3422	Pyle disease	OMIM:265900
2509	0.3422	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	OMIM:225400
2509	0.3422	D-2-hydroxyglutaric aciduria	OMIM:600721
2509	0.3422	Full schwannomatosis	ORPHA:93921
2509	0.3422	Pulmonary hypertension, primary, 5	OMIM:265400
2509	0.3422	Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies	OMIM:620236
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Full schwannomatosis	ORPHA:93921
2509	0.3422	Classical Ehlers-Danlos syndrome	ORPHA:287
2509	0.3422	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia	OMIM:613435
2509	0.3422	Progressive pseudorheumatoid dysplasia	OMIM:208230
2509	0.3422	Full schwannomatosis	ORPHA:93921
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Holoprosencephaly 12, with or without pancreatic agenesis	OMIM:618500
2509	0.3422	Classical Ehlers-Danlos syndrome	ORPHA:287
2509	0.3422	Multiple epiphyseal dysplasia due to collagen 9 anomaly	ORPHA:166002
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Takayasu arteritis	ORPHA:3287
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2509	0.3422	Acute promyelocytic leukemia	ORPHA:520
2563	0.3421	Hyperaldosteronism, familial, type III	OMIM:613677
2564	0.3419	Developmental and epileptic encephalopathy 68	OMIM:618201
2564	0.3419	Primary aldosteronism, seizures, and neurologic abnormalities	OMIM:615474
2566	0.3417	Spastic paraplegia 51, autosomal recessive	OMIM:613744
2566	0.3417	Intellectual developmental disorder, autosomal recessive 40	OMIM:615599
2566	0.3417	Spastic paraplegia 82, autosomal recessive	OMIM:618770
2569	0.3415	Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome	ORPHA:83629
2569	0.3415	Autosomal recessive spastic paraplegia type 45	ORPHA:320396
2569	0.3415	Microcephaly-thin corpus callosum-intellectual disability syndrome	ORPHA:397951
2569	0.3415	Kilquist syndrome	OMIM:619080
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2573	0.3414	MODY	ORPHA:552
2586	0.3413	Citrullinemia type II	ORPHA:247585
2587	0.3412	Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction	ORPHA:506353
2587	0.3412	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome	OMIM:618877
2587	0.3412	X-linked parkinsonism-spasticity syndrome	ORPHA:363654
2590	0.3409	Spinocerebellar ataxia type 12	ORPHA:98762
2590	0.3409	Immunodeficiency 43	OMIM:241600
2592	0.3406	3-methylglutaconic aciduria, type I	OMIM:250950
2593	0.3402	Intellectual developmental disorder, autosomal recessive 73	OMIM:619717
2593	0.3402	Beta-thalassemia major	ORPHA:231214
2593	0.3402	Dominant beta-thalassemia	ORPHA:231226
2596	0.3401	Spastic paraplegia 83, autosomal recessive	OMIM:619027
2597	0.3398	Developmental and epileptic encephalopathy 42	OMIM:617106
2597	0.3398	Mucolipidosis type IV	ORPHA:578
2597	0.3398	Joubert syndrome with hepatic defect	ORPHA:1454
2597	0.3398	X-linked sideroblastic anemia and spinocerebellar ataxia	ORPHA:2802
2597	0.3398	Joubert syndrome with hepatic defect	ORPHA:1454
2597	0.3398	COACH syndrome 1	OMIM:216360
2597	0.3398	Cerebrooculofacioskeletal syndrome 1	OMIM:214150
2597	0.3398	Cerebrooculofacioskeletal syndrome 1	OMIM:214150
2597	0.3398	Joubert syndrome with hepatic defect	ORPHA:1454
2597	0.3398	Joubert syndrome with hepatic defect	ORPHA:1454
2597	0.3398	NKX6-2-related autosomal recessive hypomyelinating leukodystrophy	ORPHA:527497
2597	0.3398	Hartnup disease	ORPHA:2116
2597	0.3398	Hartnup disease	ORPHA:2116
2610	0.3394	Sarcosinemia	ORPHA:3129
2610	0.3394	Hartnup disorder	OMIM:234500
2612	0.3389	Aromatic L-amino acid decarboxylase deficiency	OMIM:608643
2613	0.3388	Huntington disease-like 2	OMIM:606438
2614	0.3385	Hypocalcemia, autosomal dominant, with Bartter syndrome	OMIM:601198
2615	0.338	Rubinstein-Taybi syndrome 1	OMIM:180849
2616	0.3379	2-methylbutyrylglycinuria	OMIM:610006
2617	0.3377	Atypical pantothenate kinase-associated neurodegeneration	ORPHA:216873
2617	0.3377	Congenital analbuminemia	ORPHA:86816
2619	0.3376	Basilicata-Akhtar syndrome	OMIM:301032
2620	0.3372	Pontocerebellar hypoplasia, type 10	OMIM:615803
2620	0.3372	Congenital disorder of glycosylation, type Ii	OMIM:607906
2620	0.3372	Developmental and epileptic encephalopathy 83	OMIM:618744
2623	0.3371	Leukodystrophy, hypomyelinating, 22	OMIM:619328
2624	0.337	Mowat-Wilson syndrome due to a ZEB2 point mutation	ORPHA:261552
2625	0.3368	RENI syndrome	OMIM:617575
2626	0.3366	Developmental and epileptic encephalopathy 89	OMIM:619124
2626	0.3366	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	OMIM:614254
2628	0.3363	Microcephaly, epilepsy, and diabetes syndrome	OMIM:614231
2629	0.3361	Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome	ORPHA:37042
2630	0.3353	Joubert syndrome 28	OMIM:617121
2631	0.335	ALG8-CDG	ORPHA:79325
2632	0.3347	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2632	0.3347	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2632	0.3347	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2632	0.3347	Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15	ORPHA:98754
2636	0.3346	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	OMIM:605115
2637	0.3343	Von Hippel-Lindau disease	ORPHA:892
2637	0.3343	Von Hippel-Lindau disease	ORPHA:892
2639	0.3342	Microcephaly, postnatal progressive, with seizures and brain atrophy	OMIM:613668
2639	0.3342	Spastic paraplegia 53, autosomal recessive	OMIM:614898
2639	0.3342	Huntington disease-like 2	ORPHA:98934
2642	0.3337	ALG12-CDG	ORPHA:79324
2643	0.3335	Lymphoproliferative syndrome, X-linked, 1	OMIM:308240
2643	0.3335	Aldosteronism, glucocorticoid-remediable	OMIM:103900
2645	0.3334	X-linked intellectual disability-psychosis-macroorchidism syndrome	ORPHA:3077
2646	0.3332	Neuroocular syndrome	OMIM:619539
2647	0.333	Autosomal dominant congenital benign spinal muscular atrophy	ORPHA:1216
2648	0.3329	Hypoaldosteronism, congenital, due to CMO II deficiency	OMIM:610600
2649	0.3324	Full NF2-related schwannomatosis	ORPHA:637
2650	0.3319	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness	OMIM:615441
2650	0.3319	Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects	OMIM:615120
2650	0.3319	Glycogen storage disease due to LAMP-2 deficiency	ORPHA:34587
2650	0.3319	Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy	OMIM:617802
2650	0.3319	Kanzaki disease	OMIM:609242
2650	0.3319	Developmental and epileptic encephalopathy 63	OMIM:617976
2650	0.3319	Neurological conditions associated with aminoacylase 1 deficiency	ORPHA:137754
2650	0.3319	Developmental and epileptic encephalopathy 101	OMIM:619814
2650	0.3319	Ehlers-Danlos syndrome, musculocontractural type 2	OMIM:615539
2650	0.3319	Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination	OMIM:617393
2650	0.3319	Developmental and epileptic encephalopathy 70	OMIM:618298
2650	0.3319	Dentici-Novelli neurodevelopmental syndrome	OMIM:619877
2650	0.3319	Arthrochalasia Ehlers-Danlos syndrome	ORPHA:1899
2650	0.3319	Neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation	OMIM:618797
2650	0.3319	Arthrochalasia Ehlers-Danlos syndrome	ORPHA:1899
2665	0.3318	Autosomal dominant hyperinsulinism due to SUR1 deficiency	ORPHA:276575
2665	0.3318	Hyperinsulinism due to INSR deficiency	ORPHA:263458
2667	0.3316	Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome	ORPHA:522077
2668	0.3315	Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia	OMIM:619133
2669	0.3313	RIDDLE syndrome	ORPHA:420741
2670	0.3312	Smith-Lemli-Opitz syndrome	OMIM:270400
2671	0.3311	Lopes-Maciel-Rodan syndrome	OMIM:617435
2672	0.3309	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
2672	0.3309	Developmental and epileptic encephalopathy 75	OMIM:618437
2672	0.3309	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
2672	0.3309	Spastic paraplegia 47, autosomal recessive	OMIM:614066
2672	0.3309	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
2672	0.3309	Severe intellectual disability and progressive spastic paraplegia	ORPHA:280763
2672	0.3309	Spastic paraplegia 52, autosomal recessive	OMIM:614067
2672	0.3309	Parkinsonian-pyramidal syndrome	ORPHA:171695
2672	0.3309	Lissencephaly 4 (with microcephaly)	OMIM:614019
2672	0.3309	Parkinson disease 15, autosomal recessive	OMIM:260300
2672	0.3309	Parkinsonian-pyramidal syndrome	ORPHA:171695
2672	0.3309	Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome	ORPHA:477673
2672	0.3309	Primary lateral sclerosis, juvenile	OMIM:606353
2672	0.3309	?Parkinsonism with spasticity, X-linked	OMIM:300911
2672	0.3309	Cortical dysplasia, complex, with other brain malformations 12	OMIM:620316
2687	0.3304	Diarrhea 1, secretory chloride, congenital	OMIM:214700
2688	0.3299	Pettigrew syndrome	OMIM:304340
2688	0.3299	Huntington disease	OMIM:143100
2690	0.3296	Thyroid hormone resistance	OMIM:188570
2691	0.3294	Shwachman-Diamond syndrome	ORPHA:811
2691	0.3294	Shwachman-Diamond syndrome	ORPHA:811
2691	0.3294	Shwachman-Diamond syndrome	ORPHA:811
2691	0.3294	Shwachman-Diamond syndrome	ORPHA:811
2695	0.3289	Leukoencephalopathy, diffuse hereditary, with spheroids 1	OMIM:221820
2696	0.3288	Triple A syndrome	ORPHA:869
2696	0.3288	Triple A syndrome	ORPHA:869
2696	0.3288	Mitochondrial complex I deficiency, nuclear type 3	OMIM:618224
2696	0.3288	Xeroderma pigmentosum, group B	OMIM:610651
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Glutamate-cysteine ligase deficiency	ORPHA:33574
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6	OMIM:618683
2696	0.3288	Congenital disorder of glycosylation, type In	OMIM:612015
2696	0.3288	Cortical dysplasia, complex, with other brain malformations 9	OMIM:618174
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Triple A syndrome	ORPHA:869
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Leukodystrophy, hypomyelinating, 23, with ataxia, deafness, liver dysfunction, and dilated cardiomyopathy	OMIM:619688
2696	0.3288	Alexander disease type I	ORPHA:363717
2696	0.3288	Early-onset Lafora body disease	ORPHA:324290
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Epilepsy, progressive myoclonic, 11	OMIM:618876
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2696	0.3288	Behçet disease	ORPHA:117
2722	0.3287	Autoinflammation with infantile enterocolitis	OMIM:616050
2723	0.3285	Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity	ORPHA:53583
2723	0.3285	Dystonia 9	OMIM:601042
2723	0.3285	?Glutathioninuria	OMIM:231950
2726	0.3282	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
2726	0.3282	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
2726	0.3282	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
2729	0.3274	Combined hyperlipidemia, familial	OMIM:144250
2730	0.3273	Epilepsy, progressive myoclonic 4, with or without renal failure	OMIM:254900
2731	0.3272	Bartter syndrome, type 5, antenatal, transient	OMIM:300971
2732	0.3269	Congenital cataracts, hearing loss, and neurodegeneration	OMIM:614482
2733	0.3267	Combined SAP deficiency	OMIM:611721
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Aicardi-Goutieres syndrome 3	OMIM:610329
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Developmental and epileptic encephalopathy 58	OMIM:617830
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy	OMIM:617093
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	MEHMO syndrome	ORPHA:85282
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	?Peroxisome biogenesis disorder 10B	OMIM:617370
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Peroxisomal acyl-CoA oxidase deficiency	ORPHA:2971
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures	OMIM:620023
2734	0.3266	Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome	ORPHA:488627
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Fanconi anemia	ORPHA:84
2734	0.3266	Hengel-Maroofian-Schols syndrome	OMIM:619641
2734	0.3266	Spastic paraplegia, intellectual disability, nystagmus, and obesity	OMIM:617296
2734	0.3266	Neonatal adrenoleukodystrophy	ORPHA:44
2734	0.3266	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	OMIM:618381
2780	0.3265	Sturge-Weber syndrome	ORPHA:3205
2780	0.3265	Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies	OMIM:619995
2780	0.3265	Neurodevelopmental disorder with microcephaly and structural brain anomalies	OMIM:618492
2780	0.3265	Intellectual developmental disorder, autosomal dominant 44, with microcephaly	OMIM:617061
2780	0.3265	Autism spectrum disorder due to AUTS2 deficiency	ORPHA:352490
2785	0.3263	Usher syndrome type 3B	OMIM:614504
2786	0.3262	Primary lateral sclerosis	ORPHA:35689
2786	0.3262	?Leukodystrophy, hypomyelinating, 20	OMIM:619071
2786	0.3262	Pyruvate dehydrogenase E2 deficiency	ORPHA:79244
2786	0.3262	Alzheimer disease, type 3, with spastic paraparesis and apraxia	OMIM:607822
2786	0.3262	?Alzheimer disease, protection against, due to APOE3-Christchurch	OMIM:607822
2786	0.3262	Autosomal recessive spastic paraplegia type 56	ORPHA:320411
2792	0.3259	Diarrhea 10, protein-losing enteropathy type	OMIM:618183
2793	0.3253	Spastic paraplegia 79A, autosomal dominant	OMIM:620221
2794	0.3251	Autosomal recessive spastic paraplegia type 53	ORPHA:319199
2795	0.325	GLUT1 deficiency syndrome 2, childhood onset	OMIM:612126
2796	0.3249	Pyruvate carboxylase deficiency	OMIM:266150
2797	0.3248	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	OMIM:615688
2798	0.3246	Hyperphenylalaninemia, BH4-deficient, B	OMIM:233910
2798	0.3246	X-linked intellectual disability-short stature-overweight syndrome	ORPHA:457240
2798	0.3246	Frontometaphyseal dysplasia	ORPHA:1826
2798	0.3246	Frontometaphyseal dysplasia	ORPHA:1826
2802	0.3244	Hypoaldosteronism, congenital, due to CMO I deficiency	OMIM:203400
2803	0.3242	Paroxysmal exertion-induced dyskinesia	ORPHA:98811
2803	0.3242	Oculodentodigital dysplasia	OMIM:164200
2803	0.3242	Spastic paraplegia 89, autosomal recessive	OMIM:620379
2803	0.3242	Neurodevelopmental disorder with neuromuscular and skeletal abnormalities	OMIM:619833
2803	0.3242	Paroxysmal exertion-induced dyskinesia	ORPHA:98811
2808	0.3239	COG5-CDG	ORPHA:263487
2809	0.3236	Developmental and epileptic encephalopathy 49	OMIM:617281
2810	0.3235	Pseudohypoaldosteronism, type IB3, autosomal recessive	OMIM:620126
2810	0.3235	Pseudohypoaldosteronism, type IB2, autosomal recessive	OMIM:620125
2810	0.3235	Pseudohypoaldosteronism type I, autosomal dominant	OMIM:177735
2813	0.3231	ALG1-CDG	ORPHA:79327
2813	0.3231	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2813	0.3231	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2813	0.3231	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2813	0.3231	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2818	0.323	Immunodeficiency by defective expression of MHC class II	ORPHA:572
2818	0.323	Immunodeficiency by defective expression of MHC class II	ORPHA:572
2818	0.323	Immunodeficiency by defective expression of MHC class II	ORPHA:572
2818	0.323	Immunodeficiency by defective expression of MHC class II	ORPHA:572
2822	0.3229	Autosomal recessive hyperinsulinism due to Kir6.2 deficiency	ORPHA:79644
2822	0.3229	Intellectual developmental disorder, X-linked 30	OMIM:300558
2824	0.3228	Baker-Gordon syndrome	OMIM:618218
2825	0.3227	VISS syndrome	OMIM:619472
2826	0.3226	Cerebral creatine deficiency syndrome 3	OMIM:612718
2827	0.3221	Intellectual developmental disorder, autosomal dominant 1	OMIM:156200
2828	0.3217	Paroxysmal nocturnal hemoglobinuria	ORPHA:447
2829	0.3215	Lymphoproliferative syndrome, X-linked, 2	OMIM:300635
2829	0.3215	Lymphoproliferative syndrome, X-linked, 2	OMIM:300635
2829	0.3215	Trichohepatoenteric syndrome 1	OMIM:222470
2832	0.3214	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	ORPHA:2590
2833	0.3209	Solitary fibrous tumor	ORPHA:2126
2833	0.3209	Solitary fibrous tumor	ORPHA:2126
2835	0.3207	Generalized pustular psoriasis	ORPHA:247353
2835	0.3207	?Lipodystrophy, familial partial, type 5	OMIM:615238
2835	0.3207	Generalized pustular psoriasis	ORPHA:247353
2838	0.3206	Delta-sarcoglycan-related limb-girdle muscular dystrophy R6	ORPHA:219
2838	0.3206	Galloway-Mowat syndrome 3	OMIM:617729
2840	0.32	Amyotrophic lateral sclerosis 11	OMIM:612577
2840	0.32	?Arthrogryposis multiplex congenita 2, neurogenic type	OMIM:208100
2840	0.32	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	OMIM:616896
2840	0.32	Lethal congenital contracture syndrome 4	OMIM:614915
2840	0.32	Hereditary sensory and autonomic neuropathy type 2	ORPHA:970
2840	0.32	Atrial standstill	ORPHA:1344
2840	0.32	X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome	ORPHA:85329
2840	0.32	Fried syndrome	ORPHA:85335
2840	0.32	Autosomal recessive multiple pterygium syndrome	ORPHA:2990
2840	0.32	Lethal congenital contractural syndrome 3	OMIM:611369
2840	0.32	Autosomal recessive multiple pterygium syndrome	ORPHA:2990
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Werner syndrome	ORPHA:902
2840	0.32	RECON progeroid syndrome	OMIM:620370
2840	0.32	?Lethal congenital contractural syndrome 2	OMIM:607598
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Atrial standstill	ORPHA:1344
2840	0.32	Ruijs-Aalfs syndrome	OMIM:616200
2840	0.32	Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome	ORPHA:477814
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Hereditary sensory and autonomic neuropathy type 2	ORPHA:970
2840	0.32	?Alopecia, neurologic defects, and endocrinopathy syndrome	OMIM:612079
2840	0.32	Juvenile hyaline fibromatosis	ORPHA:2028
2840	0.32	Fetal akinesia deformation sequence 4	OMIM:618393
2840	0.32	Neurodevelopmental disorder with hypotonia, microcephaly, and seizures	OMIM:618862
2840	0.32	?Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 2	OMIM:619759
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Lethal congenital contracture syndrome type 1	ORPHA:1486
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	OMIM:603387
2840	0.32	?Proteasome-associated autoinflammatory syndrome 4	OMIM:619183
2840	0.32	Primary biliary cholangitis	ORPHA:186
2840	0.32	Hereditary sensory and autonomic neuropathy type 2	ORPHA:970
2840	0.32	Spastic paraplegia 64, autosomal recessive	OMIM:615683
2840	0.32	Hereditary sensory and autonomic neuropathy type 2	ORPHA:970
2840	0.32	Osteogenesis imperfecta, type XIII	OMIM:614856
2840	0.32	Legg-Calvé-Perthes disease	ORPHA:2380
2840	0.32	Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities	OMIM:618603
2840	0.32	Primary biliary cholangitis	ORPHA:186
2880	0.3198	Analbuminemia	OMIM:616000
2881	0.3197	Keratitis-ichthyosis-deafness syndrome, autosomal recessive	OMIM:242150
2882	0.3196	Hereditary pulmonary alveolar proteinosis	ORPHA:264675
2882	0.3196	Hereditary pulmonary alveolar proteinosis	ORPHA:264675
2884	0.3195	Lymphoproliferative syndrome 1	OMIM:613011
2885	0.3189	Ocular anomalies-axonal neuropathy-developmental delay syndrome	ORPHA:496790
2886	0.3187	Intellectual developmental disorder, X-linked syndromic, Cabezas type	OMIM:300354
2887	0.3185	Immunodeficiency 97 with autoinflammation	OMIM:619802
2888	0.3184	Iron overload, susceptibility to	OMIM:620121
2889	0.3178	Dehydrated hereditary stomatocytosis	ORPHA:3202
2889	0.3178	Dehydrated hereditary stomatocytosis	ORPHA:3202
2889	0.3178	Dehydrated hereditary stomatocytosis	ORPHA:3202
2892	0.3174	?Megaloblastic anemia, folate-responsive	OMIM:601775
2893	0.3173	Immunodeficiency 80 with or without cardiomyopathy	OMIM:619313
2894	0.3171	Cholestasis, progressive familial intrahepatic, 10	OMIM:619868
2895	0.3169	Resistance to thyrotropin-releasing hormone syndrome	ORPHA:99832
2896	0.3164	Nephrotic syndrome, type 1	OMIM:256300
2897	0.3163	Mucolipidosis III alpha/beta	OMIM:252600
2898	0.3161	Alpha-mannosidosis, infantile form	ORPHA:309282
2899	0.316	Hemolytic anemia due to red cell pyruvate kinase deficiency	ORPHA:766
2900	0.3152	Multiple endocrine neoplasia type 1	ORPHA:652
2900	0.3152	Multiple endocrine neoplasia type 1	ORPHA:652
2900	0.3152	Multiple endocrine neoplasia type 1	ORPHA:652
2900	0.3152	Multiple endocrine neoplasia type 1	ORPHA:652
2900	0.3152	Multiple endocrine neoplasia type 1	ORPHA:652
2905	0.3149	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	OMIM:221770
2905	0.3149	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	OMIM:618193
2907	0.314	Liang-Wang syndrome	OMIM:618729
2908	0.3133	Sitosterolemia 1	OMIM:210250
2909	0.3131	Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive	OMIM:226990
2909	0.3131	Developmental delay-facial dysmorphism syndrome due to MED13L deficiency	ORPHA:369891
2911	0.313	Transient neonatal diabetes mellitus	ORPHA:99886
2911	0.313	Transient neonatal diabetes mellitus	ORPHA:99886
2911	0.313	Tenorio syndrome	OMIM:616260
2911	0.313	Transient neonatal diabetes mellitus	ORPHA:99886
2911	0.313	Transient neonatal diabetes mellitus	ORPHA:99886
2916	0.3127	Congenital disorder of glycosylation, type IIp	OMIM:616829
2916	0.3127	Cholestasis, progressive familial intrahepatic, 8	OMIM:619662
2918	0.3126	Encephalopathy, neonatal severe	OMIM:300673
2918	0.3126	Hyperekplexia 4	OMIM:618011
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Otofaciocervical syndrome	ORPHA:2792
2918	0.3126	PEHO syndrome	ORPHA:2836
2918	0.3126	Hydranencephaly with abnormal genitalia	OMIM:300215
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Developmental and epileptic encephalopathy 93	OMIM:618012
2918	0.3126	Developmental and epileptic encephalopathy 65	OMIM:618008
2918	0.3126	Developmental and epileptic encephalopathy 28	OMIM:616211
2918	0.3126	Parkinson disease 6, early onset	OMIM:605909
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy	OMIM:615760
2918	0.3126	Parkinson disease 23, autosomal recessive, early onset	OMIM:616840
2918	0.3126	Parkinson disease, juvenile, type 2	OMIM:600116
2918	0.3126	Gaucher disease, type II	OMIM:230900
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Otofaciocervical syndrome	ORPHA:2792
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Microcephaly 17, primary, autosomal recessive	OMIM:617090
2918	0.3126	Congenital intrauterine infection-like syndrome	ORPHA:1229
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Congenital disorder of glycosylation, type Id	OMIM:601110
2918	0.3126	Intellectual developmental disorder, X-linked 63	OMIM:300387
2918	0.3126	Leukodystrophy, hypomyelinating, 17	OMIM:618006
2918	0.3126	Tonne-Kalscheuer syndrome	OMIM:300978
2918	0.3126	Luo-Schoch-Yamamoto syndrome	OMIM:619460
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	GABA-transaminase deficiency	OMIM:613163
2918	0.3126	MASA syndrome	ORPHA:2466
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Familial dyskinesia and facial myokymia	ORPHA:324588
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	OMIM:613730
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Gaze palsy, familial horizontal, with progressive scoliosis, 2	OMIM:617542
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Early myoclonic encephalopathy	ORPHA:1935
2918	0.3126	Keppen-Lubinsky syndrome	ORPHA:435628
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	?PEHO syndrome-like	OMIM:617507
2918	0.3126	Neurodevelopmental disorder with microcephaly and spastic paraplegia	OMIM:616281
2918	0.3126	Martsolf syndrome 2	OMIM:619420
2918	0.3126	Warburg micro syndrome 1	OMIM:600118
2918	0.3126	Zaki syndrome	OMIM:619648
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	17q23.1q23.2 microdeletion syndrome	ORPHA:261279
2918	0.3126	Congenital disorder of glycosylation, type Il	OMIM:608776
2918	0.3126	PEHO syndrome	OMIM:260565
2918	0.3126	PEHO syndrome	ORPHA:2836
2918	0.3126	Parkinson disease 22, autosomal dominant	OMIM:616710
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Infantile-onset ascending hereditary spastic paralysis	ORPHA:293168
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Dystonia 16	OMIM:612067
2918	0.3126	Dystonia 16	ORPHA:210571
2918	0.3126	Lissencephaly 6, with microcephaly	OMIM:616212
2918	0.3126	Neurodevelopmental disorder with spasticity, seizures, and brain abnormalities	OMIM:620001
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity	OMIM:618730
2918	0.3126	KDM5C-related syndromic X-linked intellectual disability	ORPHA:85279
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	?Halperin-Birk syndrome	OMIM:618651
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
2918	0.3126	Autosomal recessive spastic paraplegia type 23	ORPHA:101003
2918	0.3126	Early myoclonic encephalopathy	ORPHA:1935
2918	0.3126	Intellectual developmental disorder, autosomal recessive 57	OMIM:617188
2918	0.3126	Neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum	OMIM:620250
2918	0.3126	Developmental and epileptic encephalopathy 12	OMIM:613722
2918	0.3126	Diencephalic-mesencephalic junction dysplasia syndrome 1	OMIM:251280
2918	0.3126	Renpenning syndrome	OMIM:309500
2918	0.3126	Developmental and epileptic encephalopathy 5	OMIM:613477
2918	0.3126	Autosomal recessive primary microcephaly	ORPHA:2512
3001	0.3123	Rajab interstitial lung disease with brain calcifications 1	OMIM:613658
3002	0.3121	3-methylglutaconic aciduria, type VIII	OMIM:617248
3002	0.3121	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	OMIM:226300
3004	0.3116	?Immunodeficiency 94 with autoinflammation and dysmorphic facies	OMIM:619750
3005	0.3114	Parkinsonism-dystonia 3, childhood-onset	OMIM:619738
3006	0.3109	Alexander disease	OMIM:203450
3006	0.3109	Adult-onset cervical dystonia, DYT23 type	ORPHA:420492
3008	0.3107	Pick disease	OMIM:172700
3008	0.3107	Dementia, frontotemporal	OMIM:600274
3008	0.3107	Dementia, frontotemporal, with or without parkinsonism	OMIM:600274
3008	0.3107	Pick disease	OMIM:172700
3012	0.3105	Tyrosinemia, type I	OMIM:276700
3013	0.3103	Autosomal dominant hypocalcemia	ORPHA:428
3013	0.3103	Autosomal dominant hypocalcemia	ORPHA:428
3015	0.3102	Liver failure, transient infantile	OMIM:613070
3016	0.31	Polycystic kidney disease 2	OMIM:613095
3017	0.3099	Heme oxygenase-1 deficiency	OMIM:614034
3018	0.3097	Pituitary hormone deficiency, combined or isolated, 1	OMIM:613038
3019	0.3096	Congenital erythropoietic porphyria	ORPHA:79277
3019	0.3096	Congenital erythropoietic porphyria	ORPHA:79277
3021	0.3094	Meckel syndrome 1	OMIM:249000
3022	0.3092	Spinocerebellar ataxia with epilepsy	ORPHA:254881
3022	0.3092	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements	OMIM:618497
3022	0.3092	Intellectual developmental disorder, X-linked 12	OMIM:300957
3022	0.3092	Developmental and epileptic encephalopathy 37	OMIM:616981
3026	0.3091	Neurodegeneration with brain iron accumulation 2B	OMIM:610217
3026	0.3091	Sialuria	ORPHA:3166
3028	0.309	Myasthenic syndrome, congenital, 21, presynaptic	OMIM:617239
3029	0.3089	Cholestasis, progressive familial intrahepatic, 5	OMIM:617049
3030	0.3088	Mucolipidosis III gamma	OMIM:252605
3031	0.3085	Developmental and epileptic encephalopathy 72	OMIM:618374
3031	0.3085	Hyperferritinemia-cataract syndrome	OMIM:600886
3033	0.3083	Hyperthyroidism, nonautoimmune	OMIM:609152
3033	0.3083	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	OMIM:615508
3035	0.3079	Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation	ORPHA:300570
3035	0.3079	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	OMIM:242860
3037	0.3078	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	OMIM:192315
3037	0.3078	Autosomal dominant cutis laxa	ORPHA:90348
3037	0.3078	Autosomal dominant cutis laxa	ORPHA:90348
3037	0.3078	Microcephaly, growth deficiency, seizures, and brain malformations	OMIM:618346
3037	0.3078	Parkinson disease 7, autosomal recessive early-onset	OMIM:606324
3037	0.3078	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	OMIM:609446
3037	0.3078	Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures	OMIM:618737
3037	0.3078	?Pontocerebellar hypoplasia, type 15	OMIM:619302
3037	0.3078	Combined oxidative phosphorylation deficiency 39	OMIM:618397
3037	0.3078	Heart and brain malformation syndrome	OMIM:616920
3037	0.3078	Developmental delay with or without dysmorphic facies and autism	OMIM:618454
3037	0.3078	Intellectual developmental disorder, autosomal dominant 58	OMIM:618106
3037	0.3078	Marshall-Smith syndrome	OMIM:602535
3037	0.3078	Pontocerebellar hypoplasia, type 14	OMIM:619301
3037	0.3078	Rhizomelic limb shortening with dysmorphic features	OMIM:618821
3037	0.3078	Autosomal dominant cutis laxa	ORPHA:90348
3037	0.3078	Cutis laxa, autosomal dominant 3	OMIM:616603
3037	0.3078	X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome	ORPHA:480907
3037	0.3078	?Dystonia 32	OMIM:619637
3056	0.3077	Hemochromatosis, type 2B	OMIM:613313
3056	0.3077	Alström syndrome	ORPHA:64
3056	0.3077	Hemochromatosis, type 3	OMIM:604250
3056	0.3077	Severe congenital hypochromic anemia with ringed sideroblasts	ORPHA:300298
3060	0.3075	Fetal akinesia deformation sequence 1	OMIM:208150
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	?Developmental and epileptic encephalopathy 86	OMIM:618910
3060	0.3075	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome	OMIM:225790
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Wrinkly skin syndrome	OMIM:278250
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Fetal akinesia deformation sequence	ORPHA:994
3060	0.3075	Intellectual disability-developmental delay-contractures syndrome	ORPHA:3454
3060	0.3075	3MC syndrome 2	OMIM:265050
3074	0.3074	GRACILE syndrome	OMIM:603358
3075	0.3073	Hyperlipoproteinemia, type Ib	OMIM:207750
3076	0.3072	Mucopolysaccharidosis II	OMIM:309900
3077	0.3071	ICF syndrome	ORPHA:2268
3077	0.3071	ICF syndrome	ORPHA:2268
3077	0.3071	ICF syndrome	ORPHA:2268
3077	0.3071	ICF syndrome	ORPHA:2268
3081	0.3069	Alpha-mannosidosis, adult form	ORPHA:309288
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Caroli disease	ORPHA:53035
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Pancreatic agenesis-holoprosencephaly syndrome	ORPHA:556955
3082	0.3067	Cowden syndrome	ORPHA:201
3082	0.3067	Cowden syndrome	ORPHA:201
3093	0.3063	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	OMIM:614458
3094	0.306	Amyloidosis, Finnish type	OMIM:105120
3094	0.306	Familial Mediterranean fever, AR	OMIM:249100
3096	0.3059	Dyserythropoietic anemia, congenital, type IV	OMIM:613673
3097	0.3056	Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease	OMIM:613101
3097	0.3056	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline	OMIM:618868
3099	0.305	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	OMIM:607483
3100	0.3045	Congenital disorder of glycosylation, type Ih	OMIM:608104
3101	0.3044	Lhermitte-Duclos disease	ORPHA:65285
3101	0.3044	Impaired intellectual development and distinctive facial features with or without cardiac defects	OMIM:616789
3101	0.3044	Diarrhea 7, protein-losing enteropathy type	OMIM:615863
3104	0.3043	Intrinsic factor deficiency	OMIM:261000
3105	0.3042	Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency	ORPHA:453521
3106	0.3038	Warburg micro syndrome 3	OMIM:614222
3107	0.3036	Hyper-IgE recurrent infection syndrome 5, autosomal recessive	OMIM:618944
3108	0.3029	Occipital horn syndrome	ORPHA:198
3109	0.3025	Tubular aggregate myopathy	ORPHA:2593
3109	0.3025	Tubular aggregate myopathy	ORPHA:2593
3109	0.3025	Tubular aggregate myopathy	ORPHA:2593
3112	0.3019	Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian)	OMIM:220111
3113	0.3018	Diabetes mellitus, neonatal, with congenital hypothyroidism	OMIM:610199
3113	0.3018	Mucopolysaccharidosis type 2, attenuated form	ORPHA:217093
3115	0.3016	Spinocerebellar ataxia 29, congenital nonprogressive	OMIM:117360
3115	0.3016	Autoimmune lymphoproliferative syndrome, type III	OMIM:615559
3117	0.3015	Ornithine transcarbamylase deficiency	OMIM:311250
3118	0.3012	Epiphyseal chondrodysplasia, Miura type	OMIM:615923
3119	0.3011	Oculoskeletodental syndrome	OMIM:618440
3119	0.3011	Kleefstra syndrome 1	OMIM:610253
3119	0.3011	Kleefstra syndrome due to 9q34 microdeletion	ORPHA:96147
3122	0.301	Chronic visceral acid sphingomyelinase deficiency	ORPHA:77293
3123	0.3009	Short stature, Dauber-Argente type	OMIM:619489
3124	0.3001	Perry syndrome	OMIM:168605
3125	0.3	Neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures	OMIM:619876
3125	0.3	ALG3-CDG	ORPHA:79321
3125	0.3	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	OMIM:190685
3128	0.2999	Congenital disorder of glycosylation, type Ib	OMIM:602579
3128	0.2999	MPI-CDG	ORPHA:79319
3130	0.2998	Sialuria	OMIM:269921
3131	0.2996	Anemia, sideroblastic, 3, pyridoxine-refractory	OMIM:616860
3131	0.2996	Harderoporphyria	OMIM:618892
3133	0.2991	GRACILE syndrome	ORPHA:53693
3133	0.2991	Hemochromatosis, type 4	OMIM:606069
3133	0.2991	T-cell lymphoma, subcutaneous panniculitis-like	OMIM:618398
3133	0.2991	Hemophagocytic lymphohistiocytosis, familial, 4	OMIM:603552
3133	0.2991	Anemia, sideroblastic, 2, pyridoxine-refractory	OMIM:205950
3133	0.2991	?Anemia, hypochromic microcytic, with iron overload 2	OMIM:615234
3139	0.299	Fanconi-Bickel syndrome	OMIM:227810
3140	0.2989	Hypothyroidism, congenital, nongoitrous 4	OMIM:275100
3140	0.2989	Hemolytic anemia, G6PD deficient (favism)	OMIM:300908
3140	0.2989	Autosomal recessive spastic paraplegia type 61	ORPHA:401780
3140	0.2989	Immunodeficiency 87 and autoimmunity	OMIM:619573
3144	0.2987	Shprintzen-Goldberg syndrome	OMIM:182212
3144	0.2987	Neurofibromatosis, familial spinal	OMIM:162210
3144	0.2987	Neurofibromatosis-Noonan syndrome	ORPHA:638
3144	0.2987	Leukoencephalopathy with vanishing white matter 2, with or without ovarian failure	OMIM:620312
3144	0.2987	Neurofibromatosis-Noonan syndrome	ORPHA:638
3144	0.2987	Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure	OMIM:620313
3144	0.2987	Proteasome-associated autoinflammatory syndrome 2	OMIM:618048
3144	0.2987	Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome	ORPHA:2250
3152	0.2984	Simpson-Golabi-Behmel syndrome	ORPHA:373
3152	0.2984	Simpson-Golabi-Behmel syndrome	ORPHA:373
3154	0.2983	?Immunodeficiency 89 and autoimmunity	OMIM:619632
3155	0.2981	Immunodeficiency 27A, mycobacteriosis, AR	OMIM:209950
3155	0.2981	Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	OMIM:194380
3157	0.298	HFE hemochromatosis, modifier of	OMIM:235200
3157	0.298	Duane-radial ray syndrome	OMIM:607323
3157	0.298	Hemochromatosis, type 1	OMIM:235200
3157	0.298	Hemochromatosis, type 2A	OMIM:602390
3161	0.2978	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	OMIM:619580
3162	0.2976	Glycosylphosphatidylinositol biosynthesis defect 11	OMIM:616025
3163	0.2973	Hypophosphatemic rickets, X-linked dominant	OMIM:307800
3164	0.297	Alstrom syndrome	OMIM:203800
3165	0.2965	Glomerulosclerosis, focal segmental, 1	OMIM:603278
3165	0.2965	Nephrotic syndrome, type 2	OMIM:600995
3167	0.2963	Multiple pterygium syndrome, lethal type	OMIM:253290
3167	0.2963	Multiple pterygium syndrome, lethal type	OMIM:253290
3167	0.2963	Multiple pterygium syndrome, lethal type	OMIM:253290
3170	0.2959	Rh deficiency syndrome	ORPHA:71275
3170	0.2959	Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome	ORPHA:444077
3170	0.2959	Rh deficiency syndrome	ORPHA:71275
3170	0.2959	Rh deficiency syndrome	ORPHA:71275
3174	0.2957	Pyruvate kinase deficiency	OMIM:266200
3174	0.2957	Autoimmune pulmonary alveolar proteinosis	ORPHA:747
3176	0.2953	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A	OMIM:620358
3177	0.2952	?Rajab interstitial lung disease with brain calcifications 2	OMIM:619013
3178	0.2951	Hydrops, lactic acidosis, and sideroblastic anemia	OMIM:617021
3178	0.2951	Coenzyme Q10 deficiency, primary, 3	OMIM:614652
3180	0.2949	Congenital cataracts, facial dysmorphism, and neuropathy	OMIM:604168
3181	0.2947	Maturity-onset diabetes of the young, type 13	OMIM:616329
3181	0.2947	Diabetes, permanent neonatal 2, with or without neurologic features	OMIM:618856
3181	0.2947	Diabetes mellitus, transient neonatal 3	OMIM:610582
3181	0.2947	Developmental and epileptic encephalopathy 11	OMIM:613721
3181	0.2947	Hyperinsulinism-hyperammonemia syndrome	ORPHA:35878
3181	0.2947	Diabetes mellitus, permanent neonatal 1	OMIM:606176
3181	0.2947	Parkinsonism-dystonia, infantile, 1	OMIM:613135
3181	0.2947	Continuous spikes and waves during sleep	ORPHA:725
3181	0.2947	Dyskinesia, limb and orofacial, infantile-onset	OMIM:616921
3181	0.2947	Continuous spikes and waves during sleep	ORPHA:725
3181	0.2947	Diabetes mellitus, permanent neonatal 4	OMIM:618858
3181	0.2947	Microcephalic cortical malformations-short stature due to RTTN deficiency	ORPHA:468631
3193	0.2946	Polyposis, juvenile intestinal	OMIM:174900
3193	0.2946	Polyposis, juvenile intestinal	OMIM:174900
3195	0.2944	?Diarrhea 13	OMIM:620357
3195	0.2944	Acid-labile subunit, deficiency of	OMIM:615961
3195	0.2944	SLC35A2-CDG	ORPHA:356961
3195	0.2944	Intellectual developmental disorder, X-linked 98	OMIM:300912
3199	0.2943	Occipital horn syndrome	OMIM:304150
3199	0.2943	MEDNIK syndrome	ORPHA:171851
3199	0.2943	MEDNIK syndrome	ORPHA:171851
3199	0.2943	?Congenital disorder of glycosylation, type IIq	OMIM:617395
3199	0.2943	COG2-CDG	ORPHA:435934
3204	0.294	Methylmalonic aciduria, cblD type, variant 2	OMIM:277410
3205	0.2939	GM1 gangliosidosis type 1	ORPHA:79255
3206	0.2938	Bile acid synthesis defect, congenital, 6	OMIM:617308
3207	0.2937	Pseudohypoparathyroidism Ic	OMIM:612462
3207	0.2937	?Mitochondrial complex IV deficiency, nuclear type 19	OMIM:619063
3209	0.2936	Congenital myopathy with excess of muscle spindles	OMIM:218040
3210	0.2934	Nephrotic syndrome, type 11	OMIM:616730
3211	0.2933	Hypomagnesemia 3, renal	OMIM:248250
3212	0.2931	L-ferritin deficiency, dominant and recessive	OMIM:615604
3212	0.2931	Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib	ORPHA:79259
3214	0.293	Perlman syndrome	OMIM:267000
3215	0.2929	Glycogen storage disease of heart, lethal congenital	OMIM:261740
3215	0.2929	Beckwith-Wiedemann syndrome	OMIM:130650
3215	0.2929	Multiple endocrine neoplasia type 4	ORPHA:276152
3218	0.2927	Autoinflammation, panniculitis, and dermatosis syndrome	OMIM:617099
3218	0.2927	Autoinflammation with arthritis and dyskeratosis	OMIM:617388
3220	0.2926	Spinocerebellar ataxia 6	OMIM:183086
3221	0.2922	X-linked centronuclear myopathy	ORPHA:596
3221	0.2922	Pontocerebellar hypoplasia type 2B	OMIM:612389
3221	0.2922	XFE progeroid syndrome	OMIM:610965
3224	0.292	Citrullinemia	OMIM:215700
3225	0.2911	Pyruvate dehydrogenase E3 deficiency	ORPHA:2394
3226	0.291	Methylmalonic acidemia with homocystinuria, type cblC	ORPHA:79282
3227	0.2906	CHIME syndrome	OMIM:280000
3228	0.2905	Hijazi-Reis syndrome	OMIM:301094
3229	0.2903	Hypoalphalipoproteinemia, primary, 2, intermediate	OMIM:619836
3230	0.2895	Multiple congenital anomalies-hypotonia-seizures syndrome 3	OMIM:615398
3231	0.2893	Hypothyroidism, congenital, nongoitrous, 6	OMIM:614450
3232	0.2892	Idiopathic achalasia	ORPHA:930
3232	0.2892	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
3232	0.2892	Aspartylglucosaminuria	ORPHA:93
3232	0.2892	Hemorrhagic diathesis due to antithrombin Pittsburgh	OMIM:613490
3232	0.2892	Atrial standstill 2	OMIM:615745
3232	0.2892	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
3232	0.2892	Fletcher factor (prekallikrein) deficiency	OMIM:612423
3232	0.2892	Idiopathic achalasia	ORPHA:930
3232	0.2892	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
3232	0.2892	Idiopathic achalasia	ORPHA:930
3232	0.2892	Idiopathic achalasia	ORPHA:930
3243	0.2889	?Spinocerebellar ataxia 46	OMIM:617770
3244	0.2888	Carbamoylphosphate synthetase I deficiency	OMIM:237300
3245	0.2887	Galloway-Mowat syndrome 6	OMIM:618347
3245	0.2887	Epilepsy, progressive myoclonic 1B	OMIM:612437
3245	0.2887	Spinocerebellar ataxia type 27	ORPHA:98764
3248	0.2882	Short stature, microcephaly, and endocrine dysfunction	OMIM:616541
3249	0.2879	Argininosuccinic aciduria	OMIM:207900
3250	0.2875	Autosomal recessive spastic paraplegia type 57	ORPHA:431329
3250	0.2875	Spinocerebellar ataxia type 29	ORPHA:208513
3250	0.2875	?Urocanase deficiency	OMIM:276880
3253	0.2873	Spinocerebellar ataxia 17	OMIM:607136
3253	0.2873	Osteopetrosis, autosomal recessive 1	OMIM:259700
3255	0.2871	?Immunodeficiency 69, mycobacteriosis	OMIM:618963
3255	0.2871	Pseudo-TORCH syndrome 3	OMIM:618886
3257	0.287	Hyper-IgE recurrent infection syndrome 4B, autosomal recessive	OMIM:618523
3258	0.2869	Developmental and epileptic encephalopathy 15	OMIM:615006
3259	0.2867	?Mungan syndrome	OMIM:611376
3259	0.2867	Visceral myopathy 2	OMIM:619350
3259	0.2867	Visceral myopathy 1	OMIM:155310
3259	0.2867	CHOPS syndrome	OMIM:616368
3259	0.2867	Immunodeficiency 77	OMIM:619223
3259	0.2867	Cardiospondylocarpofacial syndrome	OMIM:157800
3265	0.2866	?Fanconi anemia, complementation group V	OMIM:617243
3266	0.2859	Cognitive impairment with or without cerebellar ataxia	OMIM:614306
3267	0.2856	Cerebellar atrophy with seizures and variable developmental delay	OMIM:618501
3267	0.2856	Spinocerebellar ataxia 31	OMIM:117210
3267	0.2856	Spinocerebellar ataxia 27A	OMIM:193003
3270	0.2854	?Fanconi renotubular syndrome 2	OMIM:613388
3271	0.2849	Glycine encephalopathy with normal serum glycine	OMIM:617301
3272	0.2844	Gabriele-de Vries syndrome	ORPHA:506358
3273	0.2843	Spinocerebellar ataxia type 42	ORPHA:458803
3274	0.2841	Hyperammonemia due to N-acetylglutamate synthase deficiency	ORPHA:927
3274	0.2841	Developmental malformations-deafness-dystonia syndrome	ORPHA:79107
3274	0.2841	Pseudohypoparathyroidism Ia	OMIM:103580
3277	0.284	Obesity due to congenital leptin deficiency	ORPHA:66628
3277	0.284	Obesity due to leptin receptor gene deficiency	ORPHA:179494
3279	0.2835	Immunodeficiency due to purine nucleoside phosphorylase deficiency	OMIM:613179
3279	0.2835	Obesity, susceptibility to, BMIQ19	OMIM:617885
3281	0.2834	Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	OMIM:308700
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Johanson-Blizzard syndrome	ORPHA:2315
3282	0.2831	ATTRV122I amyloidosis	ORPHA:85451
3282	0.2831	Juvenile polyposis of infancy	ORPHA:79076
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Juvenile polyposis of infancy	ORPHA:79076
3282	0.2831	Cardiomyopathy, dilated, 1D	OMIM:601494
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome	OMIM:614748
3282	0.2831	Omenn syndrome	OMIM:603554
3282	0.2831	Fibronectin glomerulopathy	ORPHA:84090
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Glomerulosclerosis, focal segmental, 6	OMIM:614131
3282	0.2831	Nephrotic syndrome, type 8	OMIM:615244
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Nephrotic syndrome, type 22	OMIM:619155
3282	0.2831	Pendred syndrome	OMIM:274600
3282	0.2831	?Galloway-Mowat syndrome 8	OMIM:618349
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Omenn syndrome	OMIM:603554
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Nephrotic syndrome, type 7	OMIM:615008
3282	0.2831	Hemolytic uremic syndrome, atypical, susceptibility to, 7	OMIM:615008
3282	0.2831	Anemia, congenital dyserythropoietic, type IIIA	OMIM:105600
3282	0.2831	Cardiomyopathy, dilated, 2F	OMIM:619747
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Pancreatic agenesis 1	OMIM:260370
3282	0.2831	Omenn syndrome	OMIM:603554
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Retinal dystrophy, iris coloboma, and comedogenic acne syndrome	OMIM:615147
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Nephrotic syndrome, type 6	OMIM:614196
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Nephrotic syndrome, type 9	OMIM:615573
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Triokinase and FMN cyclase deficiency syndrome	OMIM:618805
3282	0.2831	Hypertrophic osteoarthropathy, primary, autosomal recessive 2	OMIM:614441
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Enterokinase deficiency	OMIM:226200
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Nephrotic syndrome, type 3	OMIM:610725
3282	0.2831	Hennekam lymphangiectasia-lymphedema syndrome 1	OMIM:235510
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3282	0.2831	Nephrotic syndrome, type 15	OMIM:617609
3282	0.2831	Genetic steroid-resistant nephrotic syndrome	ORPHA:656
3342	0.2822	Acromegaly	ORPHA:963
3342	0.2822	Acromegaly	ORPHA:963
3344	0.2817	Methylmalonic aciduria and homocystinuria, cblC type, digenic	OMIM:277400
3344	0.2817	Methylmalonic aciduria and homocystinuria, cblC type	OMIM:277400
3346	0.2811	Craniodiaphyseal dysplasia, autosomal dominant	OMIM:122860
3347	0.2808	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	OMIM:618321
3348	0.2806	Leukodystrophy, hypomyelinating, 3	OMIM:260600
3349	0.2797	Congenital cataracts-facial dysmorphism-neuropathy syndrome	ORPHA:48431
3350	0.2795	Combined oxidative phosphorylation deficiency 15	OMIM:614947
3351	0.2794	Amyotrophic lateral sclerosis 19	OMIM:615515
3351	0.2794	Wilson disease	ORPHA:905
3351	0.2794	Hypotonia, infantile, with psychomotor retardation	OMIM:616816
3351	0.2794	Facioscapulohumeral muscular dystrophy 4, digenic	OMIM:619478
3355	0.2793	Maple syrup urine disease, type II	OMIM:248600
3355	0.2793	Maple syrup urine disease, type Ib	OMIM:248600
3355	0.2793	Maple syrup urine disease, type Ia	OMIM:248600
3358	0.2788	Autosomal recessive cerebellar ataxia-movement disorder syndrome	ORPHA:95434
3358	0.2788	Autosomal recessive cerebellar ataxia-movement disorder syndrome	ORPHA:95434
3360	0.2786	Celiac disease, susceptibility to	OMIM:212750
3360	0.2786	Celiac disease, susceptibility to	OMIM:212750
3362	0.2785	Creutzfeldt-Jakob disease	OMIM:123400
3362	0.2785	Creutzfeldt-Jakob disease, variant, resistance to	OMIM:123400
3364	0.2782	Hypoinsulinemic hypoglycemia and body hemihypertrophy	ORPHA:293964
3365	0.2779	Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome	ORPHA:476126
3366	0.2777	Myasthenic syndrome, congenital, 16	OMIM:614198
3366	0.2777	?Myasthenic syndrome, congenital, 15, without tubular aggregates	OMIM:616227
3368	0.2776	Insulin resistance, severe, digenic	OMIM:604367
3369	0.2775	Cerebellar dysfunction with variable cognitive and behavioral abnormalities	OMIM:614756
3370	0.2774	VEXAS syndrome, somatic	OMIM:301054
3370	0.2774	Hereditary chronic pancreatitis	ORPHA:676
3370	0.2774	Tumor necrosis factor receptor 1 associated periodic syndrome	ORPHA:32960
3370	0.2774	Autoimmune interstitial lung, joint, and kidney disease	OMIM:616414
3370	0.2774	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
3370	0.2774	Pediatric hepatocellular carcinoma	ORPHA:33402
3370	0.2774	Testicular tumor, somatic	OMIM:273300
3370	0.2774	Leukocyte adhesion deficiency	OMIM:116920
3370	0.2774	Hereditary chronic pancreatitis	ORPHA:676
3370	0.2774	Male germ cell tumor, somatic	OMIM:273300
3370	0.2774	Rheumatoid arthritis, progression of	OMIM:180300
3370	0.2774	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
3370	0.2774	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	OMIM:604416
3370	0.2774	Rheumatoid arthritis, susceptibility to	OMIM:180300
3370	0.2774	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	OMIM:617718
3370	0.2774	C1q deficiency 2	OMIM:620321
3370	0.2774	Chronic granulomatous disease 3, autosomal recessive	OMIM:613960
3370	0.2774	Germ cell tumors, somatic	OMIM:273300
3370	0.2774	Spermatocytic seminoma, somatic	OMIM:273300
3370	0.2774	Rheumatoid arthritis, susceptibility to	OMIM:180300
3370	0.2774	Neutrophilic dermatosis, acute febrile	OMIM:608068
3370	0.2774	Sweet syndrome	ORPHA:3243
3370	0.2774	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
3370	0.2774	Muckle-Wells syndrome	OMIM:191900
3370	0.2774	CINCA syndrome	ORPHA:1451
3370	0.2774	Familial cold inflammatory syndrome 1	OMIM:120100
3370	0.2774	CINCA syndrome	OMIM:607115
3370	0.2774	Familial cold autoinflammatory syndrome 2	OMIM:611762
3370	0.2774	Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis	OMIM:612852
3370	0.2774	Immunodeficiency 91 and hyperinflammation	OMIM:619644
3370	0.2774	Rheumatoid arthritis, susceptibility to	OMIM:180300
3370	0.2774	Granulomatosis with polyangiitis	ORPHA:900
3370	0.2774	Rheumatoid arthritis, susceptibility to	OMIM:180300
3370	0.2774	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2	OMIM:301074
3370	0.2774	Hereditary chronic pancreatitis	ORPHA:676
3370	0.2774	?Inflammatory bowel disease (infantile ulcerative colitis) 31	OMIM:619398
3370	0.2774	Granulomatosis with polyangiitis	ORPHA:900
3370	0.2774	Hereditary chronic pancreatitis	ORPHA:676
3370	0.2774	Pediatric hepatocellular carcinoma	ORPHA:33402
3370	0.2774	Rheumatoid arthritis, susceptibility to	OMIM:180300
3370	0.2774	Hereditary chronic pancreatitis	ORPHA:676
3370	0.2774	Hereditary chronic pancreatitis	ORPHA:676
3370	0.2774	Psoriasis 14, pustular	OMIM:614204
3370	0.2774	Iron-refractory iron deficiency anemia	OMIM:206200
3370	0.2774	Granulomatosis with polyangiitis	ORPHA:900
3370	0.2774	Granulomatosis with polyangiitis	ORPHA:900
3370	0.2774	Systemic-onset juvenile idiopathic arthritis	ORPHA:85414
3370	0.2774	Granulomatosis with polyangiitis	ORPHA:900
3418	0.2773	Cerebellar ataxia, Cayman type	ORPHA:94122
3418	0.2773	Migraine, familial basilar	OMIM:602481
3418	0.2773	?Spinocerebellar ataxia 26	OMIM:609306
3418	0.2773	Molybdenum cofactor deficiency A	OMIM:252150
3422	0.2768	Acrodysostosis 1, with or without hormone resistance	OMIM:101800
3423	0.2767	Ribose 5-phosphate isomerase deficiency	OMIM:608611
3424	0.2765	Argininosuccinic aciduria	ORPHA:23
3425	0.2762	Autosomal recessive cerebellar ataxia-psychomotor delay syndrome	ORPHA:284271
3426	0.2753	Progressive encephalopathy with leukodystrophy due to DECR deficiency	ORPHA:431361
3427	0.2752	Classic galactosemia	ORPHA:79239
3428	0.2751	Acrodermatitis enteropathica	OMIM:201100
3429	0.275	Vitamin D-dependent rickets, type 3	OMIM:619073
3429	0.275	X-linked non progressive cerebellar ataxia	ORPHA:314978
3431	0.2749	Spinocerebellar ataxia 27B, late-onset	OMIM:620174
3432	0.2743	Landau-Kleffner syndrome	ORPHA:98818
3433	0.2737	Peroxisomal acyl-CoA oxidase deficiency	OMIM:264470
3434	0.2734	Leukodystrophy, hypomyelinating, 18	OMIM:618404
3434	0.2734	Hyperinsulinemic hypoglycemia, familial, 5	OMIM:609968
3436	0.273	Galactokinase deficiency	ORPHA:79237
3437	0.2729	BDV syndrome	OMIM:619326
3437	0.2729	Benign familial neonatal epilepsy	ORPHA:1949
3437	0.2729	Pontocerebellar hypoplasia type 2D	OMIM:613811
3437	0.2729	Rabson-Mendenhall syndrome	OMIM:262190
3437	0.2729	Benign familial neonatal epilepsy	ORPHA:1949
3437	0.2729	Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome	ORPHA:477993
3443	0.2725	?Marden-Walker syndrome	OMIM:248700
3443	0.2725	Neurodegeneration with brain iron accumulation 5	OMIM:300894
3445	0.2723	Mitochondrial complex I deficiency, nuclear type 4	OMIM:618225
3445	0.2723	Congenital disorder of glycosylation, type IIt	OMIM:618885
3447	0.272	Griscelli syndrome type 1	ORPHA:79476
3447	0.272	Epidermolysis bullosa, junctional 5B, with pyloric atresia	OMIM:226730
3447	0.272	Atransferrinemia	OMIM:209300
3447	0.272	Congenital nephrotic syndrome, Finnish type	ORPHA:839
3447	0.272	Alpha-fetoprotein deficiency	OMIM:615969
3447	0.272	Pyruvate dehydrogenase E1-alpha deficiency	OMIM:312170
3453	0.2719	17q11 microdeletion syndrome	ORPHA:97685
3454	0.2718	Okur-Chung neurodevelopmental syndrome	OMIM:617062
3454	0.2718	Combined immunodeficiency with facio-oculo-skeletal anomalies	ORPHA:221139
3454	0.2718	Combined immunodeficiency with facio-oculo-skeletal anomalies	ORPHA:221139
3454	0.2718	17q21.31 microdeletion syndrome	ORPHA:363958
3458	0.2715	Lipodystrophy, congenital generalized, type 1	OMIM:608594
3458	0.2715	Lipodystrophy, congenital generalized, type 2	OMIM:269700
3460	0.2713	Purine nucleoside phosphorylase deficiency	ORPHA:760
3460	0.2713	Estrogen resistance syndrome	ORPHA:785
3460	0.2713	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures	OMIM:618879
3463	0.2711	Pituitary hormone deficiency, combined, 2	OMIM:262600
3464	0.2707	Juvenile nephropathic cystinosis	ORPHA:411634
3465	0.2706	Familial glucocorticoid deficiency	ORPHA:361
3465	0.2706	Familial glucocorticoid deficiency	ORPHA:361
3465	0.2706	Familial glucocorticoid deficiency	ORPHA:361
3465	0.2706	Familial glucocorticoid deficiency	ORPHA:361
3465	0.2706	Familial glucocorticoid deficiency	ORPHA:361
3470	0.2704	Hereditary cryohydrocytosis with reduced stomatin	ORPHA:168577
3471	0.2703	Perrault syndrome 4	OMIM:615300
3471	0.2703	McCune-Albright syndrome	ORPHA:562
3473	0.2698	Renal tubular acidosis, proximal, with ocular abnormalities	OMIM:604278
3474	0.2695	HMG-CoA lyase deficiency	OMIM:246450
3475	0.2694	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	OMIM:617186
3476	0.2693	Xeroderma pigmentosum, type F/Cockayne syndrome	OMIM:278760
3477	0.2691	Hyperinsulinemic hypoglycemia, familial, 7	OMIM:610021
3477	0.2691	L-2-hydroxyglutaric aciduria	OMIM:236792
3479	0.269	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	OMIM:612716
3479	0.269	Citrullinemia, type II, neonatal-onset	OMIM:605814
3479	0.269	Brain-lung-thyroid syndrome	ORPHA:209905
3482	0.2689	Congenital diaphragmatic hernia	ORPHA:2140
3482	0.2689	Congenital diaphragmatic hernia	ORPHA:2140
3482	0.2689	Congenital diaphragmatic hernia	ORPHA:2140
3485	0.2687	Cone-rod synaptic disorder syndrome, congenital nonprogressive	OMIM:618970
3486	0.2685	Woodhouse-Sakati syndrome	ORPHA:3464
3487	0.2684	Coproporphyria	OMIM:121300
3487	0.2684	Lead poisoning, susceptibility to	OMIM:612740
3487	0.2684	Porphyria, acute hepatic	OMIM:612740
3490	0.2682	?Leukoencephalopathy, hereditary diffuse, with spheroids 2	OMIM:619661
3490	0.2682	Parkinson disease 19a, juvenile-onset	OMIM:615528
3492	0.268	3-hydroxyisobutryl-CoA hydrolase deficiency	OMIM:250620
3492	0.268	Ceroid lipofuscinosis, neuronal, 5	OMIM:256731
3494	0.2678	Episodic ataxia, type 5	OMIM:613855
3495	0.2676	Lacticacidemia due to PDX1 deficiency	OMIM:245349
3496	0.2675	?Spinocerebellar ataxia, autosomal recessive 11	OMIM:614229
3497	0.2673	Myoclonic epilepsy, infantile, familial	OMIM:605021
3497	0.2673	Gray platelet syndrome	OMIM:139090
3497	0.2673	CLN3 disease	ORPHA:228346
3500	0.2669	Hogue-Janssens syndrome 1	OMIM:616355
3501	0.2667	Homocystinuria-megaloblastic anemia, cblG complementation type	OMIM:250940
3502	0.2666	Mandibuloacral dysplasia	OMIM:248370
3502	0.2666	Pyruvate dehydrogenase E1-alpha deficiency	ORPHA:79243
3502	0.2666	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	OMIM:613845
3502	0.2666	Pyruvate dehydrogenase E1-alpha deficiency	ORPHA:79243
3506	0.2664	Mitochondrial DNA depletion syndrome 4A (Alpers type)	OMIM:203700
3507	0.2663	Intellectual developmental disorder with macrocephaly, seizures, and speech delay	OMIM:618158
3507	0.2663	Megalencephaly-severe kyphoscoliosis-overgrowth syndrome	ORPHA:457359
3509	0.266	Dihydrolipoamide dehydrogenase deficiency	OMIM:246900
3509	0.266	Intellectual disability-severe speech delay-mild dysmorphism syndrome	ORPHA:391372
3511	0.2659	Growth delay due to insulin-like growth factor type 1 deficiency	ORPHA:73272
3511	0.2659	?Polyendocrine-polyneuropathy syndrome	OMIM:616113
3513	0.2658	Mitochondrial complex II deficiency, nuclear type 3	OMIM:619167
3514	0.2657	AGel amyloidosis	ORPHA:85448
3515	0.2655	?Combined oxidative phosphorylation deficiency 34	OMIM:617872
3516	0.2654	Developmental and epileptic encephalopathy 90	OMIM:301058
3517	0.2653	Severe phosphoribosylpyrophosphate synthetase superactivity	ORPHA:411543
3517	0.2653	Phosphoribosylpyrophosphate synthetase superactivity	OMIM:300661
3517	0.2653	Ataxia, cerebellar, Cayman type	OMIM:601238
3517	0.2653	Estrogen resistance	OMIM:615363
3517	0.2653	Spinocerebellar ataxia type 21	ORPHA:98773
3517	0.2653	Christianson syndrome	ORPHA:85278
3523	0.2651	?Spinocerebellar ataxia, autosomal recessive 24	OMIM:617133
3523	0.2651	Hypoinsulinemic hypoglycemia with hemihypertrophy	OMIM:240900
3523	0.2651	Spinocerebellar ataxia, autosomal recessive 32	OMIM:619862
3526	0.265	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
3526	0.265	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
3526	0.265	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
3526	0.265	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
3526	0.265	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
3526	0.265	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
3532	0.2649	Intellectual developmental disorder, autosomal dominant 56	OMIM:617854
3532	0.2649	Spinocerebellar ataxia 45	OMIM:617769
3534	0.2648	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3534	0.2648	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3534	0.2648	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3534	0.2648	Xeroderma pigmentosum-Cockayne syndrome complex	ORPHA:220295
3534	0.2648	Tyrosinemia type 2	ORPHA:28378
3539	0.2646	Knobloch syndrome, type 1	OMIM:267750
3540	0.2645	Spinocerebellar ataxia type 37	ORPHA:363710
3541	0.2644	Hypophosphatemic rickets	OMIM:300554
3542	0.2643	Nicolaides-Baraitser syndrome	OMIM:601358
3542	0.2643	Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome	ORPHA:369837
3544	0.2642	?Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2	OMIM:620085
3544	0.2642	CHARGE syndrome	ORPHA:138
3544	0.2642	CHARGE syndrome	ORPHA:138
3547	0.264	Hyperammonemia due to carbonic anhydrase VA deficiency	OMIM:615751
3548	0.2639	Mitochondrial DNA depletion syndrome 8B (MNGIE type)	OMIM:612075
3549	0.2638	Pyridoxal phosphate-responsive seizures	ORPHA:79096
3550	0.2636	Radio-Tartaglia syndrome	OMIM:619312
3551	0.2634	Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy	ORPHA:199354
3552	0.2633	Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency	ORPHA:363432
3553	0.263	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter	OMIM:617807
3553	0.263	Leukodystrophy, hypomyelinating, 25	OMIM:620243
3555	0.2628	Sclerosteosis 2	OMIM:614305
3556	0.2622	Pituitary hormone deficiency, combined, 6	OMIM:613986
3556	0.2622	Abetalipoproteinemia	OMIM:200100
3558	0.262	Trichomegaly-retina pigmentary degeneration-dwarfism syndrome	ORPHA:3363
3558	0.262	Arboleda-Tham syndrome	OMIM:616268
3560	0.2619	Thyroid dyshormonogenesis 1	OMIM:274400
3560	0.2619	Thyroid hypoplasia	ORPHA:95720
3560	0.2619	Coffin-Siris syndrome 4	OMIM:614609
3560	0.2619	Coffin-Siris syndrome 3	OMIM:614608
3560	0.2619	Aspartylglucosaminuria	OMIM:208400
3560	0.2619	Lethal congenital contracture syndrome 10	OMIM:617022
3560	0.2619	Zimmermann-Laband syndrome	ORPHA:3473
3560	0.2619	Anauxetic dysplasia 2	OMIM:617396
3560	0.2619	Zimmermann-Laband syndrome	ORPHA:3473
3560	0.2619	Simpson-Golabi-Behmel syndrome, type 1	OMIM:312870
3560	0.2619	Costello syndrome	ORPHA:3071
3560	0.2619	Hurler syndrome	ORPHA:93473
3560	0.2619	Mucopolysaccharidosis Ih	OMIM:607014
3560	0.2619	Thyroid hypoplasia	ORPHA:95720
3560	0.2619	Mucopolysaccharidosis VII	OMIM:253220
3560	0.2619	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	OMIM:253200
3560	0.2619	Robinow syndrome, autosomal dominant 1	OMIM:180700
3560	0.2619	Robinow syndrome, autosomal recessive	OMIM:268310
3560	0.2619	Neurofacioskeletal syndrome with or without renal agenesis	OMIM:619194
3560	0.2619	Schinzel-Giedion midface retraction syndrome	OMIM:269150
3560	0.2619	Schinzel-Giedion syndrome	ORPHA:798
3560	0.2619	Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion	ORPHA:254528
3560	0.2619	Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14	ORPHA:96334
3560	0.2619	Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14	ORPHA:96334
3560	0.2619	Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion	ORPHA:254528
3560	0.2619	Zimmermann-Laband syndrome 2	OMIM:616455
3560	0.2619	Zimmermann-Laband syndrome	ORPHA:3473
3560	0.2619	Thyroid hypoplasia	ORPHA:95720
3560	0.2619	Zimmermann-Laband syndrome	ORPHA:3473
3560	0.2619	Thauvin-Robinet-Faivre syndrome	OMIM:617107
3560	0.2619	Tall stature-intellectual disability-renal anomalies syndrome	ORPHA:500095
3560	0.2619	Congenital disorder of deglycosylation 2	OMIM:619775
3560	0.2619	?Candidiasis, familial, 8	OMIM:615527
3560	0.2619	Alpha-thalassemia-X-linked intellectual disability syndrome	ORPHA:847
3560	0.2619	Alpha-thalassemia/impaired intellectual development syndrome	OMIM:301040
3560	0.2619	Coffin-Siris syndrome 2	OMIM:614607
3596	0.2618	Biotinidase deficiency	OMIM:253260
3596	0.2618	Holocarboxylase synthetase deficiency	ORPHA:79242
3598	0.2616	?Tumoral calcinosis, hyperphosphatemic, familial, 3	OMIM:617994
3599	0.2614	Leukoencephalopathy, progressive, infantile-onset, with or without deafness	OMIM:619147
3600	0.2613	Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2	OMIM:619418
3600	0.2613	Beta-mannosidosis	ORPHA:118
3600	0.2613	Hydrolethalus syndrome	OMIM:236680
3603	0.2611	Hypocalcemic vitamin D-resistant rickets	ORPHA:93160
3604	0.261	Dravet syndrome	ORPHA:33069
3604	0.261	Dravet syndrome	ORPHA:33069
3604	0.261	Dravet syndrome	ORPHA:33069
3604	0.261	Dravet syndrome	ORPHA:33069
3604	0.261	Dravet syndrome	ORPHA:33069
3604	0.261	Dravet syndrome	ORPHA:33069
3604	0.261	Dravet syndrome	ORPHA:33069
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3611	0.2608	46,XX gonadal dysgenesis	ORPHA:243
3622	0.26	Fructose-1,6-bisphosphatase deficiency	ORPHA:348
3623	0.2599	Gastrointestinal defects and immunodeficiency syndrome 2	OMIM:619708
3624	0.2598	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	OMIM:610978
3625	0.2594	Mandibuloacral dysplasia with type B lipodystrophy	OMIM:608612
3625	0.2594	Trichothiodystrophy 5, nonphotosensitive	OMIM:300953
3627	0.2589	Dent disease 1	OMIM:300009
3628	0.2588	Microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum	OMIM:618284
3628	0.2588	Generalized arterial calcification of infancy	ORPHA:51608
3628	0.2588	Generalized arterial calcification of infancy	ORPHA:51608
3631	0.2586	Nijmegen breakage syndrome-like disorder	OMIM:613078
3632	0.2581	Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations	ORPHA:247691
3633	0.258	Folate malabsorption, hereditary	OMIM:229050
3634	0.2579	Deafness, congenital, and adult-onset progressive leukoencephalopathy	OMIM:619196
3635	0.2578	SRD5A3-CDG	ORPHA:324737
3635	0.2578	Thrombocytopenia-absent radius syndrome	OMIM:274000
3637	0.2576	Pterin-4 alpha-carbinolamine dehydratase deficiency	ORPHA:1578
3637	0.2576	Deficiency in anterior pituitary function-variable immunodeficiency syndrome	ORPHA:293978
3639	0.257	Spinocerebellar ataxia, autosomal recessive 23	OMIM:616949
3640	0.2565	Sotos syndrome	ORPHA:821
3640	0.2565	Glutaryl-CoA dehydrogenase deficiency	ORPHA:25
3640	0.2565	Sotos syndrome	ORPHA:821
3640	0.2565	Sotos syndrome	ORPHA:821
3644	0.2563	Hyperprolinemia, type I	OMIM:239500
3645	0.2561	Null syndrome	ORPHA:280234
3645	0.2561	Leukodystrophy, hypomyelinating, 6	OMIM:612438
3647	0.2559	Cockayne syndrome type 2	ORPHA:90322
3647	0.2559	Cockayne syndrome type 2	ORPHA:90322
3647	0.2559	Cockayne syndrome type 2	ORPHA:90322
3647	0.2559	Cockayne syndrome type 2	ORPHA:90322
3651	0.2558	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset	OMIM:619352
3652	0.2557	RIDDLE syndrome	OMIM:611943
3652	0.2557	Epilepsy, progressive myoclonic, 12	OMIM:619191
3654	0.2556	Episodic ataxia type 5	ORPHA:211067
3655	0.2553	Pseudohypoparathyroidism, type IB	OMIM:603233
3655	0.2553	Familial isolated hyperparathyroidism	ORPHA:99879
3655	0.2553	Hyperparathyroidism, neonatal	OMIM:239200
3655	0.2553	Pseudopseudohypoparathyroidism	ORPHA:79445
3655	0.2553	Pseudohypoparathyroidism Ib	OMIM:603233
3655	0.2553	Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency	ORPHA:95699
3655	0.2553	Familial isolated hyperparathyroidism	ORPHA:99879
3655	0.2553	Familial isolated hyperparathyroidism	ORPHA:99879
3663	0.2551	Odontohypophosphatasia	OMIM:146300
3664	0.255	Endocrinopathy due to proprotein convertase 1/3 deficiency	OMIM:600955
3665	0.2548	Autism susceptibility, X-linked 3	OMIM:300496
3665	0.2548	Mitochondrial complex I deficiency, nuclear type 36	OMIM:619170
3665	0.2548	15q11.2 microdeletion syndrome	ORPHA:261183
3665	0.2548	15q11.2 microdeletion syndrome	ORPHA:261183
3665	0.2548	Autism susceptibility, X-linked 1	OMIM:300425
3665	0.2548	Intellectual developmental disorder, X-linked	OMIM:300495
3665	0.2548	Autism susceptibility, X-linked 2	OMIM:300495
3665	0.2548	15q11.2 microdeletion syndrome	ORPHA:261183
3673	0.2543	3-methylglutaconic aciduria type 1	ORPHA:67046
3674	0.2542	Mitochondrial complex I deficiency, nuclear type 27	OMIM:618248
3675	0.2539	Joubert syndrome 2	OMIM:608091
3676	0.2538	Mitochondrial complex IV deficiency, nuclear type 2	OMIM:604377
3677	0.2537	Molybdenum cofactor deficiency B	OMIM:252160
3678	0.2536	Glycogen storage disease VI	OMIM:232700
3679	0.2534	X-linked creatine transporter deficiency	ORPHA:52503
3679	0.2534	Developmental and epileptic encephalopathy 43	OMIM:617113
3679	0.2534	Global developmental delay, progressive ataxia, and elevated glutamine	OMIM:618412
3679	0.2534	Wrinkly skin syndrome	ORPHA:2834
3679	0.2534	X-linked intellectual disability-cerebellar hypoplasia syndrome	ORPHA:137831
3684	0.2533	Mitochondrial pyruvate carrier deficiency	OMIM:614741
3685	0.2532	Hypoplasminogenemia	ORPHA:722
3685	0.2532	Dysplasminogenemia	OMIM:217090
3685	0.2532	Congenital plasminogen activator inhibitor type 1 deficiency	ORPHA:465
3685	0.2532	Branchiooculofacial syndrome	OMIM:113620
3685	0.2532	Sclerosteosis 1	OMIM:269500
3685	0.2532	Endosteal hyperostosis, Worth type	ORPHA:2790
3685	0.2532	GAPO syndrome	OMIM:230740
3692	0.253	Mullegama-Klein-Martinez syndrome	OMIM:301022
3692	0.253	Epilepsy, progressive myoclonic, 8	OMIM:616230
3692	0.253	Epilepsy, juvenile myoclonic, susceptibility to, 6	OMIM:607682
3692	0.253	Blepharophimosis-ptosis-epicanthus inversus syndrome plus	ORPHA:572333
3692	0.253	Episodic ataxia, type 6	OMIM:612656
3697	0.2529	Intellectual developmental disorder, autosomal dominant 55, with seizures	OMIM:617831
3697	0.2529	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	OMIM:617915
3697	0.2529	?Spinocerebellar ataxia 41	OMIM:616410
3697	0.2529	Intellectual developmental disorder, X-linked syndromic 35	OMIM:300998
3697	0.2529	Niemann-Pick disease, type C1	OMIM:257220
3697	0.2529	Progressive epilepsy-intellectual disability syndrome, Finnish type	ORPHA:1947
3697	0.2529	Pitt-Hopkins syndrome	ORPHA:2896
3697	0.2529	Joubert syndrome 27	OMIM:617120
3697	0.2529	Cerebellar ataxia, impaired intellectual development and dysequilibrium syndrome 3	OMIM:613227
3697	0.2529	Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome	ORPHA:513456
3707	0.2528	Mitochondrial complex III deficiency, nuclear type 5	OMIM:615160
3707	0.2528	DEGCAGS syndrome	OMIM:619488
3709	0.2526	Fanconi anemia, complementation group S	OMIM:617883
3709	0.2526	Hermansky-Pudlak syndrome 3	OMIM:614072
3709	0.2526	Hermansky-Pudlak syndrome 8	OMIM:614077
3712	0.2525	Intellectual developmental disorder 60 with seizures	OMIM:618587
3712	0.2525	Leukoencephalopathy with ataxia	OMIM:615651
3712	0.2525	Fructose intolerance, hereditary	OMIM:229600
3712	0.2525	?Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4	OMIM:615268
3712	0.2525	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	OMIM:618090
3717	0.2524	HSD10 mitochondrial disease	OMIM:300438
3718	0.2521	Xeroderma pigmentosum, group G	OMIM:278780
3719	0.2516	Hemolytic uremic syndrome, atypical, susceptibility to, 1	OMIM:235400
3719	0.2516	Hemolytic uremic syndrome, atypical, susceptibility to	OMIM:235400
3719	0.2516	Hemolytic uremic syndrome, atypical, susceptibility to	OMIM:235400
3722	0.2515	Distal 16p11.2 microdeletion syndrome	ORPHA:261222
3723	0.2514	Pituitary hormone deficiency, combined or isolated, 8	OMIM:620303
3723	0.2514	Combined oxidative phosphorylation deficiency 4	OMIM:610678
3725	0.2513	Gaucher disease type 3	ORPHA:77261
3725	0.2513	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay	OMIM:616084
3727	0.2509	Spinocerebellar ataxia type 11	ORPHA:98767
3728	0.2508	Obesity due to prohormone convertase I deficiency	ORPHA:71528
3728	0.2508	Obesity due to pro-opiomelanocortin deficiency	ORPHA:71526
3728	0.2508	Osteopetrosis, autosomal recessive 7	OMIM:612301
3731	0.2507	Coffin-Siris syndrome 1	OMIM:135900
3731	0.2507	Hyperimmunoglobulinemia D with periodic fever	ORPHA:343
3731	0.2507	Familial renal glucosuria	ORPHA:69076
3731	0.2507	Intellectual developmental disorder, X-linked syndromic, Billuart type	OMIM:300486
3731	0.2507	Pyruvate dehydrogenase phosphatase deficiency	OMIM:608782
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
3736	0.2506	Intellectual developmental disorder with short stature and behavioral abnormalities	OMIM:618687
3736	0.2506	Intellectual developmental disorder, autosomal recessive 66	OMIM:618221
3754	0.2504	Canavan disease	OMIM:271900
3754	0.2504	Senior-Boichis syndrome	ORPHA:84081
3754	0.2504	Senior-Boichis syndrome	ORPHA:84081
3757	0.2503	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	OMIM:616277
3757	0.2503	Thrombotic thrombocytopenic purpura, hereditary	OMIM:274150
3759	0.2501	Spinocerebellar ataxia, autosomal recessive 28	OMIM:618800
3760	0.25	Atypical Rett syndrome	ORPHA:3095
3760	0.25	Atypical Rett syndrome	ORPHA:3095
3760	0.25	Atypical Rett syndrome	ORPHA:3095
3760	0.25	Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder	ORPHA:500180
3760	0.25	Hypothyroidism, congenital, nongoitrous, 8	OMIM:301033
3760	0.25	CHARGE syndrome	OMIM:214800
3760	0.25	Atypical Rett syndrome	ORPHA:3095
3760	0.25	Atypical Rett syndrome	ORPHA:3095
3760	0.25	Intellectual disability-epilepsy-extrapyramidal syndrome	ORPHA:468620
3769	0.2497	Combined oxidative phosphorylation deficiency 21	OMIM:615918
3769	0.2497	Neurodevelopmental disorder with hypotonia, impaired language, and dysmorphic features	OMIM:616579
3771	0.2495	White-Sutton syndrome	OMIM:616364
3772	0.2494	Thyroid hormone resistance, autosomal recessive	OMIM:274300
3772	0.2494	Combined oxidative phosphorylation deficiency 57	OMIM:620167
3774	0.2489	Insulin-like growth factor I deficiency	OMIM:608747
3775	0.2488	Waldenström macroglobulinemia	ORPHA:33226
3776	0.2486	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome	OMIM:620186
3776	0.2486	Smith-Lemli-Opitz syndrome	ORPHA:818
3778	0.2484	WHIM syndrome	ORPHA:51636
3779	0.2483	Hypomagnesemia 5, renal, with ocular involvement	OMIM:248190
3780	0.2482	Autosomal recessive malignant osteopetrosis	ORPHA:667
3780	0.2482	Autosomal recessive malignant osteopetrosis	ORPHA:667
3780	0.2482	Autosomal recessive malignant osteopetrosis	ORPHA:667
3780	0.2482	Autosomal recessive malignant osteopetrosis	ORPHA:667
3784	0.2481	Bachmann-Bupp syndrome	OMIM:619075
3785	0.2479	Contractural arachnodactyly, congenital	OMIM:121050
3785	0.2479	Obesity due to melanocortin 4 receptor deficiency	ORPHA:71529
3787	0.2478	Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young	OMIM:616026
3788	0.2476	Fatty acid hydroxylase-associated neurodegeneration	ORPHA:329308
3789	0.2475	Carbamoyl-phosphate synthetase 1 deficiency	ORPHA:147
3789	0.2475	Multiple endocrine neoplasia IIA	OMIM:171400
3791	0.2474	Hyperproinsulinemia	OMIM:616214
3792	0.2471	?Immunodeficiency 61	OMIM:300310
3793	0.2468	Glycogen storage disease Ia	OMIM:232200
3793	0.2468	Methylcobalamin deficiency type cblE	ORPHA:2169
3795	0.2465	Albers-Schönberg osteopetrosis	ORPHA:53
3795	0.2465	DiGeorge syndrome	OMIM:188400
3797	0.2463	Hyperinsulinism-hyperammonemia syndrome	OMIM:606762
3798	0.2462	Mitochondrial complex I deficiency, nuclear type 14	OMIM:618236
3799	0.2459	von Willebrand disease, type 1	OMIM:193400
3799	0.2459	von Willebrand disease, type 3	OMIM:277480
3801	0.2458	Hereditary fructose intolerance	ORPHA:469
3801	0.2458	Pyridoxamine 5'-phosphate oxidase deficiency	OMIM:610090
3801	0.2458	Intellectual developmental disorder, X-linked syndromic 16	OMIM:305400
3804	0.2456	Intellectual developmental disorder, X-linked syndromic, with pigmentary mosaicism and coarse facies	OMIM:301066
3805	0.2453	Dihydropyrimidinuria	OMIM:222748
3806	0.245	Ceroid lipofuscinosis, neuronal, 10	OMIM:610127
3807	0.2449	Osteopetrosis, autosomal dominant 2	OMIM:166600
3808	0.2448	Glycogen storage disease, type IXa2	OMIM:306000
3809	0.2447	Hyperlysinemia	OMIM:238700
3810	0.2446	Glycosylphosphatidylinositol biosynthesis defect 17	OMIM:618010
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
3811	0.2435	Lobar holoprosencephaly	ORPHA:93924
3811	0.2435	Semilobar holoprosencephaly	ORPHA:220386
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3811	0.2435	Alobar holoprosencephaly	ORPHA:93925
3877	0.2434	Congenital disorder of glycosylation, type Im	OMIM:610768
3878	0.2432	Neurodegeneration, childhood-onset, with brain atrophy	OMIM:617672
3879	0.2431	Papillorenal syndrome	OMIM:120330
3879	0.2431	Hypotaurinemic retinal degeneration and cardiomyopathy	OMIM:145350
3881	0.243	Intellectual developmental disorder, X-linked 29	OMIM:300419
3881	0.243	Developmental and epileptic encephalopathy 41	OMIM:617105
3881	0.243	Pontocerebellar hypoplasia type 2	ORPHA:2524
3881	0.243	Pontocerebellar hypoplasia type 2	ORPHA:2524
3881	0.243	Pontocerebellar hypoplasia type 2	ORPHA:2524
3881	0.243	Methylmalonic aciduria, vitamin B12-responsive, cblB type	OMIM:251110
3881	0.243	Pontocerebellar hypoplasia type 2	ORPHA:2524
3881	0.243	Pontocerebellar hypoplasia type 2	ORPHA:2524
3881	0.243	Dystonia 33	OMIM:619687
3881	0.243	Warburg micro syndrome 4	OMIM:615663
3891	0.2428	Developmental and epileptic encephalopathy 47	OMIM:617166
3891	0.2428	Progressive myoclonic epilepsy type 1	ORPHA:308
3891	0.2428	?IVIC syndrome	OMIM:147750
3891	0.2428	Spinocerebellar ataxia 47	OMIM:617931
3891	0.2428	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate	OMIM:618384
3891	0.2428	Progressive myoclonic epilepsy type 1	ORPHA:308
3891	0.2428	Progressive myoclonic epilepsy type 1	ORPHA:308
3898	0.2427	Dihydropyrimidine dehydrogenase deficiency	OMIM:274270
3899	0.2425	Autoimmune lymphoproliferative syndrome	ORPHA:3261
3899	0.2425	Autoimmune lymphoproliferative syndrome	ORPHA:3261
3899	0.2425	Autoimmune lymphoproliferative syndrome	ORPHA:3261
3899	0.2425	Autoimmune lymphoproliferative syndrome	ORPHA:3261
3899	0.2425	Autoimmune lymphoproliferative syndrome	ORPHA:3261
3904	0.2423	Gaucher disease, atypical	OMIM:610539
3905	0.2422	Hutchinson-Gilford progeria syndrome	ORPHA:740
3905	0.2422	Hutchinson-Gilford progeria syndrome	ORPHA:740
3905	0.2422	Complete androgen insensitivity syndrome	ORPHA:99429
3905	0.2422	Nestor-Guillermo progeria syndrome	OMIM:614008
3905	0.2422	Obesity, morbid, due to leptin deficiency	OMIM:614962
3910	0.2421	Symptomatic form of fragile X syndrome in female carriers	ORPHA:449291
3910	0.2421	Floating-Harbor syndrome	ORPHA:2044
3912	0.242	Vici syndrome	ORPHA:1493
3913	0.2419	Hermansky-Pudlak syndrome 2	OMIM:608233
3913	0.2419	Becker nevus syndrome	ORPHA:64755
3913	0.2419	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis	OMIM:618590
3913	0.2419	Hermansky-Pudlak syndrome 5	OMIM:614074
3913	0.2419	Siddiqi syndrome	OMIM:618635
3918	0.2418	den Hoed-de Boer-Voisin syndrome	OMIM:619229
3919	0.2417	X-linked intellectual disability, Van Esch type	ORPHA:163976
3920	0.2416	Fanconi anemia, complementation group T	OMIM:616435
3920	0.2416	Infantile systemic hyalinosis	ORPHA:2176
3922	0.2415	Pigmented nodular adrenocortical disease, primary, 1	OMIM:610489
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3922	0.2415	22q11.2 deletion syndrome	ORPHA:567
3932	0.2412	Renal cysts and diabetes syndrome	OMIM:137920
3933	0.2411	Fanconi-Bickel syndrome	ORPHA:2088
3933	0.2411	Combined oxidative phosphorylation deficiency 5	OMIM:611719
3935	0.241	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	OMIM:141500
3935	0.241	Familial paroxysmal ataxia	ORPHA:97
3935	0.241	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects	OMIM:620083
3935	0.241	Joubert syndrome with ocular defect	ORPHA:220493
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Wolfram syndrome	ORPHA:3463
3935	0.241	Joubert syndrome with ocular defect	ORPHA:220493
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease	ORPHA:163746
3935	0.241	Gillespie syndrome	OMIM:206700
3935	0.241	?Laurence-Moon syndrome	OMIM:245800
3935	0.241	Laurence-Moon syndrome	ORPHA:2377
3935	0.241	Cerebellar ataxia-hypogonadism syndrome	ORPHA:1173
3935	0.241	Salla disease	OMIM:604369
3935	0.241	Alternating hemiplegia of childhood 2	OMIM:614820
3935	0.241	Peroxisome biogenesis disorder 4B	OMIM:614863
3935	0.241	Wolf-Hirschhorn syndrome	ORPHA:280
3935	0.241	Bardet-Biedl syndrome 1	OMIM:209900
3935	0.241	Bardet-Biedl syndrome 1	OMIM:209900
3935	0.241	Bardet-Biedl syndrome 1, modifier of	OMIM:209900
3935	0.241	Bardet-Biedl syndrome 1, modifier of	OMIM:209900
3935	0.241	Joubert syndrome 5	OMIM:610188
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Revesz syndrome	OMIM:268130
3935	0.241	Wolf-Hirschhorn syndrome	ORPHA:280
3935	0.241	Joubert syndrome 4	OMIM:609583
3935	0.241	Joubert syndrome with renal defect	ORPHA:220497
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Yoon-Bellen neurodevelopmental syndrome	OMIM:619701
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	OMIM:618060
3935	0.241	Intellectual developmental disorder, autosomal recessive 46	OMIM:616116
3935	0.241	Wolf-Hirschhorn syndrome	ORPHA:280
3935	0.241	Usher syndrome type 2	ORPHA:231178
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Congenital disorder of glycosylation, type If	OMIM:609180
3935	0.241	Leukodystrophy, hypomyelinating, 21	OMIM:619310
3935	0.241	Hereditary renal hypouricemia	ORPHA:94088
3935	0.241	Wolfram syndrome	ORPHA:3463
3935	0.241	Wolfram syndrome 1	OMIM:222300
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Spondyloepiphyseal dysplasia, sensorineural hearing loss, intellectual developmental disorder, and Leber congenital amaurosis	OMIM:619260
3935	0.241	Subcortical laminal heterotopia, X-linked	OMIM:300067
3935	0.241	Spinocerebellar ataxia, autosomal recessive 29	OMIM:619389
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Cerebellar ataxia and hypogonadotropic hypogonadism	OMIM:212840
3935	0.241	Cerebellar ataxia-hypogonadism syndrome	ORPHA:1173
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Wolf-Hirschhorn syndrome	ORPHA:280
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome 3	OMIM:608629
3935	0.241	Joubert syndrome with ocular defect	ORPHA:220493
3935	0.241	Spinocerebellar ataxia 50	OMIM:620158
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Spondyloepimetaphyseal dysplasia, Camera-Genevieve type	OMIM:610442
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome with renal defect	ORPHA:220497
3935	0.241	Joubert syndrome 7	OMIM:611560
3935	0.241	Leukoencephalopathy, cystic, without megalencephaly	OMIM:612951
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome 32	OMIM:617757
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Neurodevelopmental disorder with or without variable brain abnormalities	OMIM:618443
3935	0.241	Wolf-Hirschhorn syndrome	ORPHA:280
3935	0.241	Hereditary renal hypouricemia	ORPHA:94088
3935	0.241	Joubert syndrome with ocular defect	ORPHA:220493
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Usher syndrome type 2	ORPHA:231178
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Optic atrophy 10 with or without ataxia, impaired intellectual development and seizures	OMIM:616732
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	3-methylglutaconic aciduria type 3	ORPHA:67047
3935	0.241	Usher syndrome type 2	ORPHA:231178
3935	0.241	Usher syndrome type 2	ORPHA:231178
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Thiamine-responsive megaloblastic anemia syndrome	OMIM:249270
3935	0.241	Usher syndrome type 2	ORPHA:231178
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome 21	OMIM:615636
3935	0.241	Spinocerebellar ataxia 37	OMIM:615945
3935	0.241	3-methylglutaconic aciduria type 3	ORPHA:67047
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Neurodevelopmental disorder with eye movement abnormalities and ataxia	OMIM:620094
3935	0.241	Waardenburg syndrome, type 4A	OMIM:277580
3935	0.241	Joubert syndrome 14	OMIM:614424
3935	0.241	Joubert syndrome with oculorenal defect	ORPHA:2318
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome with renal defect	ORPHA:220497
3935	0.241	?Spinocerebellar ataxia, X-linked 1	OMIM:302500
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	OMIM:213000
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Joubert syndrome with ocular defect	ORPHA:220493
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Leukodystrophy, hypomyelinating, 15	OMIM:617951
3935	0.241	Orofaciodigital syndrome type 6	ORPHA:2754
3935	0.241	Joubert syndrome	ORPHA:475
3935	0.241	Wolf-Hirschhorn syndrome	ORPHA:280
3935	0.241	Joubert syndrome	ORPHA:475
4052	0.2409	Xanthinuria, type II	OMIM:603592
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Optic atrophy plus syndrome	OMIM:125250
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Developmental and epileptic encephalopathy 24	OMIM:615871
4053	0.2408	Developmental and epileptic encephalopathy 56	OMIM:617665
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4053	0.2408	15q11q13 microduplication syndrome	ORPHA:238446
4053	0.2408	Periventricular nodular heterotopia 7	OMIM:617201
4053	0.2408	Myoclonic-atonic epilepsy	OMIM:616421
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4053	0.2408	Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures	OMIM:618709
4053	0.2408	TELO2-related intellectual disability-neurodevelopmental disorder	ORPHA:488642
4053	0.2408	You-Hoover-Fong syndrome	OMIM:616954
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4053	0.2408	Episodic ataxia type 6	ORPHA:209967
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4053	0.2408	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies	OMIM:619556
4053	0.2408	Neurodevelopmental disorder with epilepsy and brain atrophy	OMIM:619971
4053	0.2408	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities	OMIM:619725
4053	0.2408	Intellectual developmental disorder, autosomal dominant 65	OMIM:619320
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Intellectual developmental disorder, X-linked syndromic, Bain type	OMIM:300986
4053	0.2408	Myoclonic-astatic epilepsy	ORPHA:1942
4053	0.2408	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
4082	0.2406	AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome	ORPHA:412069
4083	0.2403	Methylmalonic aciduria and homocystinuria, cblF type	OMIM:277380
4084	0.2402	Intellectual developmental disorder, X-linked syndromic, Lubs type	OMIM:300260
4084	0.2402	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta	OMIM:615905
4084	0.2402	Ritscher-Schinzel syndrome 4	OMIM:619435
4084	0.2402	Intellectual developmental disorder, X-linked syndromic 34	OMIM:300967
4084	0.2402	Cranioectodermal dysplasia 2	OMIM:613610
4084	0.2402	Sneddon syndrome	OMIM:182410
4090	0.2401	Hyperparathyroidism, transient neonatal	OMIM:618188
4090	0.2401	Neurodevelopmental disorder with or without seizures and gait abnormalities	OMIM:617864
4092	0.24	Methylmalonic aciduria and homocystinuria, cblJ type	OMIM:614857
4093	0.2399	Desmosterolosis	OMIM:602398
4093	0.2399	Dias-Logan syndrome	OMIM:617101
4095	0.2398	Macrocephaly/autism syndrome	OMIM:605309
4096	0.2397	Sialic acid storage disorder, infantile	OMIM:269920
4097	0.2396	Hemolytic uremic syndrome, atypical, susceptibility to, 5	OMIM:612925
4097	0.2396	Interstitial nephritis, karyomegalic	OMIM:614817
4097	0.2396	Hemolytic uremic syndrome, atypical, susceptibility to, 6	OMIM:612926
4097	0.2396	?Fanconi anemia, complementation group U	OMIM:617247
4097	0.2396	Hemolytic uremic syndrome, atypical, susceptibility to, 3	OMIM:612923
4097	0.2396	Progressive myoclonic epilepsy type 3	ORPHA:263516
4097	0.2396	Hemolytic uremic syndrome, atypical, susceptibility to, 2	OMIM:612922
4097	0.2396	Hemolytic uremic syndrome, atypical, susceptibility to, 4	OMIM:612924
4105	0.2395	Fanconi anemia, complementation group L	OMIM:614083
4105	0.2395	Autosomal dominant Kenny-Caffey syndrome	ORPHA:93325
4105	0.2395	FINCA syndrome	OMIM:618278
4108	0.2394	Chondrodysplasia punctata, X-linked dominant	OMIM:302960
4109	0.2393	Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement	ORPHA:2196
4110	0.239	?N-acetylaspartate deficiency	OMIM:614063
4110	0.239	Fanconi anemia, complementation group D2	OMIM:227646
4112	0.2388	Witteveen-Kolk syndrome	OMIM:613406
4112	0.2388	Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome	ORPHA:85167
4114	0.2385	Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities	OMIM:619026
4115	0.2383	Combined oxidative phosphorylation deficiency 10	OMIM:614702
4115	0.2383	Glycogen storage disease Ib	OMIM:232220
4115	0.2383	Glycogen storage disease Ic	OMIM:232240
4118	0.2381	Episodic ataxia, type 9	OMIM:618924
4118	0.2381	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment	OMIM:620066
4118	0.2381	Malan overgrowth syndrome	ORPHA:420179
4118	0.2381	Joubert syndrome 31	OMIM:617761
4118	0.2381	Galloway-Mowat syndrome 2, X-linked	OMIM:301006
4123	0.238	Immunodeficiency 8	OMIM:615401
4123	0.238	Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome	ORPHA:457351
4123	0.238	Peroxisome biogenesis disorder 7A (Zellweger)	OMIM:614872
4123	0.238	Hyperlipoproteinemia, type 1D	OMIM:615947
4127	0.2379	Multiple endocrine neoplasia IIB	OMIM:162300
4127	0.2379	GCGR-related hyperglucagonemia	ORPHA:438274
4127	0.2379	Mahvash disease	OMIM:619290
4127	0.2379	Intellectual developmental disorder with autistic features and language delay, with or without seizures	OMIM:618906
4131	0.2378	Transketolase deficiency	ORPHA:488618
4132	0.2377	Mitochondrial complex III deficiency, nuclear type 6	OMIM:615453
4133	0.2376	Methylmalonic aciduria, mut(0) type	OMIM:251000
4133	0.2376	Cranioectodermal dysplasia 1	OMIM:218330
4135	0.2372	Kabuki syndrome 2	OMIM:300867
4135	0.2372	Severe hemophilia A	ORPHA:169802
4137	0.237	Intellectual disability-strabismus syndrome	ORPHA:363528
4138	0.2369	Leber congenital amaurosis 1	OMIM:204000
4139	0.2368	Silver-Russell syndrome due to a point mutation	ORPHA:397590
4139	0.2368	Silver-Russell syndrome due to a point mutation	ORPHA:397590
4139	0.2368	Silver-Russell syndrome due to a point mutation	ORPHA:397590
4139	0.2368	Silver-Russell syndrome due to a point mutation	ORPHA:397590
4143	0.2366	Neurodevelopmental disorder with language delay and seizures	OMIM:619908
4143	0.2366	Cholesteryl ester storage disease	OMIM:278000
4145	0.2362	Intellectual developmental disorder, autosomal dominant 45	OMIM:617600
4145	0.2362	Distal deletion 15q	ORPHA:1596
4147	0.2358	X-linked intellectual disability with isolated growth hormone deficiency	ORPHA:67045
4147	0.2358	Methylmalonic acidemia with homocystinuria type cblF	ORPHA:79284
4149	0.2354	Hyperinsulinemic hypoglycemia, familial, 2	OMIM:601820
4149	0.2354	Alport syndrome 3, autosomal dominant	OMIM:104200
4151	0.2352	Neurooculorenal syndrome	OMIM:620305
4152	0.2351	Kaufman oculocerebrofacial syndrome	OMIM:244450
4153	0.235	?Combined oxidative phosphorylation deficiency 38	OMIM:618378
4154	0.2348	Mitochondrial complex I deficiency, nuclear type 16	OMIM:618238
4154	0.2348	Mitochondrial complex I deficiency, nuclear type 9	OMIM:618232
4154	0.2348	Mitochondrial complex I deficiency, nuclear type 7	OMIM:618229
4154	0.2348	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, encephalopathic type	OMIM:615228
4154	0.2348	?Combined oxidative phosphorylation deficiency 51	OMIM:619057
4154	0.2348	Oculoauricular syndrome	OMIM:612109
4160	0.2347	Generalized glucocorticoid resistance syndrome	ORPHA:786
4161	0.2345	Rapid-onset dystonia-parkinsonism	ORPHA:71517
4161	0.2345	Pontocerebellar hypoplasia, type 13	OMIM:618606
4161	0.2345	Spinocerebellar ataxia type 41	ORPHA:458798
4161	0.2345	PCNA-related progressive neurodegenerative photosensitivity syndrome	ORPHA:438134
4161	0.2345	Al-Raqad syndrome	OMIM:616459
4161	0.2345	Hao-Fountain syndrome due to 16p13.2 microdeletion	ORPHA:500055
4161	0.2345	Houge-Janssen syndrome 2	OMIM:616362
4161	0.2345	Intellectual developmental disorder, autosomal recessive 65	OMIM:618109
4161	0.2345	?Intellectual developmental disorder, autosomal recessive 79	OMIM:620393
4161	0.2345	Dystonia 4, torsion, autosomal dominant	OMIM:128101
4161	0.2345	Segawa syndrome, recessive	OMIM:605407
4161	0.2345	Pitt-Hopkins syndrome	OMIM:610954
4161	0.2345	Neurodevelopmental disorder with language impairment and behavioral abnormalities	OMIM:618917
4161	0.2345	Macrocephaly, dysmorphic facies, and psychomotor retardation	OMIM:617011
4161	0.2345	Chung-Jansen syndrome	OMIM:617991
4161	0.2345	Neurodevelopmental disorder with seizures and gingival overgrowth	OMIM:619323
4177	0.2344	Familial partial lipodystrophy, Köbberling type	ORPHA:79084
4177	0.2344	Obesity (BMIQ20)	OMIM:618406
4177	0.2344	Obesity, resistance to (BMIQ20)	OMIM:618406
4177	0.2344	Nail-patella syndrome	OMIM:161200
4177	0.2344	Perlman syndrome	ORPHA:2849
4182	0.2343	Cholesterol-ester transfer protein deficiency	ORPHA:79506
4183	0.2337	Hyperinsulinemic hypoglycemia, familial, 4	OMIM:609975
4183	0.2337	Hyperinsulinemic hypoglycemia, familial, 1	OMIM:256450
4183	0.2337	Hyperinsulinemic hypoglycemia, familial, 3	OMIM:602485
4186	0.2335	?Spondyloepimetaphyseal dysplasia, Krakow type	OMIM:618162
4186	0.2335	Wiedemann-Steiner syndrome	ORPHA:319182
4188	0.2333	Propionicacidemia	OMIM:606054
4188	0.2333	Propionicacidemia	OMIM:606054
4190	0.2331	Nystagmus, infantile periodic alternating, X-linked	OMIM:310700
4190	0.2331	Frontonasal dysplasia 2	OMIM:613451
4192	0.233	Dyskeratosis congenita, X-linked	OMIM:305000
4192	0.233	Takenouchi-Kosaki syndrome	OMIM:616737
4194	0.2329	?Spermatogenic failure 15	OMIM:616950
4194	0.2329	Van Esch-O'Driscoll syndrome	OMIM:301030
4194	0.2329	Spermatogenic failure 2	OMIM:108420
4197	0.2326	Hypogonadotropic hypogonadism 22, with or without anosmia	OMIM:616030
4197	0.2326	Hypogonadotropic hypogonadism 16 with or without anosmia	OMIM:614897
4199	0.2324	Cerebral creatine deficiency syndrome 1	OMIM:300352
4199	0.2324	Rubinstein-Taybi syndrome due to EP300 haploinsufficiency	ORPHA:353284
4199	0.2324	Rubinstein-Taybi syndrome due to CREBBP mutations	ORPHA:353277
4202	0.2321	Blepharophimosis, epicanthus inversus, and ptosis, type 2	OMIM:110100
4203	0.232	SPONASTRIME dysplasia	ORPHA:93357
4204	0.2319	3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	OMIM:614739
4205	0.2317	Fragile X syndrome	ORPHA:908
4205	0.2317	D-bifunctional protein deficiency	OMIM:261515
4207	0.2316	?Hermansky-Pudlak syndrome 9	OMIM:614171
4208	0.2313	Trichothiodystrophy 1, photosensitive	OMIM:601675
4209	0.2309	Hyperchylomicronemia, late-onset	OMIM:144650
4209	0.2309	Osteoporosis-pseudoglioma syndrome	ORPHA:2788
4211	0.2307	Citrullinemia, adult-onset type II	OMIM:603471
4212	0.2306	Congenital bile acid synthesis defect type 2	ORPHA:79303
4213	0.2301	?Hypogonadotropic hypogonadism 12 with or without anosmia	OMIM:614841
4214	0.2299	Mitochondrial complex I deficiency, nuclear type 33	OMIM:618253
4214	0.2299	Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion	ORPHA:363700
4214	0.2299	?Mitochondrial complex III deficiency, nuclear type 11	OMIM:620137
4217	0.2296	Hermansky-Pudlak syndrome 7	OMIM:614076
4217	0.2296	Pigmented nodular adrenocortical disease, primary, 2	OMIM:610475
4219	0.2293	Rolandic epilepsy	ORPHA:1945
4219	0.2293	Legius syndrome	ORPHA:137605
4219	0.2293	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	OMIM:618342
4219	0.2293	Rolandic epilepsy	ORPHA:1945
4219	0.2293	Hermansky-Pudlak syndrome 6	OMIM:614075
4219	0.2293	Hermansky-Pudlak syndrome 11	OMIM:619172
4219	0.2293	Rolandic epilepsy	ORPHA:1945
4226	0.2292	Lipoprotein lipase deficiency	OMIM:238600
4227	0.229	?Mitochondrial DNA depletion syndrome 17	OMIM:618567
4228	0.2288	Temple syndrome due to paternal 14q32.2 hypomethylation	ORPHA:254531
4228	0.2288	Temple syndrome due to paternal 14q32.2 hypomethylation	ORPHA:254531
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4230	0.2287	Septopreoptic holoprosencephaly	ORPHA:280195
4245	0.2284	Tubulointerstitial kidney disease, autosomal dominant, 5	OMIM:617056
4245	0.2284	Tubulointerstitial kidney disease, autosomal dominant, 2	OMIM:174000
4245	0.2284	Hypouricemia, renal	OMIM:220150
4248	0.2282	Glucocorticoid resistance	OMIM:615962
4249	0.2277	Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia	OMIM:617780
4250	0.2276	Glanzmann thrombasthenia 1	OMIM:273800
4250	0.2276	Combined deficiency of factor V and factor VIII	ORPHA:35909
4250	0.2276	Combined deficiency of factor V and factor VIII	ORPHA:35909
4253	0.2264	Fragile X syndrome	OMIM:300624
4254	0.2263	Frontonasal dysplasia 1	OMIM:136760
4254	0.2263	Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome	ORPHA:306542
4256	0.2262	Aphasia, primary progressive	OMIM:607485
4257	0.2261	Glanzmann thrombasthenia	ORPHA:849
4257	0.2261	Glanzmann thrombasthenia	ORPHA:849
4257	0.2261	?Osteopetrosis, autosomal recessive 9	OMIM:620366
4260	0.2257	15q24 microdeletion syndrome	ORPHA:94065
4260	0.2257	Cardiofaciocutaneous syndrome 4	OMIM:615280
4260	0.2257	Joubert syndrome 26	OMIM:616784
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4263	0.2256	Hereditary late-onset Parkinson disease	ORPHA:411602
4270	0.2252	Woodhouse-Sakati syndrome	OMIM:241080
4271	0.2249	Lathosterolosis	OMIM:607330
4272	0.2247	Propionic acidemia	ORPHA:35
4272	0.2247	Propionic acidemia	ORPHA:35
4272	0.2247	Vertebral anomalies and variable endocrine and T-cell dysfunction	OMIM:618223
4275	0.2246	Delayed puberty, self-limited	OMIM:619613
4275	0.2246	Hypogonadotropic hypogonadism 10 with or without anosmia	OMIM:614839
4277	0.2245	?Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type)	OMIM:619425
4277	0.2245	Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant	OMIM:162350
4277	0.2245	Lafora disease	ORPHA:501
4277	0.2245	Ethylmalonic encephalopathy	ORPHA:51188
4277	0.2245	Developmental delay with variable intellectual impairment and behavioral abnormalities	OMIM:618430
4277	0.2245	Neuroblastoma, susceptibility to, 1	OMIM:256700
4277	0.2245	Ataxia-oculomotor apraxia type 1	ORPHA:1168
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	MERRF	ORPHA:551
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Pendred syndrome	ORPHA:705
4277	0.2245	Neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities	OMIM:620317
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Aniridia-cerebellar ataxia-intellectual disability syndrome	ORPHA:1065
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Ataxia-hypogonadism-choroidal dystrophy syndrome	ORPHA:1180
4277	0.2245	Intellectual developmental disorder, autosomal dominant 38	OMIM:616393
4277	0.2245	Ceroid lipofuscinosis, neuronal, 2	OMIM:204500
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Developmental and epileptic encephalopathy 38	OMIM:617020
4277	0.2245	Developmental delay and seizures with or without movement abnormalities	OMIM:617836
4277	0.2245	Developmental and epileptic encephalopathy 92	OMIM:617829
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Developmental and epileptic encephalopathy 32	OMIM:616366
4277	0.2245	Acyl-CoA dehydrogenase, short-chain, deficiency of	OMIM:201470
4277	0.2245	GM1-gangliosidosis, type II	OMIM:230600
4277	0.2245	Mucopolysaccharidosis type IVB (Morquio)	OMIM:253010
4277	0.2245	Developmental and epileptic encephalopathy 45	OMIM:617153
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	OMIM:254800
4277	0.2245	Spinocerebellar ataxia type 17	ORPHA:98759
4277	0.2245	Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome	ORPHA:88637
4277	0.2245	Leukodystrophy, hypomyelinating, 11	OMIM:616494
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Miller-Dieker syndrome	ORPHA:531
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	?Microcephaly 29, primary, autosomal recessive	OMIM:620047
4277	0.2245	Gaucher disease, type III	OMIM:231000
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Dyskeratosis congenita, autosomal dominant 3	OMIM:613990
4277	0.2245	Familial infantile myoclonic epilepsy	ORPHA:352582
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Joubert syndrome 6	OMIM:610688
4277	0.2245	Ceroid lipofuscinosis, neuronal, 1	OMIM:256730
4277	0.2245	Epilepsy, progressive myoclonic 7	OMIM:616187
4277	0.2245	Usher syndrome type 3	ORPHA:231183
4277	0.2245	Cerebroretinal microangiopathy with calcifications and cysts 2	OMIM:617341
4277	0.2245	Joubert syndrome 35	OMIM:618161
4277	0.2245	Insomnia, fatal familial	OMIM:600072
4277	0.2245	Leber hereditary optic neuropathy	ORPHA:104
4277	0.2245	Lissencephaly 3	OMIM:611603
4277	0.2245	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities	OMIM:620270
4277	0.2245	Aniridia-cerebellar ataxia-intellectual disability syndrome	ORPHA:1065
4277	0.2245	Dementia, familial Danish	OMIM:117300
4277	0.2245	Intellectual developmental disorder, autosomal dominant 7	OMIM:614104
4277	0.2245	Lafora disease	ORPHA:501
4277	0.2245	Pendred syndrome	ORPHA:705
4277	0.2245	X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome	ORPHA:459070
4277	0.2245	Autosomal recessive spastic paraplegia type 44	ORPHA:320401
4277	0.2245	Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome	ORPHA:88637
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	Turcot syndrome with polyposis	ORPHA:99818
4277	0.2245	Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome	ORPHA:88637
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Dyskeratosis congenita, autosomal recessive 6	OMIM:616353
4277	0.2245	Dravet syndrome	OMIM:607208
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Familial infantile myoclonic epilepsy	ORPHA:352582
4277	0.2245	Cerebrofacioarticular syndrome	ORPHA:314679
4277	0.2245	RFT1-CDG	ORPHA:244310
4277	0.2245	Intellectual developmental disorder with paroxysmal dyskinesia or seizures	OMIM:619150
4277	0.2245	Miller-Dieker syndrome	ORPHA:531
4277	0.2245	Megalencephalic leukoencephalopathy with subcortical cysts 1	OMIM:604004
4277	0.2245	Developmental delay, hypotonia, and impaired language	OMIM:620012
4277	0.2245	CHAND syndrome	ORPHA:1401
4277	0.2245	Piebaldism	ORPHA:2884
4277	0.2245	Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome	ORPHA:505237
4277	0.2245	CIMDAG syndrome	OMIM:619273
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Ceroid lipofuscinosis, neuronal, 6B (Kufs type)	OMIM:204300
4277	0.2245	Ceroid lipofuscinosis, neuronal, 8	OMIM:600143
4277	0.2245	Orofaciodigital syndrome type 1	ORPHA:2750
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Glutathione synthetase deficiency	OMIM:266130
4277	0.2245	Usher syndrome type 3	ORPHA:231183
4277	0.2245	Ceroid lipofuscinosis, neuronal, 7	OMIM:610951
4277	0.2245	Piebaldism	ORPHA:2884
4277	0.2245	Cerebroretinal microangiopathy with calcifications and cysts	OMIM:612199
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Succinic semialdehyde dehydrogenase deficiency	ORPHA:22
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	?COACH syndrome 3	OMIM:619113
4277	0.2245	Rafiq syndrome	OMIM:614202
4277	0.2245	Niemann-pick disease, type C2	OMIM:607625
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Joubert syndrome 8	OMIM:612291
4277	0.2245	Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency	ORPHA:404493
4277	0.2245	Guanidinoacetate methyltransferase deficiency	ORPHA:382
4277	0.2245	Developmental delay with dysmorphic facies and dental anomalies	OMIM:619228
4277	0.2245	Mevalonic aciduria	ORPHA:29
4277	0.2245	Pendred syndrome	ORPHA:705
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	CAMOS syndrome	ORPHA:83472
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	Dentatorubral-pallidoluysian atrophy	OMIM:125370
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	Usher syndrome type 1	ORPHA:231169
4277	0.2245	Joubert syndrome 33	OMIM:617767
4277	0.2245	Cerebrofacioarticular syndrome	ORPHA:314679
4277	0.2245	Usher syndrome type 3	ORPHA:231183
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	?Myoclonus, familial, 1	OMIM:614937
4277	0.2245	Usher syndrome type 3	ORPHA:231183
4277	0.2245	Megalencephalic leukoencephalopathy with subcortical cysts 2A	OMIM:613925
4277	0.2245	Galloway-Mowat syndrome 5	OMIM:617731
4277	0.2245	CAMOS syndrome	ORPHA:83472
4277	0.2245	Joubert syndrome 17	OMIM:614615
4277	0.2245	Congenital limbs-face contractures-hypotonia-developmental delay syndrome	ORPHA:562528
4277	0.2245	Joubert syndrome 25	OMIM:616781
4277	0.2245	Gingival fibromatosis-hypertrichosis syndrome	ORPHA:2026
4277	0.2245	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
4277	0.2245	Senior-Loken syndrome	ORPHA:3156
4277	0.2245	Schwannomatosis, vestibular	OMIM:101000
4277	0.2245	2q23.1 microdeletion syndrome	ORPHA:228402
4277	0.2245	Ceroid lipofuscinosis, neuronal, 11	OMIM:614706
4277	0.2245	Miller-Dieker syndrome	ORPHA:531
4277	0.2245	Epilepsy, familial adult myoclonic, 2	OMIM:607876
4277	0.2245	Joubert syndrome 15	OMIM:614464
4277	0.2245	?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia	OMIM:616819
4277	0.2245	Spastic paraplegia and psychomotor retardation with or without seizures	OMIM:616756
4277	0.2245	Spastic paraplegia-severe developmental delay-epilepsy syndrome	ORPHA:464282
4277	0.2245	Kohlschutter-Tonz syndrome	OMIM:226750
4277	0.2245	Orofaciodigital syndrome XVI	OMIM:617563
4277	0.2245	Meckel syndrome 13	OMIM:617562
4277	0.2245	?Joubert syndrome 29	OMIM:617562
4277	0.2245	Cortical dysplasia, complex, with other brain malformations 6	OMIM:615771
4277	0.2245	Intellectual developmental disorder, autosomal recessive 69	OMIM:618383
4425	0.2243	ACTH-independent macronodular adrenal hyperplasia 2	OMIM:615954
4426	0.2241	?Hypogonadotropic hypogonadism 13 with or without anosmia	OMIM:614842
4427	0.2238	Waardenburg syndrome, type 2E, with or without neurologic involvement	OMIM:611584
4427	0.2238	3-methylcrotonyl-CoA carboxylase deficiency	ORPHA:6
4427	0.2238	3-methylcrotonyl-CoA carboxylase deficiency	ORPHA:6
4427	0.2238	Neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities	OMIM:620024
4431	0.2236	Glanzmann thrombasthenia 2	OMIM:619267
4432	0.2228	Pyruvate dehydrogenase E3-binding protein deficiency	ORPHA:255182
4432	0.2228	Beta-ureidopropionase deficiency	OMIM:613161
4432	0.2228	RERE-related neurodevelopmental syndrome	ORPHA:494344
4435	0.2224	Fish-eye disease	OMIM:136120
4436	0.2221	Microcephaly, short stature, and impaired glucose metabolism 1	OMIM:616033
4436	0.2221	Insulinomatosis and diabetes mellitus	OMIM:147630
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4438	0.2218	Non-acquired panhypopituitarism	ORPHA:90695
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4438	0.2218	Immunodeficiency, common variable, 10	OMIM:615577
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4438	0.2218	Non-acquired panhypopituitarism	ORPHA:90695
4438	0.2218	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
4448	0.2215	Congenital disorder of glycosylation, type IIi	OMIM:613612
4448	0.2215	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development	OMIM:152950
4448	0.2215	Dubowitz syndrome	ORPHA:235
4448	0.2215	Developmental and epileptic encephalopathy 52	OMIM:617350
4448	0.2215	Benign familial neonatal-infantile seizures	ORPHA:140927
4448	0.2215	Cornelia de Lange syndrome	ORPHA:199
4448	0.2215	Cornelia de Lange syndrome	ORPHA:199
4448	0.2215	Cornelia de Lange syndrome	ORPHA:199
4448	0.2215	Benign familial neonatal-infantile seizures	ORPHA:140927
4448	0.2215	Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia	OMIM:617182
4448	0.2215	Optic atrophy-intellectual disability syndrome	ORPHA:401777
4448	0.2215	Huntington disease-like 1	OMIM:603218
4448	0.2215	Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities	OMIM:620073
4448	0.2215	White-Kernohan syndrome	OMIM:619426
4448	0.2215	Congenital heart defects and ectodermal dysplasia	OMIM:617364
4448	0.2215	Hyperphenylalaninemia, mild, non-BH4-deficient	OMIM:617384
4448	0.2215	Dubowitz syndrome	ORPHA:235
4448	0.2215	Wolfram-like syndrome	ORPHA:411590
4448	0.2215	Cornelia de Lange syndrome	ORPHA:199
4448	0.2215	Cornelia de Lange syndrome	ORPHA:199
4448	0.2215	Primary dystonia, DYT4 type	ORPHA:98805
4448	0.2215	Intellectual developmental disorder, autosomal dominant 68	OMIM:619934
4448	0.2215	Autosomal dominant striatal neurodegeneration	ORPHA:228169
4448	0.2215	Intellectual developmental disorder with language impairment with or without autistic features	OMIM:613670
4448	0.2215	Cornelia de Lange syndrome	ORPHA:199
4448	0.2215	Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations	OMIM:618273
4448	0.2215	Intellectual developmental disorder, autosomal dominant 64	OMIM:619188
4448	0.2215	Beck-Fahrner syndrome	OMIM:618798
4448	0.2215	Raynaud-Claes syndrome	OMIM:300114
4448	0.2215	CLCN4-related X-linked intellectual disability syndrome	ORPHA:485350
4448	0.2215	Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	OMIM:611726
4448	0.2215	Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome	ORPHA:466688
4480	0.2214	?Nystagmus 8, congenital, autosomal recessive	OMIM:257400
4480	0.2214	Optic disc anomalies with retinal and/or macular dystrophy	OMIM:212550
4480	0.2214	Leber congenital amaurosis 7	OMIM:613829
4480	0.2214	Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp	OMIM:608105
4480	0.2214	Jalili syndrome	OMIM:217080
4480	0.2214	Leber congenital amaurosis 9	OMIM:608553
4480	0.2214	Achromatopsia 2	OMIM:216900
4480	0.2214	Ocular albinism, type I, Nettleship-Falls type	OMIM:300500
4480	0.2214	Cerebral palsy, spastic quadriplegic, 3	OMIM:617008
4480	0.2214	Blue cone monochromacy	OMIM:303700
4480	0.2214	Blue cone monochromacy	OMIM:303700
4491	0.2213	?Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies	OMIM:619321
4491	0.2213	Deafness, neurosensory, without vestibular involvement, autosomal dominant	OMIM:609006
4491	0.2213	?Deafness, autosomal recessive 103	OMIM:616042
4494	0.2208	Achromatopsia 3	OMIM:262300
4495	0.2207	Infantile nephropathic cystinosis	ORPHA:411629
4496	0.2206	Spermatogenic failure 77	OMIM:620103
4496	0.2206	?Spermatogenic failure 14	OMIM:615842
4498	0.2205	Vitamin B12-unresponsive methylmalonic acidemia type mut-	ORPHA:79312
4498	0.2205	Dysbetalipoproteinemia	ORPHA:412
4498	0.2205	Morbid obesity and spermatogenic failure	OMIM:615703
4501	0.2204	Basal ganglia calcification, idiopathic, 4	OMIM:615007
4502	0.2203	Hypophosphatasia, infantile	OMIM:241500
4503	0.2202	Hypoparathyroidism-retardation-dysmorphism syndrome	OMIM:241410
4503	0.2202	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	OMIM:620005
4505	0.22	Galactosemia	OMIM:230400
4506	0.2199	Developmental and epileptic encephalopathy 98	OMIM:619605
4506	0.2199	Intellectual developmental disorder, X-linked syndromic, Houge type	OMIM:301008
4506	0.2199	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	OMIM:618929
4506	0.2199	Tuberous sclerosis complex	ORPHA:805
4506	0.2199	Tuberous sclerosis complex	ORPHA:805
4506	0.2199	Tuberous sclerosis complex	ORPHA:805
4506	0.2199	Developmental delay, language impairment, and ocular abnormalities	OMIM:620141
4506	0.2199	Macrocephaly, acquired, with impaired intellectual development	OMIM:618286
4506	0.2199	Shukla-Vernon syndrome	OMIM:301029
4506	0.2199	PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome	ORPHA:589905
4506	0.2199	Autism, susceptibility to, X-linked 4	OMIM:300830
4517	0.2196	Blepharophimosis-impaired intellectual development syndrome	OMIM:619293
4517	0.2196	Metaphyseal chondrodysplasia, Murk Jansen type	OMIM:156400
4519	0.2192	?46XY sex reversal 5	OMIM:613080
4519	0.2192	Brunet-Wagner neurodevelopmental syndrome	OMIM:619690
4521	0.2191	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss	OMIM:619658
4521	0.2191	Developmental and epileptic encephalopathy 36	OMIM:300884
4523	0.219	Mitochondrial complex IV deficiency, nuclear type 4	OMIM:619048
4524	0.2189	Osteogenesis imperfecta, type XXII	OMIM:619795
4525	0.2186	Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities	OMIM:620327
4525	0.2186	Intrahepatic cholestasis of pregnancy	ORPHA:69665
4525	0.2186	Lipoyltransferase 1 deficiency	OMIM:616299
4525	0.2186	Intrahepatic cholestasis of pregnancy	ORPHA:69665
4525	0.2186	Intrahepatic cholestasis of pregnancy	ORPHA:69665
4525	0.2186	Intrahepatic cholestasis of pregnancy	ORPHA:69665
4531	0.2182	Dermatosparaxis Ehlers-Danlos syndrome	ORPHA:1901
4531	0.2182	Dermatosparaxis Ehlers-Danlos syndrome	ORPHA:1901
4533	0.218	Syndromic diarrhea	ORPHA:84064
4533	0.218	Syndromic diarrhea	ORPHA:84064
4535	0.2177	Combined oxidative phosphorylation deficiency 2	OMIM:610498
4535	0.2177	Mitochondrial complex III deficiency, nuclear type 7	OMIM:615824
4537	0.2176	Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities	OMIM:619522
4537	0.2176	Intellectual developmental disorder, autosomal recessive 54	OMIM:617028
4539	0.2175	Bleeding disorder, platelet-type, 24, autosomal dominant	OMIM:619271
4540	0.2172	Glycogen storage disease due to liver glycogen phosphorylase deficiency	ORPHA:369
4541	0.2171	Obesity, adrenal insufficiency, and red hair due to POMC deficiency	OMIM:609734
4542	0.217	Sanjad-Sakati syndrome	ORPHA:2323
4543	0.2168	Hypoparathyroidism, familial isolated 1	OMIM:146200
4543	0.2168	Hypoparathyroidism, familial isolated 2	OMIM:618883
4545	0.2167	Glycogen storage disease due to hepatic glycogen synthase deficiency	ORPHA:2089
4546	0.2166	Homozygous familial hypercholesterolemia	ORPHA:391665
4546	0.2166	Homozygous familial hypercholesterolemia	ORPHA:391665
4546	0.2166	Homozygous familial hypercholesterolemia	ORPHA:391665
4546	0.2166	Homozygous familial hypercholesterolemia	ORPHA:391665
4546	0.2166	Homozygous familial hypercholesterolemia	ORPHA:391665
4546	0.2166	Homozygous familial hypercholesterolemia	ORPHA:391665
4546	0.2166	Immunodeficiency 47	OMIM:300972
4553	0.2164	Familial isolated hypoparathyroidism due to agenesis of parathyroid gland	ORPHA:2239
4554	0.2163	Abdominal obesity-metabolic syndrome 3	OMIM:615812
4555	0.2159	Griscelli syndrome type 2	ORPHA:79477
4556	0.2153	Glycogen storage disease IXc	OMIM:613027
4556	0.2153	Congenital isolated ACTH deficiency	ORPHA:199296
4558	0.2149	Phosphoenolpyruvate carboxykinase deficiency, cytosolic	OMIM:261680
4559	0.2148	Glycogen storage disease due to glycogen debranching enzyme deficiency	ORPHA:366
4560	0.2145	Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency	OMIM:201810
4561	0.2144	Rubinstein-Taybi syndrome due to 16p13.3 microdeletion	ORPHA:353281
4562	0.2142	Sickle cell anemia	ORPHA:232
4562	0.2142	Hypogonadotropic hypogonadism 8 with or without anosmia	OMIM:614837
4562	0.2142	?Hypogonadotropic hypogonadism 27 without anosmia	OMIM:619755
4565	0.2141	Immunodeficiency 109 with lymphoproliferation	OMIM:620282
4566	0.2138	Xanthinuria, type I	OMIM:278300
4567	0.2137	Aplasia cutis congenita	ORPHA:1114
4567	0.2137	Aplasia cutis congenita	ORPHA:1114
4567	0.2137	Branchiootic syndrome	ORPHA:52429
4567	0.2137	BOR syndrome	ORPHA:107
4567	0.2137	Sclerosteosis	ORPHA:3152
4567	0.2137	?Hyperostosis cranalis interna	OMIM:144755
4567	0.2137	3-hydroxyacyl-CoA dehydrogenase deficiency	OMIM:231530
4567	0.2137	Blau syndrome	ORPHA:90340
4567	0.2137	Branchiootic syndrome	ORPHA:52429
4567	0.2137	BOR syndrome	ORPHA:107
4567	0.2137	Branchiootorenal syndrome 1, with or without cataracts	OMIM:113650
4567	0.2137	Craniometaphyseal dysplasia, autosomal recessive	OMIM:218400
4567	0.2137	Craniometaphyseal dysplasia	ORPHA:1522
4567	0.2137	Aplasia cutis congenita	ORPHA:1114
4567	0.2137	Sclerosteosis	ORPHA:3152
4567	0.2137	Hyperostosis corticalis generalisata	ORPHA:3416
4567	0.2137	Aplasia cutis congenita	ORPHA:1114
4567	0.2137	?Facial palsy, congenital, with ptosis and velopharyngeal dysfunction	OMIM:617732
4567	0.2137	BOR syndrome	ORPHA:107
4567	0.2137	Aplasia cutis congenita	ORPHA:1114
4567	0.2137	Hyperostosis corticalis generalisata	ORPHA:3416
4567	0.2137	Facial paresis, hereditary congenital, 3	OMIM:614744
4567	0.2137	Osteopetrosis, autosomal recessive 4	OMIM:611490
4567	0.2137	Osteopathia striata with cranial sclerosis	OMIM:300373
4567	0.2137	Osteopathia striata-cranial sclerosis syndrome	ORPHA:2780
4567	0.2137	Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome	ORPHA:508498
4567	0.2137	Fibrosis of extraocular muscles, congenital, 3A	OMIM:600638
4567	0.2137	Cold-induced sweating syndrome 1	OMIM:272430
4567	0.2137	Lenz-Majewski hyperostotic dwarfism	ORPHA:2658
4567	0.2137	Coffin-Siris syndrome 12	OMIM:619325
4567	0.2137	Craniometaphyseal dysplasia	OMIM:123000
4567	0.2137	Craniometaphyseal dysplasia	ORPHA:1522
4567	0.2137	Osteopetrosis, autosomal recessive 8	OMIM:615085
4567	0.2137	Sarcoidosis, susceptibility to, 2	OMIM:612387
4601	0.2136	Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities	OMIM:616577
4601	0.2136	Ichthyosis follicularis-alopecia-photophobia syndrome	ORPHA:2273
4603	0.2135	Glycogen storage disease 0, liver	OMIM:240600
4603	0.2135	Mosaic variegated aneuploidy syndrome 1	OMIM:257300
4605	0.2133	?Immunodeficiency 59 and hypoglycemia	OMIM:233600
4606	0.2132	Formiminoglutamic aciduria	ORPHA:51208
4606	0.2132	Squalene synthase deficiency	OMIM:618156
4606	0.2132	Nephronophthisis 2, infantile	OMIM:602088
4609	0.2128	46,XY difference of sex development due to isolated 17,20-lyase deficiency	ORPHA:90796
4609	0.2128	46,XY difference of sex development due to isolated 17,20-lyase deficiency	ORPHA:90796
4611	0.2126	SIN3A-related intellectual disability syndrome due to a point mutation	ORPHA:500166
4611	0.2126	SIN3A-related intellectual disability syndrome due to a point mutation	ORPHA:500166
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Short stature, brachydactyly, intellectual developmental disability, and seizures	OMIM:617157
4611	0.2126	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
4611	0.2126	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
4611	0.2126	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	OMIM:613563
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Rolandic epilepsy-speech dyspraxia syndrome	ORPHA:163721
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Opitz GBBB syndrome	ORPHA:2745
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Neurodevelopmental disorder with speech impairment and dysmorphic facies	OMIM:619056
4611	0.2126	Intellectual developmental disorder, autosomal recessive 3	OMIM:608443
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	?Impaired intellectual development, anterior maxillary protrusion, and strabismus	OMIM:613671
4611	0.2126	Autosomal dominant polycystic kidney disease	ORPHA:730
4611	0.2126	Rolandic epilepsy-speech dyspraxia syndrome	ORPHA:163721
4611	0.2126	Dyserythropoietic anemia, congenital, type Ia	OMIM:224120
4611	0.2126	Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities	OMIM:618089
4634	0.2125	Hypermanganesemia with dystonia 1	OMIM:613280
4635	0.2124	Niemann-Pick disease, type B	OMIM:607616
4635	0.2124	Apolipoprotein C-III deficiency	OMIM:614028
4635	0.2124	Abdominal obesity-metabolic syndrome 4	OMIM:618620
4638	0.2122	Mild phosphoribosylpyrophosphate synthetase superactivity	ORPHA:411536
4638	0.2122	Tubulointerstitial kidney disease, autosomal dominant, 4	OMIM:613092
4638	0.2122	Uric acid concentration, serum, QTL 2	OMIM:612076
4638	0.2122	Hypouricemia, renal, 2	OMIM:612076
4638	0.2122	Hyperuricemia, HRPT-related	OMIM:300323
4638	0.2122	Lesch-Nyhan syndrome	ORPHA:510
4638	0.2122	?Spermatogenic failure 13	OMIM:615841
4638	0.2122	Juvenile Paget disease	ORPHA:2801
4638	0.2122	HNF1B-related autosomal dominant tubulointerstitial kidney disease	ORPHA:93111
4638	0.2122	Juvenile Paget disease	ORPHA:2801
4638	0.2122	Tubulointerstitial kidney disease, autosomal dominant, 1	OMIM:162000
4638	0.2122	Hypogonadotropic hypogonadism 25 with anosmia	OMIM:618841
4638	0.2122	Burkitt lymphoma	ORPHA:543
4651	0.2121	Thrombocytopenia, autosomal dominant, 7	OMIM:619130
4652	0.2119	Congenital disorder of glycosylation, type Ig	OMIM:607143
4653	0.2118	Imerslund-Gräsbeck syndrome	ORPHA:35858
4653	0.2118	Imerslund-Gräsbeck syndrome	ORPHA:35858
4655	0.2117	Combined oxidative phosphorylation defect type 29	ORPHA:478029
4655	0.2117	?Combined oxidative phosphorylation deficiency 29	OMIM:616811
4655	0.2117	Congenital dyserythropoietic anemia type III	ORPHA:98870
4655	0.2117	Congenital dyserythropoietic anemia type III	ORPHA:98870
4659	0.2113	Cholestasis, progressive familial intrahepatic, 12	OMIM:620010
4660	0.2112	Neurodevelopmental disorder with dysmorphic facies and thin corpus callosum	OMIM:619480
4661	0.2109	?Bile acid synthesis defect, congenital, 5	OMIM:616278
4662	0.2108	Developmental and epileptic encephalopathy 82	OMIM:618721
4663	0.2107	Microcephaly, congenital cataract, and psoriasiform dermatitis	OMIM:616834
4664	0.2106	Combined oxidative phosphorylation defect type 27	ORPHA:477774
4665	0.2105	Ornithine transcarbamylase deficiency	ORPHA:664
4665	0.2105	Hepatic lipase deficiency	OMIM:614025
4665	0.2105	Hypertriglyceridemia 2	OMIM:619324
4665	0.2105	Infantile liver failure syndrome 2	OMIM:616483
4669	0.2103	Johanson-Blizzard syndrome	OMIM:243800
4670	0.2102	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy	OMIM:620152
4671	0.2101	Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities	OMIM:617668
4672	0.21	Partial androgen insensitivity syndrome	ORPHA:90797
4672	0.21	Argininemia	OMIM:207800
4674	0.2099	Erythrocytosis, familial, 5	OMIM:617907
4674	0.2099	Erythrocytosis, familial, 4	OMIM:611783
4674	0.2099	Erythrocytosis, familial, 2	OMIM:263400
4677	0.2098	N-acetylglutamate synthase deficiency	OMIM:237310
4677	0.2098	Hypogonadotropic hypogonadism 24 without anosmia	OMIM:229070
4677	0.2098	?Premature ovarian failure 17	OMIM:619146
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	OMIM:125310
4680	0.2095	Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy	ORPHA:136
4680	0.2095	Perry syndrome	ORPHA:178509
4680	0.2095	Gaucher disease, perinatal lethal	OMIM:608013
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Basal ganglia calcification, idiopathic, 5	OMIM:615483
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Lissencephaly type 1 due to doublecortin gene mutation	ORPHA:2148
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Pyruvate dehydrogenase phosphatase deficiency	ORPHA:79246
4680	0.2095	Supranuclear palsy, progressive	OMIM:601104
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Semantic dementia	ORPHA:100069
4680	0.2095	Kleine-Levin syndrome	ORPHA:33543
4696	0.2093	Hypophosphatasia, childhood	OMIM:241510
4697	0.2089	Transaldolase deficiency	ORPHA:101028
4697	0.2089	?Reynolds syndrome	OMIM:613471
4697	0.2089	Bile acid synthesis defect, congenital, 2	OMIM:235555
4697	0.2089	Congenital bile acid synthesis defect type 3	ORPHA:79302
4697	0.2089	Bile acid synthesis defect, congenital, 3	OMIM:613812
4702	0.2088	Hereditary arterial and articular multiple calcification syndrome	ORPHA:289601
4702	0.2088	Bile acid synthesis defect, congenital, 4	OMIM:214950
4702	0.2088	Kenny-Caffey syndrome, type 2	OMIM:127000
4705	0.2087	Congenital ptosis	ORPHA:91411
4705	0.2087	Congenital ptosis	ORPHA:91411
4705	0.2087	Hypogonadotropic hypogonadism 23 with or without anosmia	OMIM:228300
4708	0.2086	Polycystic liver disease 1	OMIM:174050
4708	0.2086	Cholestasis, benign recurrent intrahepatic, 2	OMIM:605479
4708	0.2086	Cholestasis, progressive familial intrahepatic 2	OMIM:601847
4708	0.2086	?Cholestasis, progressive familial intrahepatic, 6	OMIM:619484
4712	0.2085	Multiple endocrine neoplasia 1	OMIM:131100
4712	0.2085	X-linked hypophosphatemia	ORPHA:89936
4712	0.2085	Raine syndrome	OMIM:259775
4715	0.2079	?Mitochondrial complex I deficiency, nuclear type 35	OMIM:619003
4716	0.2078	Fumarase deficiency	OMIM:606812
4717	0.2076	Intermediate osteopetrosis	ORPHA:210110
4717	0.2076	Intermediate osteopetrosis	ORPHA:210110
4717	0.2076	Paget disease of bone 2, early-onset	OMIM:602080
4717	0.2076	Intermediate osteopetrosis	ORPHA:210110
4721	0.2074	Hyperphenylalaninemia, BH4-deficient, D	OMIM:264070
4722	0.2072	Cole disease	OMIM:615522
4723	0.2071	Hypocalcemia, autosomal dominant 2	OMIM:615361
4723	0.2071	X-linked agammaglobulinemia	ORPHA:47
4725	0.207	?[Dysalbuminemic hypertriiodothyroninemia]	OMIM:615999
4726	0.2068	Hypercholesterolemia, familial, 4	OMIM:603813
4726	0.2068	Congenital disorder of glycosylation, type IIw	OMIM:619525
4728	0.2067	Immunodeficiency 44	OMIM:616636
4729	0.2061	Tumoral calcinosis, hyperphosphatemic, familial, 1	OMIM:211900
4730	0.206	Glycerol kinase deficiency	OMIM:307030
4731	0.2059	Holt-Oram syndrome	OMIM:142900
4731	0.2059	Ulnar-mammary syndrome	ORPHA:3138
4731	0.2059	Neurodevelopmental disorder with ataxia, hypotonia, and microcephaly	OMIM:618569
4734	0.2056	Bernard-Soulier syndrome, type A2 (dominant)	OMIM:153670
4735	0.2055	Paragangliomas 3	OMIM:605373
4735	0.2055	Paragangliomas 1, with or without deafness	OMIM:168000
4735	0.2055	Hypophosphatemic rickets, autosomal recessive, 2	OMIM:613312
4735	0.2055	Paragangliomas 6	OMIM:618464
4739	0.2047	Fabry disease	ORPHA:324
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features	OMIM:301091
4740	0.2046	Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome	ORPHA:1369
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Night blindness, congenital stationary (complete), 1C, autosomal recessive	OMIM:613216
4740	0.2046	Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome	ORPHA:1369
4740	0.2046	Nephrotic syndrome, type 5, with or without ocular abnormalities	OMIM:614199
4740	0.2046	Isolated ectopia lentis	ORPHA:1885
4740	0.2046	MORM syndrome	ORPHA:75858
4740	0.2046	Corpus callosum agenesis-neuronopathy syndrome	ORPHA:1496
4740	0.2046	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties	OMIM:616158
4740	0.2046	Aicardi-Goutieres syndrome 6	OMIM:615010
4740	0.2046	?Aicardi-Goutieres syndrome 8	OMIM:619486
4740	0.2046	Linear skin defects with multiple congenital anomalies 3	OMIM:300952
4740	0.2046	Isolated aniridia	ORPHA:250923
4740	0.2046	Peters anomaly	ORPHA:708
4740	0.2046	Corpus callosum agenesis-abnormal genitalia syndrome	ORPHA:2508
4740	0.2046	Proud syndrome	OMIM:300004
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Cardiofaciocutaneous syndrome	ORPHA:1340
4740	0.2046	Oculoectodermal syndrome, somatic	OMIM:600268
4740	0.2046	Noonan syndrome 3	OMIM:609942
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Microphthalmia, syndromic 6	OMIM:607932
4740	0.2046	Microphthalmia with brain and digit anomalies	ORPHA:139471
4740	0.2046	CODAS syndrome	ORPHA:1458
4740	0.2046	Auditory neuropathy and optic atrophy	OMIM:617717
4740	0.2046	Alternating hemiplegia of childhood 1	OMIM:104290
4740	0.2046	Developmental and epileptic encephalopathy 74	OMIM:618396
4740	0.2046	Developmental and epileptic encephalopathy 66	OMIM:618067
4740	0.2046	Intellectual developmental disorder, autosomal recessive 67	OMIM:618295
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Cataract 9, multiple types	OMIM:604219
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Cataract 2, multiple types	OMIM:604307
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Cataract 17, multiple types	OMIM:611544
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Cenani-Lenz syndrome	ORPHA:3258
4740	0.2046	Peters anomaly	ORPHA:708
4740	0.2046	Anterior segment dysgenesis 2, multiple subtypes	OMIM:610256
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Night blindness, congenital stationary (complete), 1E, autosomal recessive	OMIM:614565
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Spondylometaphyseal dysplasia with cone-rod dystrophy	OMIM:608940
4740	0.2046	Cerebral palsy, spastic quadriplegic, 2	OMIM:612900
4740	0.2046	?Bardet-Biedl syndrome 14	OMIM:615991
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	WAGR syndrome	ORPHA:893
4740	0.2046	Knobloch syndrome	ORPHA:1571
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Bardet-Biedl syndrome 14, modifier of	OMIM:615991
4740	0.2046	Nephronophthisis 11	OMIM:613550
4740	0.2046	Potocki-Shaffer syndrome	ORPHA:52022
4740	0.2046	Marshall syndrome	ORPHA:560
4740	0.2046	Knobloch syndrome	ORPHA:1571
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia	OMIM:617173
4740	0.2046	Developmental and epileptic encephalopathy 105 with hypopituitarism	OMIM:619983
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Bosch-Boonstra-Schaaf optic atrophy syndrome	OMIM:615722
4740	0.2046	Generalized epilepsy-paroxysmal dyskinesia syndrome	ORPHA:79137
4740	0.2046	Stankiewicz-Isidor syndrome	OMIM:617516
4740	0.2046	Osteopetrosis, autosomal recessive 2	OMIM:259710
4740	0.2046	Pseudopseudohypoparathyroidism	OMIM:612463
4740	0.2046	Poretti-Boltshauser syndrome	OMIM:615960
4740	0.2046	Lissencephaly due to TUBA1A mutation	ORPHA:171680
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Night blindness, congenital stationary (incomplete), 2A, X-linked	OMIM:300071
4740	0.2046	Cone-rod dystrophy, X-linked, 3	OMIM:300476
4740	0.2046	Aland Island eye disease	OMIM:300600
4740	0.2046	Åland Islands eye disease	ORPHA:178333
4740	0.2046	Noonan syndrome-like disorder with loose anagen hair 2	OMIM:617506
4740	0.2046	Isolated aniridia	ORPHA:250923
4740	0.2046	Cataract with late-onset corneal dystrophy	OMIM:106210
4740	0.2046	Morning glory disc anomaly	ORPHA:35737
4740	0.2046	WAGR syndrome	ORPHA:893
4740	0.2046	Foveal hypoplasia-presenile cataract syndrome	ORPHA:2253
4740	0.2046	Peters anomaly	ORPHA:708
4740	0.2046	Anterior segment dysgenesis 5, multiple subtypes	OMIM:604229
4740	0.2046	?Coloboma, ocular	OMIM:120200
4740	0.2046	Optic nerve hypoplasia	OMIM:165550
4740	0.2046	?Leber congenital amaurosis 19	OMIM:618513
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Potocki-Shaffer syndrome	ORPHA:52022
4740	0.2046	Peters anomaly	ORPHA:708
4740	0.2046	Cardiofaciocutaneous syndrome 3	OMIM:615279
4740	0.2046	Cardiofaciocutaneous syndrome	ORPHA:1340
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Cardiofaciocutaneous syndrome	ORPHA:1340
4740	0.2046	Ohdo syndrome, X-linked	OMIM:300895
4740	0.2046	?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2	OMIM:193220
4740	0.2046	Vitreoretinochoroidopathy	OMIM:193220
4740	0.2046	Mucoepithelial dysplasia, hereditary	OMIM:158310
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Neurocardiofaciodigital syndrome	OMIM:619869
4740	0.2046	Acro-renal-ocular syndrome	ORPHA:959
4740	0.2046	Usher syndrome, type 1B	OMIM:276900
4740	0.2046	Uveal coloboma-cleft lip and palate-intellectual disability	ORPHA:1473
4740	0.2046	X-linked recessive ocular albinism	ORPHA:54
4740	0.2046	Ocular albinism with late-onset sensorineural deafness	ORPHA:1000
4740	0.2046	Cataract 19, multiple types	OMIM:615277
4740	0.2046	Cenani-Lenz syndrome	ORPHA:3258
4740	0.2046	Intellectual developmental disorder, X-linked 106	OMIM:300997
4740	0.2046	Isolated ectopia lentis	ORPHA:1885
4740	0.2046	Focal dermal hypoplasia	OMIM:305600
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Nance-Horan syndrome	OMIM:302350
4740	0.2046	Nance-Horan syndrome	ORPHA:627
4740	0.2046	Retinitis pigmentosa 41	OMIM:612095
4740	0.2046	Gorlin-Chaudhry-Moss syndrome	ORPHA:2095
4740	0.2046	Hypotrichosis with juvenile macular degeneration	ORPHA:1573
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Horizontal gaze palsy with progressive scoliosis	ORPHA:2744
4740	0.2046	Gaze palsy, familial horizontal, with progressive scoliosis, 1	OMIM:607313
4740	0.2046	Congenital disorder of glycosylation, type Iq	OMIM:612379
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Leber congenital amaurosis 11	OMIM:613837
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Hydrocephalus with stenosis of the aqueduct of Sylvius	ORPHA:2182
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Retinal cone dystrophy 3	OMIM:610024
4740	0.2046	Retinal dystrophy and microvillus inclusion disease	OMIM:619446
4740	0.2046	Cone dystrophy 4	OMIM:613093
4740	0.2046	Craniofrontonasal dysplasia	OMIM:304110
4740	0.2046	Jalili syndrome	ORPHA:1873
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Mosaic variegated aneuploidy syndrome 3	OMIM:617598
4740	0.2046	Trichothiodystrophy 4, nonphotosensitive	OMIM:234050
4740	0.2046	Nephronophthisis 15	OMIM:614845
4740	0.2046	?Microcephaly 13, primary, autosomal recessive	OMIM:616051
4740	0.2046	Cornelia de Lange syndrome 1	OMIM:122470
4740	0.2046	Horizontal gaze palsy with progressive scoliosis	ORPHA:2744
4740	0.2046	Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition	OMIM:620189
4740	0.2046	Renal coloboma syndrome	ORPHA:1475
4740	0.2046	Cortical dysplasia, complex, with other brain malformations 3	OMIM:615411
4740	0.2046	Trichothiodystrophy 6, nonphotosensitive	OMIM:616943
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Neurodevelopmental disorder with seizures and brain abnormalities	OMIM:619517
4740	0.2046	Neurodevelopmental disorder with hypotonia and brain abnormalities	OMIM:619512
4740	0.2046	Roberts syndrome	ORPHA:3103
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Leber congenital amaurosis with early-onset deafness	OMIM:617879
4740	0.2046	Congenital disorder of glycosylation with defective fucosylation 2	OMIM:618324
4740	0.2046	Peters-plus syndrome	OMIM:261540
4740	0.2046	Peters plus syndrome	ORPHA:709
4740	0.2046	Autosomal recessive chorioretinopathy-microcephaly syndrome	ORPHA:2518
4740	0.2046	Cone-rod dystrophy and hearing loss	OMIM:617236
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Autosomal recessive chorioretinopathy-microcephaly syndrome	ORPHA:2518
4740	0.2046	Microcephaly and chorioretinopathy, autosomal recessive, 1	OMIM:251270
4740	0.2046	Microcephaly and chorioretinopathy, autosomal recessive, 3	OMIM:616335
4740	0.2046	Autosomal recessive chorioretinopathy-microcephaly syndrome	ORPHA:2518
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Cone-rod dystrophy 6	OMIM:601777
4740	0.2046	Joubert syndrome 9	OMIM:612285
4740	0.2046	Cranioectodermal dysplasia	ORPHA:1515
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Night blindness, congenital stationary, type 1H	OMIM:617024
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Bryant-Li-Bhoj neurodevelopmental syndrome 1	OMIM:619720
4740	0.2046	Hermansky-Pudlak syndrome 1	OMIM:203300
4740	0.2046	Achromatopsia 4	OMIM:613856
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome	ORPHA:52055
4740	0.2046	?Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia	OMIM:300472
4740	0.2046	Cranioectodermal dysplasia	ORPHA:1515
4740	0.2046	Microphthalmia with coloboma 6, digenic	OMIM:613703
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Oculocutaneous albinism type 1B	ORPHA:79434
4740	0.2046	Oculocutaneous albinism type 1A	ORPHA:79431
4740	0.2046	Albinism, oculocutaneous, type IB	OMIM:606952
4740	0.2046	Albinism, oculocutaneous, type IA	OMIM:203100
4740	0.2046	Phosphoglycerate dehydrogenase deficiency	OMIM:601815
4740	0.2046	Albinism, oculocutaneous, type VII	OMIM:615179
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Joubert syndrome 12	OMIM:200990
4740	0.2046	Peters anomaly	ORPHA:708
4740	0.2046	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	OMIM:617763
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Achromatopsia 7	OMIM:616517
4740	0.2046	Albinism, oculocutaneous, type II, modifier of	OMIM:203200
4740	0.2046	Oculocutaneous albinism type 2	ORPHA:79432
4740	0.2046	Senior-Loken syndrome 9	OMIM:616629
4740	0.2046	Microphthalmia, isolated, with coloboma 6	OMIM:613703
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Malan syndrome	OMIM:614753
4740	0.2046	Oculocutaneous albinism type 3	ORPHA:79433
4740	0.2046	Albinism, oculocutaneous, type III	OMIM:203290
4740	0.2046	X-linked recessive ocular albinism	ORPHA:54
4740	0.2046	Oculocutaneous albinism type 4	ORPHA:79435
4740	0.2046	Albinism, oculocutaneous, type IV	OMIM:606574
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Leber congenital amaurosis 5	OMIM:604537
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Kabuki syndrome	ORPHA:2322
4740	0.2046	Spondylo-ocular syndrome	ORPHA:85194
4740	0.2046	Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies	OMIM:618731
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Cone-rod synaptic disorder, congenital nonprogressive	OMIM:610427
4740	0.2046	Leukodystrophy and acquired microcephaly with or without dystonia	OMIM:616763
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Leber congenital amaurosis 14	OMIM:613341
4740	0.2046	Neurodevelopmental disorder with hypotonia, seizures, and absent language	OMIM:617268
4740	0.2046	Cranioectodermal dysplasia	ORPHA:1515
4740	0.2046	Short-rib thoracic dysplasia 16 with or without polydactyly	OMIM:617102
4740	0.2046	Oculocutaneous albinism, type VIII	OMIM:619165
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Dysosteosclerosis	ORPHA:1782
4740	0.2046	Congenital hereditary endothelial dystrophy type II	ORPHA:293603
4740	0.2046	Corneal dystrophy-perceptive deafness syndrome	ORPHA:1490
4740	0.2046	Septo-optic dysplasia spectrum	ORPHA:3157
4740	0.2046	Short stature with microcephaly and distinctive facies	OMIM:615789
4740	0.2046	Kabuki syndrome	ORPHA:2322
4740	0.2046	Albinism, oculocutaneous, type VI	OMIM:113750
4740	0.2046	Oculocutaneous albinism type 6	ORPHA:370097
4740	0.2046	Spondylometaphyseal dysplasia, axial	OMIM:602271
4740	0.2046	Leber congenital amaurosis 15	OMIM:613843
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Retinitis pigmentosa 14	OMIM:600132
4740	0.2046	Intellectual developmental disorder with ocular anomalies and distinctive facial features	OMIM:620086
4740	0.2046	Microphthalmia, Lenz type	ORPHA:568
4740	0.2046	Potocki-Shaffer syndrome	ORPHA:52022
4740	0.2046	Frontonasal dysplasia-alopecia-genital anomalies syndrome	ORPHA:228390
4740	0.2046	Exudative vitreoretinopathy 2, X-linked	OMIM:305390
4740	0.2046	Leber congenital amaurosis 2	OMIM:204100
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Retinitis pigmentosa 20	OMIM:613794
4740	0.2046	Intellectual developmental disorder, X-linked 58	OMIM:300210
4740	0.2046	Leber congenital amaurosis 8	OMIM:613835
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Retinitis pigmentosa-12	OMIM:600105
4740	0.2046	Dysosteosclerosis	ORPHA:1782
4740	0.2046	Cortical dysplasia, complex, with other brain malformations 1	OMIM:614039
4740	0.2046	Oguchi disease	ORPHA:75382
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Cranioectodermal dysplasia	ORPHA:1515
4740	0.2046	?Cataract 49	OMIM:619593
4740	0.2046	GAPO syndrome	ORPHA:2067
4740	0.2046	Oguchi disease	ORPHA:75382
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	Khan-Khan-Katsanis syndrome	OMIM:618460
4740	0.2046	CEBALID syndrome	OMIM:618774
4740	0.2046	Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome	ORPHA:1369
4740	0.2046	Encephalopathy, familial, with neuroserpin inclusion bodies	OMIM:604218
4740	0.2046	Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome	ORPHA:521390
4740	0.2046	Ichthyosis with confetti	OMIM:609165
4740	0.2046	?Coloboma, ocular, autosomal recessive	OMIM:216820
4740	0.2046	?Aniridia 3	OMIM:617142
4740	0.2046	Isolated aniridia	ORPHA:250923
4740	0.2046	Cranioectodermal dysplasia	ORPHA:1515
4740	0.2046	Albinism, brown oculocutaneous	OMIM:203200
4740	0.2046	Oculocutaneous albinism type 2	ORPHA:79432
4740	0.2046	Microphthalmia/coloboma and skeletal dysplasia syndrome	OMIM:615877
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Leber congenital amaurosis 12	OMIM:610612
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Neurodevelopmental disorder with dysmorphic facies and variable seizures	OMIM:619264
4740	0.2046	KINSSHIP syndrome	OMIM:619297
4740	0.2046	Congenital stationary night blindness	ORPHA:215
4740	0.2046	?Deafness, autosomal recessive 104	OMIM:616515
4740	0.2046	Orofaciodigital syndrome VI	OMIM:277170
4740	0.2046	Leber congenital amaurosis 3	OMIM:604232
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Hypotonia-speech impairment-severe cognitive delay syndrome	ORPHA:371364
4740	0.2046	Borjeson-Forssman-Lehmann syndrome	OMIM:301900
4740	0.2046	Intellectual developmental disorder, autosomal recessive 77	OMIM:619988
4740	0.2046	Hypotonia-speech impairment-severe cognitive delay syndrome	ORPHA:371364
4740	0.2046	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2	OMIM:616801
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Cardiofaciocutaneous syndrome	ORPHA:1340
4740	0.2046	Cardiofaciocutaneous syndrome	OMIM:115150
4740	0.2046	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	OMIM:619184
4740	0.2046	Intellectual developmental disorder, autosomal recessive 78	OMIM:620237
4740	0.2046	Dysosteosclerosis	ORPHA:1782
4740	0.2046	X-linked intellectual disability, Najm type	ORPHA:163937
4740	0.2046	Exudative vitreoretinopathy 7	OMIM:617572
4740	0.2046	Cohen syndrome	ORPHA:193
4740	0.2046	Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome	ORPHA:488613
4740	0.2046	Schuurs-Hoeijmakers syndrome	OMIM:615009
4740	0.2046	Cone-rod dystrophy, X-linked, 1	OMIM:304020
4740	0.2046	Microphthalmia, Lenz type	ORPHA:568
4740	0.2046	Intellectual developmental disorder with speech delay, autism, and dysmorphic facies	OMIM:618672
4740	0.2046	WAGR syndrome	ORPHA:893
4740	0.2046	Cataract-microcornea syndrome	ORPHA:1377
4740	0.2046	Leber congenital amaurosis 16	OMIM:614186
4740	0.2046	Leber congenital amaurosis	ORPHA:65
4740	0.2046	Neurodegeneration, childhood-onset, hypotonia, respiratory insufficiency and brain imaging abnormalities	OMIM:619173
4740	0.2046	Developmental delay with variable neurologic and brain abnormalities	OMIM:619694
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	1p36 deletion syndrome	ORPHA:1606
4740	0.2046	Cone-rod dystrophy 20	OMIM:615973
4740	0.2046	Baller-Gerold syndrome	ORPHA:1225
4740	0.2046	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies, somatic mosaic	OMIM:618727
4740	0.2046	Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis	OMIM:609218
5045	0.2045	Lipodystrophy, congenital generalized, type 3	OMIM:612526
5046	0.2043	Thyroid hormone metabolism, abnormal, 1	OMIM:609698
5047	0.2037	Amyotrophic lateral sclerosis 20	OMIM:615426
5048	0.2036	Alpha-aminoadipic and alpha-ketoadipic aciduria	OMIM:204750
5048	0.2036	Childhood absence epilepsy	ORPHA:64280
5048	0.2036	Jacobsen syndrome	ORPHA:2308
5048	0.2036	Genitourinary and/or/brain malformation syndrome	OMIM:618820
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Microcephaly 20, primary, autosomal recessive	OMIM:617914
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Childhood absence epilepsy	ORPHA:64280
5048	0.2036	Epilepsy, familial focal, with variable foci 4	OMIM:617935
5048	0.2036	Marbach-Schaaf neurodevelopmental syndrome	OMIM:619680
5048	0.2036	Legius syndrome	OMIM:611431
5048	0.2036	?Attention deficit-hyperactivity disorder 8	OMIM:619957
5048	0.2036	Nasu-Hakola disease	ORPHA:2770
5048	0.2036	Childhood absence epilepsy	ORPHA:64280
5048	0.2036	Childhood absence epilepsy	ORPHA:64280
5048	0.2036	Periventricular nodular heterotopia 9	OMIM:618918
5048	0.2036	Au-Kline syndrome	OMIM:616580
5048	0.2036	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	OMIM:620029
5048	0.2036	Gabriele-de Vries syndrome	OMIM:617557
5048	0.2036	Macrocephaly-intellectual disability-autism syndrome	ORPHA:210548
5048	0.2036	TSC2 angiomyolipomas, renal, modifier of	OMIM:613254
5048	0.2036	Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures	OMIM:618725
5048	0.2036	Short stature, developmental delay, and congenital heart defects	OMIM:617044
5048	0.2036	Snijders Blok-Campeau syndrome	OMIM:618205
5048	0.2036	2q37 microdeletion syndrome	ORPHA:1001
5048	0.2036	Parenti-Mignot neurodevelopmental syndrome	OMIM:619873
5048	0.2036	Childhood absence epilepsy	ORPHA:64280
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Tuberous sclerosis-2	OMIM:613254
5048	0.2036	Tuberous sclerosis-1	OMIM:191100
5048	0.2036	Chilton-Okur-Chung neurodevelopmental syndrome	OMIM:619841
5048	0.2036	Noonan syndrome 13	OMIM:619087
5048	0.2036	Houge-Janssens syndrome 3	OMIM:618354
5048	0.2036	Lujan-Fryns syndrome	ORPHA:776
5048	0.2036	Neurodevelopmental disorder with hypotonia and gross motor and speech delay	OMIM:619639
5048	0.2036	Intellectual developmental disorder, autosomal dominant 67	OMIM:619927
5048	0.2036	Epilepsy, focal, with speech disorder and with or without impaired intellectual development	OMIM:245570
5048	0.2036	Opitz-Kaveggia syndrome	OMIM:305450
5048	0.2036	Lujan-Fryns syndrome	ORPHA:776
5048	0.2036	FG syndrome type 1	ORPHA:93932
5048	0.2036	Intellectual developmental disorder with hypotonia and behavioral abnormalities	OMIM:618748
5048	0.2036	Intellectual developmental disorder, autosomal dominant 61	OMIM:618009
5048	0.2036	AMED syndrome, digenic	OMIM:619151
5048	0.2036	Developmental delay with variable intellectual disability and dysmorphic facies	OMIM:620098
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Intellectual developmental disorder, autosomal recessive 70	OMIM:618402
5048	0.2036	Intellectual developmental disorder, autosomal recessive 71	OMIM:618504
5048	0.2036	Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies	OMIM:618659
5048	0.2036	Rothmund-Thomson syndrome type 1	ORPHA:221008
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Incontinentia pigmenti	ORPHA:464
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Teebi hypertelorism syndrome 2	OMIM:619736
5048	0.2036	Turnpenny-Fry syndrome	OMIM:618371
5048	0.2036	?Neurodevelopmental disorder with microcephaly, hypotonia, and absent language	OMIM:620038
5048	0.2036	Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome	ORPHA:544488
5048	0.2036	Microcephalic osteodysplastic primordial dwarfism type II	ORPHA:2637
5048	0.2036	Tolchin-Le Caignec syndrome	OMIM:618971
5048	0.2036	Kury-Isidor syndrome	OMIM:619762
5048	0.2036	17p11.2 microduplication syndrome	ORPHA:1713
5048	0.2036	Gilles de la Tourette syndrome, susceptibility to	OMIM:137580
5048	0.2036	Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart	OMIM:616975
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Polymicrogyria due to TUBB2B mutation	ORPHA:300573
5048	0.2036	Familial peripheral male-limited precocious puberty	ORPHA:3000
5048	0.2036	Attention deficit-hyperactivity disorder, susceptibility to	OMIM:143465
5048	0.2036	Noonan syndrome-like with loose anagen hair 1	OMIM:607721
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Intellectual developmental disorder, autosomal dominant 63, with macrocephaly	OMIM:618825
5048	0.2036	15q13.3 microdeletion syndrome	ORPHA:199318
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Nasu-Hakola disease	ORPHA:2770
5048	0.2036	Recessive X-linked ichthyosis	ORPHA:461
5048	0.2036	Syndromic recessive X-linked ichthyosis	ORPHA:281090
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Lessel-Kreienkamp syndrome	OMIM:619149
5048	0.2036	Muenke syndrome	OMIM:602849
5048	0.2036	Intellectual developmental disorder, X-linked 90	OMIM:300850
5048	0.2036	Intellectual developmental disorder, autosomal dominant 57	OMIM:618050
5048	0.2036	Alzheimer disease 9, susceptibility to	OMIM:608907
5048	0.2036	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type	OMIM:301039
5048	0.2036	Skeletal dysplasia, mild, with joint laxity and advanced bone age	OMIM:618870
5048	0.2036	Intellectual developmental disorder, autosomal dominant 29	OMIM:616078
5048	0.2036	Jansen-de Vries syndrome	OMIM:617450
5048	0.2036	Intellectual developmental disorder, autosomal recessive 2	OMIM:607417
5048	0.2036	Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures	OMIM:620292
5048	0.2036	1p31p32 microdeletion syndrome	ORPHA:401986
5048	0.2036	Microtia	ORPHA:83463
5048	0.2036	Nizon-Isidor syndrome	OMIM:618872
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Aarskog-Scott syndrome	ORPHA:915
5048	0.2036	Autism, susceptibility to, 20	OMIM:618830
5048	0.2036	?Attention deficit-hyperactivity disorder, susceptibility to, 7	OMIM:613003
5048	0.2036	Proximal 16p11.2 microdeletion syndrome	ORPHA:261197
5048	0.2036	2q32q33 microdeletion syndrome	ORPHA:251019
5048	0.2036	SATB2-associated syndrome due to a pathogenic variant	ORPHA:576283
5048	0.2036	22q11.2 duplication syndrome	ORPHA:1727
5048	0.2036	Global developmental delay with speech and behavioral abnormalities	OMIM:619243
5048	0.2036	Intellectual developmental disorder, autosomal dominant 50, with behavioral abnormalities	OMIM:617787
5048	0.2036	KBG syndrome	OMIM:148050
5048	0.2036	Developmental and epileptic encephalopathy 9	OMIM:300088
5048	0.2036	ADNP syndrome	ORPHA:404448
5048	0.2036	Tourette syndrome	OMIM:137580
5048	0.2036	Recessive X-linked ichthyosis	ORPHA:461
5048	0.2036	Microcephaly 5, primary, autosomal recessive	OMIM:608716
5048	0.2036	Developmental delay, behavioral abnormalities, and neuropsychiatric disorders	OMIM:620065
5048	0.2036	Vertebral, cardiac, tracheoesophageal, renal, and limb defects	OMIM:619227
5048	0.2036	?Intellectual developmental disorder, X-linked 107	OMIM:301013
5048	0.2036	Macrocephaly-intellectual disability-autism syndrome	ORPHA:210548
5048	0.2036	Chopra-Amiel-Gordon syndrome	OMIM:619504
5048	0.2036	?Intellectual developmental disorder, autosomal dominant 69	OMIM:617863
5048	0.2036	Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome	ORPHA:459061
5048	0.2036	Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome	ORPHA:459061
5048	0.2036	Neurodevelopmental disorder with or without early-onset generalized epilepsy	OMIM:619157
5048	0.2036	Diets-Jongmans syndrome	OMIM:618846
5048	0.2036	Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency	ORPHA:404440
5048	0.2036	Lynch syndrome	ORPHA:144
5048	0.2036	Lujan-Fryns syndrome	ORPHA:776
5048	0.2036	Intellectual developmental disorder, autosomal recessive 72	OMIM:618665
5048	0.2036	CATIFA syndrome	OMIM:618761
5048	0.2036	Intellectual developmental disorder and retinitis pigmentosa	OMIM:618195
5048	0.2036	Intellectual developmental disorder with autism and dysmorphic facies	OMIM:620021
5048	0.2036	Desanto-Shinawi syndrome	OMIM:616708
5048	0.2036	Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion	ORPHA:284169
5048	0.2036	Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation	ORPHA:466950
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Intellectual developmental disorder, autosomal dominant 51	OMIM:617788
5048	0.2036	Attention deficit-hyperactivity disorder	OMIM:143465
5048	0.2036	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	OMIM:619005
5048	0.2036	?Microcephaly 25, primary, autosomal recessive	OMIM:618351
5048	0.2036	Coffin-Siris syndrome 6	OMIM:617808
5048	0.2036	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
5048	0.2036	Li-Ghorgani-Weisz-Hubshman syndrome	OMIM:618974
5048	0.2036	?Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome	OMIM:618878
5048	0.2036	Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities	OMIM:619103
5048	0.2036	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly	OMIM:619827
5048	0.2036	Atelis syndrome 1	OMIM:620184
5048	0.2036	Developmental and speech delay due to SOX5 deficiency	ORPHA:313892
5190	0.2034	Mitochondrial complex III deficiency, nuclear type 3	OMIM:615158
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5191	0.2032	46,XY partial gonadal dysgenesis	ORPHA:251510
5203	0.2029	Hypohidrotic ectodermal dysplasia with immunodeficiency	ORPHA:98813
5203	0.2029	Hypohidrotic ectodermal dysplasia with immunodeficiency	ORPHA:98813
5205	0.2028	Myoclonus, intractable, neonatal	OMIM:617235
5205	0.2028	Mitochondrial complex IV deficiency, nuclear type 6	OMIM:615119
5205	0.2028	Night blindness, congenital stationary (complete), 1B, autosomal recessive	OMIM:257270
5205	0.2028	Pierpont syndrome	ORPHA:487825
5205	0.2028	Pierpont syndrome	OMIM:602342
5205	0.2028	Autosomal dominant primary microcephaly	ORPHA:2514
5205	0.2028	Gaucher disease, type IIIC	OMIM:231005
5205	0.2028	Zimmermann-Laband syndrome 1	OMIM:135500
5205	0.2028	Retinal cone dystrophy 3B	OMIM:610356
5205	0.2028	Foveal hypoplasia 1	OMIM:136520
5205	0.2028	Autosomal dominant keratitis	ORPHA:2334
5205	0.2028	Hypoparathyroidism, sensorineural deafness, and renal dysplasia	OMIM:146255
5205	0.2028	Striatonigral degeneration, infantile	OMIM:271930
5205	0.2028	Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome	ORPHA:163727
5205	0.2028	Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria	ORPHA:99646
5205	0.2028	Microphthalmia, syndromic 15	OMIM:615145
5205	0.2028	?Microphthalmia, isolated, with coloboma 9	OMIM:615145
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	Senior-Loken syndrome 4	OMIM:606996
5205	0.2028	Intellectual developmental disorder, autosomal dominant 52	OMIM:617796
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	Hermansky-Pudlak syndrome 4	OMIM:614073
5205	0.2028	Hydrocephalus, congenital, 2, with or without brain or eye anomalies	OMIM:615219
5205	0.2028	Autosomal dominant primary microcephaly	ORPHA:2514
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	Leber congenital amaurosis 4	OMIM:604393
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	Nystagmus 6, congenital, X-linked	OMIM:300814
5205	0.2028	Leukodystrophy, hypomyelinating, 26, with chondrodysplasia	OMIM:620269
5205	0.2028	Persistent hyperplastic primary vitreous, autosomal recessive	OMIM:221900
5205	0.2028	?Dystonia 34, myoclonic	OMIM:619724
5205	0.2028	Cataract 48	OMIM:618415
5205	0.2028	Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities	OMIM:618493
5205	0.2028	Optic atrophy 7	OMIM:612989
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	Leber congenital amaurosis 6	OMIM:613826
5205	0.2028	Tritanopia	ORPHA:88629
5205	0.2028	?Exudative vitreoretinopathy 6	OMIM:616468
5205	0.2028	Achromatopsia	ORPHA:49382
5205	0.2028	?Microphthalmia, syndromic 13	OMIM:300915
5246	0.2027	Imerslund-Grasbeck syndrome 1	OMIM:261100
5247	0.2026	Autoimmune polyendocrinopathy type 1	ORPHA:3453
5248	0.2024	Immunodeficiency 103, susceptibility to fungal infection	OMIM:212050
5249	0.2023	X-linked intellectual disability, Stocco Dos Santos type	ORPHA:85288
5250	0.202	CODAS syndrome	OMIM:600373
5251	0.2018	46XY sex reversal 11	OMIM:273250
5252	0.2016	MIRAGE syndrome	OMIM:617053
5253	0.2014	?Ovarian dysgenesis 8	OMIM:618187
5253	0.2014	Ovarian dysgenesis 9	OMIM:619665
5255	0.2013	Hereditary elliptocytosis	ORPHA:288
5255	0.2013	Hereditary elliptocytosis	ORPHA:288
5255	0.2013	Hereditary elliptocytosis	ORPHA:288
5255	0.2013	Rotor syndrome	ORPHA:3111
5255	0.2013	Rotor syndrome	ORPHA:3111
5255	0.2013	Hereditary elliptocytosis	ORPHA:288
5261	0.2011	DEEAH syndrome	OMIM:619004
5262	0.201	Growth hormone deficiency, isolated, type IA	OMIM:262400
5262	0.201	Orofaciodigital syndrome type 3	ORPHA:2752
5264	0.2004	HDL deficiency, familial, 1	OMIM:604091
5264	0.2004	Hyperlipidemia due to hepatic triacylglycerol lipase deficiency	ORPHA:140905
5264	0.2004	Norum disease	OMIM:245900
5264	0.2004	Mitchell-Riley syndrome	OMIM:615710
5268	0.2003	?Immunodeficiency 25	OMIM:610163
5269	0.2001	Hardikar syndrome	OMIM:301068
5270	0.1996	Combined malonic and methylmalonic acidemia	ORPHA:289504
5271	0.1993	?Fanconi renotubular syndrome 3	OMIM:615605
5271	0.1993	Senior-Loken syndrome-1	OMIM:266900
5271	0.1993	Preeclampsia	ORPHA:275555
5271	0.1993	Adenine phosphoribosyltransferase deficiency	OMIM:614723
5271	0.1993	Branched-chain keto acid dehydrogenase kinase deficiency	OMIM:614923
5271	0.1993	COACH syndrome 2	OMIM:619111
5271	0.1993	Short-rib thoracic dysplasia 5 with or without polydactyly	OMIM:614376
5271	0.1993	Preeclampsia	ORPHA:275555
5271	0.1993	?Nephronophthisis-like nephropathy 2	OMIM:619468
5271	0.1993	Cystinosis, ocular nonnephropathic	OMIM:219750
5271	0.1993	Preeclampsia	ORPHA:275555
5271	0.1993	Structural heart defects and renal anomalies syndrome	OMIM:617478
5283	0.1991	Crigler-Najjar syndrome type 1	ORPHA:79234
5283	0.1991	Crigler-Najjar syndrome type 2	ORPHA:79235
5283	0.1991	Seckel syndrome 10	OMIM:617253
5286	0.1989	Vertebral, cardiac, renal, and limb defects syndrome 1	OMIM:617660
5287	0.1987	Apolipoprotein A-I deficiency	ORPHA:425
5287	0.1987	Apolipoprotein A-I deficiency	ORPHA:425
5289	0.1986	Bernard-Soulier syndrome	ORPHA:274
5289	0.1986	Bernard-Soulier syndrome	ORPHA:274
5289	0.1986	Bernard-Soulier syndrome	ORPHA:274
5292	0.1985	?Paganini-Miozzo syndrome	OMIM:301025
5292	0.1985	Combined oxidative phosphorylation deficiency 9	OMIM:614582
5292	0.1985	Combined oxidative phosphorylation deficiency 30	OMIM:616974
5292	0.1985	Combined oxidative phosphorylation deficiency 31	OMIM:617228
5296	0.1984	Autosomal recessive Kenny-Caffey syndrome	ORPHA:93324
5296	0.1984	Hypertriglyceridemia, susceptibility to	OMIM:145750
5298	0.1981	Combined D-2- and L-2-hydroxyglutaric aciduria	OMIM:615182
5298	0.1981	Schaaf-Yang syndrome	OMIM:615547
5298	0.1981	Developmental and epileptic encephalopathy 78	OMIM:618557
5298	0.1981	Obesity, hyperphagia, and developmental delay	OMIM:613886
5298	0.1981	Developmental and epileptic encephalopathy 44	OMIM:617132
5298	0.1981	Autosomal dominant epilepsy with auditory features	ORPHA:101046
5298	0.1981	Developmental and epileptic encephalopathy 2	OMIM:300672
5298	0.1981	Dystonia 30	OMIM:619291
5298	0.1981	?Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development	OMIM:618339
5298	0.1981	Chromosome 5q14.3 deletion syndrome	OMIM:613443
5298	0.1981	Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language	OMIM:613443
5298	0.1981	Rett syndrome, congenital variant	OMIM:613454
5298	0.1981	Periventricular heterotopia with microcephaly	OMIM:608097
5298	0.1981	Developmental and epileptic encephalopathy 27	OMIM:616139
5298	0.1981	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	OMIM:617820
5298	0.1981	Severe combined immunodeficiency, X-linked	OMIM:300400
5298	0.1981	Neurodevelopmental, jaw, eye, and digital syndrome	OMIM:618914
5298	0.1981	Developmental and epileptic encephalopathy 85, with or without midline brain defects	OMIM:301044
5298	0.1981	Microcephaly 4, primary, autosomal recessive	OMIM:604321
5298	0.1981	Brunner syndrome	OMIM:300615
5298	0.1981	Antisocial behavior	OMIM:300615
5298	0.1981	Microcephaly 9, primary, autosomal recessive	OMIM:614852
5298	0.1981	Developmental and epileptic encephalopathy 61	OMIM:617933
5298	0.1981	8q24.3 microdeletion syndrome	ORPHA:508488
5298	0.1981	Female restricted epilepsy with intellectual disability	ORPHA:101039
5298	0.1981	Koolen-De Vries syndrome	OMIM:610443
5298	0.1981	Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome	ORPHA:411986
5298	0.1981	Developmental and epileptic encephalopathy 67	OMIM:618141
5298	0.1981	Autosomal dominant epilepsy with auditory features	ORPHA:101046
5298	0.1981	?Developmental and epileptic encephalopathy 40	OMIM:617065
5298	0.1981	Intellectual developmental disorder, X-linked 21	OMIM:300143
5298	0.1981	Vulto-van Silfout-de Vries syndrome	OMIM:615828
5298	0.1981	Autosomal dominant epilepsy with auditory features	ORPHA:101046
5298	0.1981	FRAXE intellectual disability	ORPHA:100973
5298	0.1981	Intellectual developmental disorder, X-linked 109	OMIM:309548
5298	0.1981	?Abnormal hair, joint laxity, and developmental delay	OMIM:261990
5334	0.1976	Bleeding disorder, platelet-type, 11	OMIM:614201
5335	0.1975	Orotic aciduria	OMIM:258900
5335	0.1975	Acatalasemia	ORPHA:926
5335	0.1975	Acatalasemia	OMIM:614097
5335	0.1975	Dyserythropoietic anemia, congenital, type II	OMIM:224100
5335	0.1975	Hemolytic anemia due to glutathione synthetase deficiency	OMIM:231900
5335	0.1975	Spondyloepimetaphyseal dysplasia, X-linked	OMIM:300106
5335	0.1975	Cherubism	OMIM:118400
5335	0.1975	Exudative vitreoretinopathy 4	OMIM:601813
5343	0.1974	Pseudohypoaldosteronism, type IB1, autosomal recessive	OMIM:264350
5343	0.1974	Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form	ORPHA:79408
5343	0.1974	Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form	ORPHA:79408
5346	0.1973	3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form	ORPHA:79351
5347	0.1972	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination	OMIM:618367
5348	0.1971	Pseudohypoaldosteronism, type IIE	OMIM:614496
5348	0.1971	Pseudohypoaldosteronism, type IID	OMIM:614495
5348	0.1971	Pseudohypoaldosteronism, type IIB	OMIM:614491
5351	0.1969	Hypercalcemia, infantile, 2	OMIM:616963
5351	0.1969	Ectodermal dysplasia and immunodeficiency 1	OMIM:300291
5353	0.1968	Adrenal hypoplasia, congenital	OMIM:300200
5353	0.1968	Bile acid synthesis defect, congenital, 1	OMIM:607765
5355	0.1966	Coronary artery disease, autosomal dominant, 2	OMIM:610947
5355	0.1966	Hypobetalipoproteinemia, familial, 2	OMIM:605019
5355	0.1966	Cholestasis, benign recurrent intrahepatic	OMIM:243300
5355	0.1966	Hypercholanemia, familial 2	OMIM:619256
5359	0.1965	Developmental and epileptic encephalopathy 50	OMIM:616457
5359	0.1965	Interstitial lung and liver disease	OMIM:615486
5359	0.1965	Vitamin B12-unresponsive methylmalonic acidemia type mut0	ORPHA:289916
5359	0.1965	Argininemia	ORPHA:90
5359	0.1965	Congenital disorder of glycosylation, type Ip	OMIM:613661
5359	0.1965	Hawkinsinuria	ORPHA:2118
5359	0.1965	Holocarboxylase synthetase deficiency	OMIM:253270
5359	0.1965	Infantile liver failure syndrome 3	OMIM:618641
5359	0.1965	Hydroxykynureninuria	ORPHA:79155
5359	0.1965	Iminoglycinuria	ORPHA:42062
5359	0.1965	Iminoglycinuria	ORPHA:42062
5359	0.1965	TMEM70-related mitochondrial encephalo-cardio-myopathy	ORPHA:1194
5359	0.1965	Iminoglycinuria	ORPHA:42062
5359	0.1965	Iminoglycinuria	ORPHA:42062
5373	0.1962	Polycythemia vera, somatic	OMIM:263300
5373	0.1962	Erythrocytosis, somatic	OMIM:133100
5373	0.1962	Hypothyroidism, congenital nongoitrous, 5	OMIM:225250
5373	0.1962	Erythrocytosis, familial, 8	OMIM:222800
5373	0.1962	Isobutyryl-CoA dehydrogenase deficiency	ORPHA:79159
5373	0.1962	Erythrocytosis, familial, 7	OMIM:617981
5373	0.1962	Erythrocytosis, familial, 7	OMIM:617981
5373	0.1962	Erythrocytosis, familial, 6	OMIM:617980
5373	0.1962	Erythrocytosis, familial, 3	OMIM:609820
5373	0.1962	Erythrocytosis, somatic	OMIM:133100
5383	0.1961	Enamel-renal syndrome	ORPHA:1031
5384	0.1959	Agammaglobulinemia 8B, autosomal recessive	OMIM:619824
5384	0.1959	Agammaglobulinemia, X-linked 1	OMIM:300755
5386	0.1957	Adenosine deaminase deficiency, partial	OMIM:102700
5387	0.1956	Orofaciodigital syndrome V	OMIM:174300
5388	0.1953	Immunodeficiency-centromeric instability-facial anomalies syndrome 2	OMIM:614069
5388	0.1953	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation	OMIM:616100
5390	0.195	Immunodeficiency 70	OMIM:618969
5391	0.1948	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
5391	0.1948	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
5391	0.1948	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
5391	0.1948	Hypophosphatemic rickets, AR	OMIM:241520
5391	0.1948	Fanconi renotubular syndrome 5	OMIM:618913
5396	0.1947	HELLP syndrome, maternal, of pregnancy	OMIM:609016
5396	0.1947	Hypercholesterolemia, familial, 2	OMIM:144010
5398	0.1945	Trichohepatoenteric syndrome 2	OMIM:614602
5399	0.1943	Diabetes, type 1, susceptibility to	OMIM:222100
5399	0.1943	Type 1 diabetes mellitus	OMIM:222100
5399	0.1943	Diabetes mellitus, insulin-dependent	OMIM:222100
5399	0.1943	D-glyceric aciduria	ORPHA:941
5399	0.1943	Diabetes, type 1, susceptibility to	OMIM:222100
5404	0.1941	Schimke immunoosseous dysplasia	OMIM:242900
5405	0.1937	Glutamate formiminotransferase deficiency	OMIM:229100
5405	0.1937	Glutaricaciduria, type I	OMIM:231670
5407	0.1936	Paget disease of bone 3	OMIM:167250
5407	0.1936	Osteosarcoma	ORPHA:668
5407	0.1936	Fibrodysplasia ossificans progressiva	OMIM:135100
5407	0.1936	Calvarial doughnut lesions with bone fragility with or without spondylometaphyseal dysplasia	OMIM:126550
5407	0.1936	Osteosarcoma	ORPHA:668
5407	0.1936	Vascular malformation, primary intraosseous	OMIM:606893
5407	0.1936	Hyperphosphatasia with impaired intellectual development syndrome 1	OMIM:239300
5407	0.1936	Glycosylphosphatidylinositol biosynthesis defect 16	OMIM:617816
5407	0.1936	Eiken syndrome	OMIM:600002
5407	0.1936	Gallbladder disease 1	OMIM:600803
5407	0.1936	Hyperphosphatasia with impaired intellectual development syndrome 2	OMIM:614749
5407	0.1936	Osteogenesis imperfecta, type XI	OMIM:610968
5407	0.1936	Osteolysis, familial expansile	OMIM:174810
5407	0.1936	Hyperphosphatasia with impaired intellectual development syndrome 4	OMIM:615716
5407	0.1936	Paget disease of bone 6	OMIM:616833
5407	0.1936	?Glycosylphosphatidylinositol biosynthesis defect 25	OMIM:619985
5407	0.1936	Osteosarcoma	ORPHA:668
5424	0.1933	?ACAT2 deficiency	OMIM:614055
5425	0.1932	?Combined oxidative phosphorylation deficiency 47	OMIM:618958
5426	0.1931	Hypercalcemia, infantile, 1	OMIM:143880
5426	0.1931	Tumoral calcinosis, familial, normophosphatemic	OMIM:610455
5428	0.193	Carpal tunnel syndrome 2	OMIM:619161
5428	0.193	Lysyl hydroxylase 3 deficiency	OMIM:612394
5428	0.193	Mucopolysaccharidosis Ih/s	OMIM:607015
5428	0.193	?Immunodeficiency, common variable, 7	OMIM:614699
5428	0.193	SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome	ORPHA:157965
5428	0.193	Ehlers-Danlos syndrome, spondylodysplastic type, 3	OMIM:612350
5434	0.1929	Palmoplantar hyperkeratosis and true hermaphroditism	OMIM:610644
5434	0.1929	Cholesteryl ester storage disease	ORPHA:75234
5436	0.1924	Immunodeficiency with hyper-IgM, type 3	OMIM:606843
5436	0.1924	?Immunodeficiency 22	OMIM:615758
5438	0.1923	?Premature ovarian failure 18	OMIM:619203
5439	0.1921	Galactose mutarotase deficiency	ORPHA:570422
5440	0.192	?Phosphoserine aminotransferase deficiency	OMIM:610992
5441	0.1918	Mandibuloacral dysplasia with type B lipodystrophy	ORPHA:90154
5441	0.1918	Mandibuloacral dysplasia with type A lipodystrophy	ORPHA:90153
5441	0.1918	Aromatase deficiency	ORPHA:91
5441	0.1918	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal	OMIM:618810
5445	0.1917	Mitochondrial complex I deficiency, nuclear type 11	OMIM:618234
5445	0.1917	?Mitochondrial complex I deficiency, nuclear type 24	OMIM:618245
5445	0.1917	Mitochondrial complex I deficiency, nuclear type 8	OMIM:618230
5445	0.1917	Immunodeficiency 24	OMIM:615897
5445	0.1917	?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	OMIM:604273
5450	0.1916	Immunodeficiency, common variable, 8, with autoimmunity	OMIM:614700
5451	0.1914	Immunodeficiency with hyper-IgM, type 2	OMIM:605258
5452	0.1913	?Immunodeficiency, common variable, 14	OMIM:617765
5452	0.1913	?Proteasome-associated autoinflammatory syndrome 3 and digenic forms	OMIM:617591
5452	0.1913	?Proteasome-associated autoinflammatory syndrome 3, digenic	OMIM:617591
5455	0.1911	Immunodeficiency, common variable, 2	OMIM:240500
5455	0.1911	Disordered steroidogenesis due to cytochrome P450 oxidoreductase	OMIM:613571
5457	0.1909	Immunodeficiency, common variable, 3	OMIM:613493
5458	0.1908	Methylmalonate semialdehyde dehydrogenase deficiency	OMIM:614105
5459	0.1906	RNF13-related severe early-onset epileptic encephalopathy	ORPHA:544503
5459	0.1906	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	OMIM:240300
5461	0.1903	Low density lipoprotein cholesterol level QTL 1	OMIM:603776
5461	0.1903	Hypercholesterolemia, familial, 3	OMIM:603776
5463	0.1901	2p21 microdeletion syndrome	ORPHA:163693
5463	0.1901	Timothy syndrome	OMIM:601005
5463	0.1901	AICA-ribosiduria due to ATIC deficiency	OMIM:608688
5463	0.1901	2p21 microdeletion syndrome	ORPHA:163693
5463	0.1901	2p21 microdeletion syndrome	ORPHA:163693
5463	0.1901	2p21 microdeletion syndrome	ORPHA:163693
5469	0.1898	Short stature due to partial GHR deficiency	ORPHA:314802
5469	0.1898	Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency	ORPHA:5
5469	0.1898	Severe combined immunodeficiency due to complete RAG1/2 deficiency	ORPHA:331206
5469	0.1898	Short stature due to GHSR deficiency	ORPHA:314811
5469	0.1898	Severe combined immunodeficiency due to complete RAG1/2 deficiency	ORPHA:331206
5474	0.1892	Thrombosis, hyperhomocysteinemic	OMIM:236200
5475	0.1891	Kenny-Caffey syndrome, type 1	OMIM:244460
5475	0.1891	Hypomagnesemia, seizures, and impaired intellectual development 2	OMIM:618314
5475	0.1891	Hypocalciuric hypercalcemia, type II	OMIM:145981
5475	0.1891	Pituitary gigantism	ORPHA:99725
5475	0.1891	Hypocalciuric hypercalcemia, type I	OMIM:145980
5475	0.1891	Oculoskeletodental syndrome	ORPHA:557003
5475	0.1891	Hypomagnesemia 1, intestinal	OMIM:602014
5475	0.1891	Glucose-galactose malabsorption	ORPHA:35710
5475	0.1891	Pituitary adenoma 1, multiple types	OMIM:102200
5475	0.1891	Pituitary gigantism	ORPHA:99725
5475	0.1891	HELIX syndrome	OMIM:617671
5475	0.1891	Hyperchlorhidrosis, isolated	OMIM:143860
5487	0.1888	Laron syndrome	ORPHA:633
5488	0.1887	Mitochondrial complex I deficiency, nuclear type 19	OMIM:618241
5489	0.1886	Alzheimer disease, late-onset, susceptibility to	OMIM:104300
5489	0.1886	Alzheimer disease, late-onset, susceptibility to	OMIM:104300
5489	0.1886	Alzheimer disease, susceptibility to	OMIM:104300
5489	0.1886	Alzheimer disease 1, familial	OMIM:104300
5493	0.1884	Immunodeficiency 102	OMIM:301082
5494	0.1883	Specific granule deficiency	OMIM:245480
5495	0.188	PEPCK deficiency, mitochondrial	OMIM:261650
5495	0.188	Essential fructosuria	ORPHA:2056
5497	0.1876	Osteootohepatoenteric syndrome	OMIM:619377
5497	0.1876	Hypoparathyroidism-sensorineural deafness-renal disease syndrome	ORPHA:2237
5497	0.1876	Diarrhea 6	OMIM:614616
5497	0.1876	Autosomal recessive polycystic kidney disease	ORPHA:731
5497	0.1876	Bernard-Soulier syndrome, type A1 (recessive)	OMIM:231200
5497	0.1876	Giant platelet disorder, isolated	OMIM:231200
5497	0.1876	Bernard-Soulier syndrome, type C	OMIM:231200
5497	0.1876	Imerslund-Grasbeck syndrome 2	OMIM:618882
5497	0.1876	Autosomal recessive polycystic kidney disease	ORPHA:731
5506	0.1875	Spermatogenic failure 28	OMIM:618086
5506	0.1875	Spermatogenic failure, X-linked, 4	OMIM:301077
5508	0.1874	Methylmalonic aciduria, transient, due to transcobalamin receptor defect	OMIM:613646
5508	0.1874	Methylmalonic aciduria and homocysteinemia, cblX type	OMIM:309541
5510	0.1869	Smith-Kingsmore syndrome	OMIM:616638
5511	0.1868	Thyroid hormone metabolism, abnormal, 2	OMIM:619855
5512	0.1867	Immunodeficiency with hyper IgM, type 5	OMIM:608106
5512	0.1867	Immunodeficiency, common variable, 1	OMIM:607594
5512	0.1867	Immunodeficiency 36	OMIM:616005
5515	0.1866	Riboflavin deficiency	OMIM:615026
5516	0.1864	Autoinflammatory disease, systemic, X-linked	OMIM:301081
5517	0.1863	Hennekam syndrome	ORPHA:2136
5517	0.1863	Hennekam syndrome	ORPHA:2136
5517	0.1863	Hennekam syndrome	ORPHA:2136
5520	0.1861	Hemolytic anemia due to hexokinase deficiency	OMIM:235700
5520	0.1861	Dehydrated hereditary stomatocytosis 2	OMIM:616689
5520	0.1861	Hemolytic anemia due to glutathione reductase deficiency	OMIM:618660
5520	0.1861	Spherocytosis, type 1	OMIM:182900
5520	0.1861	Spherocytosis, type 2	OMIM:616649
5520	0.1861	Hemolytic anemia due to elevated adenosine deaminase	OMIM:301083
5520	0.1861	Beta-thalassemia intermedia	ORPHA:231222
5520	0.1861	Overhydrated hereditary stomatocytosis	OMIM:185000
5520	0.1861	Spherocytosis, type 4	OMIM:612653
5529	0.1858	Immunodeficiency 41 with lymphoproliferation and autoimmunity	OMIM:606367
5530	0.1856	Hypoalphalipoproteinemia, primary, 2	OMIM:618463
5530	0.1856	Methylmalonyl-CoA epimerase deficiency	OMIM:251120
5530	0.1856	Immunodeficiency 11A	OMIM:615206
5530	0.1856	Fish-eye disease	ORPHA:79292
5530	0.1856	Hyperalphalipoproteinemia	OMIM:143470
5530	0.1856	?Maple syrup urine disease, mild variant	OMIM:615135
5536	0.1855	Hyperaldosteronism, familial, type II	OMIM:605635
5536	0.1855	Immunodeficiency 14A, autosomal dominant	OMIM:615513
5536	0.1855	Cirrhosis, noncryptogenic, susceptibility to	OMIM:215600
5536	0.1855	Cirrhosis, cryptogenic	OMIM:215600
5540	0.1853	Adrenocorticotropic hormone deficiency	OMIM:201400
5541	0.1852	Hyperthyroidism, familial gestational	OMIM:603373
5541	0.1852	Immunodeficiency, common variable, 4	OMIM:613494
5541	0.1852	Hypothyroidism, congenital, nongoitrous, 9	OMIM:301035
5544	0.1841	?Premature ovarian failure 15	OMIM:618096
5545	0.184	Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome	ORPHA:457485
5545	0.184	Growth hormone insensitivity with immune dysregulation 2, autosomal dominant	OMIM:618985
5547	0.1839	Wiskott-Aldrich syndrome	OMIM:301000
5547	0.1839	Bloom syndrome	OMIM:210900
5547	0.1839	Recurrent infections associated with rare immunoglobulin isotypes deficiency	ORPHA:183675
5547	0.1839	Recurrent infections associated with rare immunoglobulin isotypes deficiency	ORPHA:183675
5551	0.1838	Hemolytic anemia due to glutathione peroxidase deficiency	OMIM:614164
5551	0.1838	Crigler-Najjar syndrome, type II	OMIM:606785
5551	0.1838	Hyperbilirubinemia, familial transient neonatal	OMIM:237900
5551	0.1838	Crigler-Najjar syndrome, type I	OMIM:218800
5551	0.1838	Elliptocytosis-2	OMIM:130600
5551	0.1838	Isolated polycystic liver disease	ORPHA:2924
5551	0.1838	Isolated polycystic liver disease	ORPHA:2924
5551	0.1838	Bile acid conjugation defect 1	OMIM:619232
5551	0.1838	Arthrogryposis, renal dysfunction, and cholestasis 1	OMIM:208085
5551	0.1838	X-linked intellectual disability, Nascimento type	ORPHA:163956
5551	0.1838	Dubin-Johnson syndrome	ORPHA:234
5551	0.1838	Dubin-Johnson syndrome	OMIM:237500
5551	0.1838	Arthrogryposis, renal dysfunction, and cholestasis 2	OMIM:613404
5551	0.1838	Isolated polycystic liver disease	ORPHA:2924
5551	0.1838	Anemia, hemolytic, Rh-null, regulator type	OMIM:268150
5551	0.1838	Cholestasis, progressive familial intrahepatic 1	OMIM:211600
5551	0.1838	Hyperbilirubinemia, Rotor type, digenic	OMIM:237450
5551	0.1838	Hyperbilirubinemia, Rotor type, digenic	OMIM:237450
5569	0.1837	Short chain acyl-CoA dehydrogenase deficiency	ORPHA:26792
5569	0.1837	Leukoencephalopathy with vanishing white matter 1, with or without ovarian failure	OMIM:603896
5571	0.1835	?Caspase 8 lymphadenopathy syndrome	OMIM:607271
5572	0.1834	Premature ovarian failure 8	OMIM:615723
5572	0.1834	Ovarian dysgenesis 7	OMIM:618117
5572	0.1834	?Ovarian dysgenesis 10	OMIM:619834
5572	0.1834	?Premature ovarian failure 14	OMIM:618014
5572	0.1834	Ovarian dysgenesis 5	OMIM:617690
5577	0.1831	IMAGE syndrome	OMIM:614732
5577	0.1831	?Webb-Dattani syndrome	OMIM:615926
5579	0.1829	Immunodeficiency 15B	OMIM:615592
5580	0.1828	Idiopathic hypercalciuria	ORPHA:2197
5581	0.1826	Nephrolithiasis/osteoporosis, hypophosphatemic, 1	OMIM:612286
5581	0.1826	Nephrolithiasis/osteoporosis, hypophosphatemic, 2	OMIM:612287
5581	0.1826	Opsismodysplasia	OMIM:258480
5581	0.1826	Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	OMIM:308990
5585	0.1825	?Immunodeficiency 62	OMIM:618459
5586	0.1822	Gastrointestinal defects and immunodeficiency syndrome	OMIM:243150
5587	0.182	Neonatal severe primary hyperparathyroidism	ORPHA:417
5587	0.182	Neonatal severe primary hyperparathyroidism	ORPHA:417
5589	0.1818	T-B+ severe combined immunodeficiency due to gamma chain deficiency	ORPHA:276
5590	0.1817	Hypercholesterolemia, familial, modifier of	OMIM:143890
5590	0.1817	HARP syndrome	OMIM:607236
5590	0.1817	Hypercholesterolemia, familial, modifier of	OMIM:143890
5590	0.1817	LDL cholesterol level QTL2	OMIM:143890
5590	0.1817	Hypercholesterolemia, susceptibility to	OMIM:143890
5590	0.1817	Combined low LDL and fibrinogen	OMIM:620364
5590	0.1817	Hypercholesterolemia, familial, due to LDLR defect, modifier of	OMIM:143890
5597	0.1813	Growth hormone deficiency, isolated, type II	OMIM:173100
5597	0.1813	Pycnodysostosis	ORPHA:763
5597	0.1813	Growth hormone deficiency, isolated, type IV	OMIM:618157
5597	0.1813	Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome	ORPHA:436174
5597	0.1813	?Joubert syndrome 38	OMIM:619476
5602	0.181	Isolated follicle stimulating hormone deficiency	ORPHA:52901
5603	0.1808	Reticular dysgenesis	ORPHA:33355
5603	0.1808	Reticular dysgenesis	ORPHA:33355
5605	0.1806	Severe combined immunodeficiency, Athabascan type	OMIM:602450
5606	0.1803	Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic	OMIM:608232
5606	0.1803	Boudin-Mortier syndrome	OMIM:619543
5606	0.1803	Leukemia, Philadelphia chromosome-positive, resistant to imatinib	OMIM:608232
5606	0.1803	?Neutrophilia, hereditary	OMIM:162830
5610	0.18	Methemoglobinemia and ambiguous genitalia	OMIM:250790
5611	0.1799	Immunodeficiency 33	OMIM:300636
5612	0.1798	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	OMIM:615381
5612	0.1798	Protoporphyria, erythropoietic, 1	OMIM:177000
5612	0.1798	Werner syndrome	OMIM:277700
5612	0.1798	Galactokinase deficiency with cataracts	OMIM:230200
5612	0.1798	Microcephalic primordial dwarfism-insulin resistance syndrome	ORPHA:436182
5612	0.1798	Proteasome-associated autoinflammatory syndrome 5	OMIM:619175
5612	0.1798	Galactosemia IV	OMIM:618881
5612	0.1798	Galactose epimerase deficiency	OMIM:230350
5612	0.1798	Mandibuloacral dysplasia progeroid syndrome	OMIM:619127
5612	0.1798	Microcephalic primordial dwarfism-insulin resistance syndrome	ORPHA:436182
5612	0.1798	Hypertriglyceridemia, transient infantile	OMIM:614480
5612	0.1798	Classical-like Ehlers-Danlos syndrome type 2	ORPHA:536532
5612	0.1798	Lipase deficiency, combined	OMIM:246650
5612	0.1798	Hemophagocytic lymphohistiocytosis, familial, 3	OMIM:608898
5626	0.1794	Cystathioninuria	ORPHA:212
5627	0.1787	Combined oxidative phosphorylation deficiency 14	OMIM:614946
5627	0.1787	Immunodeficiency 105, severe combined	OMIM:619924
5627	0.1787	Bloom syndrome	ORPHA:125
5627	0.1787	MOGS-CDG	ORPHA:79330
5627	0.1787	Cardiomyopathy-hypotonia-lactic acidosis syndrome	ORPHA:91130
5627	0.1787	Hyperglycinemia, lactic acidosis, and seizures	OMIM:614462
5627	0.1787	Cardiomyopathy, dilated, 2C	OMIM:618189
5627	0.1787	?Mitochondrial complex IV deficiency, nuclear type 10	OMIM:619053
5627	0.1787	Transcobalamin deficiency	ORPHA:859
5627	0.1787	Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency	ORPHA:436159
5627	0.1787	T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency	ORPHA:169154
5627	0.1787	Epilepsy, early-onset, 1, vitamin B6-dependent	OMIM:617290
5639	0.1786	Immunodeficiency 86, mycobacteriosis	OMIM:619549
5640	0.1782	Growth hormone deficiency, isolated, type IB	OMIM:612781
5640	0.1782	?RHYNS syndrome	OMIM:602152
5642	0.1776	Immunodeficiency 10	OMIM:612783
5642	0.1776	Dyskeratosis congenita, autosomal recessive 8	OMIM:620133
5644	0.1773	Agammaglobulinemia 10, autosomal dominant	OMIM:619707
5644	0.1773	Agammaglobulinemia 6	OMIM:612692
5644	0.1773	Histidinemia	ORPHA:2157
5644	0.1773	?Agammaglobulinemia 4	OMIM:613502
5644	0.1773	3-phosphoserine phosphatase deficiency, infantile/juvenile form	ORPHA:79350
5644	0.1773	Phosphoserine phosphatase deficiency	OMIM:614023
5650	0.1772	Hyperekplexia 1	OMIM:149400
5650	0.1772	Hyperekplexia-epilepsy syndrome	ORPHA:163985
5650	0.1772	Developmental and epileptic encephalopathy 8	OMIM:300607
5650	0.1772	Sudden infant death with dysgenesis of the testes syndrome	OMIM:608800
5650	0.1772	Neurodevelopmental disorder with speech impairment and with or without seizures	OMIM:620114
5655	0.1768	Mullerian aplasia and hyperandrogenism	OMIM:158330
5656	0.1767	Sitosterolemia 2	OMIM:618666
5657	0.1765	B-cell expansion with NFKB and T-cell anergy	OMIM:616452
5658	0.1763	Immunodeficiency 92	OMIM:619652
5659	0.1759	Spondylometaphyseal dysplasia, 'corner fracture' type	ORPHA:93315
5659	0.1759	Immunodeficiency 64	OMIM:618534
5659	0.1759	Hyper-IgE recurrent infection syndrome 4A, autosomal dominant	OMIM:619752
5659	0.1759	Immunodeficiency 60 and autoimmunity	OMIM:618394
5659	0.1759	?Immunodeficiency 85 and autoimmunity	OMIM:619510
5659	0.1759	Spondylometaphyseal dysplasia, 'corner fracture' type	ORPHA:93315
5665	0.1756	Acyl-CoA dehydrogenase, medium chain, deficiency of	OMIM:201450
5665	0.1756	Pituitary hormone deficiency, combined, 4	OMIM:262700
5665	0.1756	Bardet-Biedl syndrome 9	OMIM:615986
5665	0.1756	Histiocytoid cardiomyopathy	ORPHA:137675
5665	0.1756	Pyridoxine-dependent epilepsy	ORPHA:3006
5665	0.1756	Greig cephalopolysyndactyly syndrome	OMIM:175700
5665	0.1756	Fructose-1,6-bisphosphatase deficiency	OMIM:229700
5665	0.1756	3-hydroxy-3-methylglutaryl-CoA synthase deficiency	ORPHA:35701
5665	0.1756	MODY, type III	OMIM:600496
5665	0.1756	Malonyl-CoA decarboxylase deficiency	OMIM:248360
5665	0.1756	Pancreatic agenesis and congenital heart defects	OMIM:600001
5665	0.1756	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures	OMIM:620224
5665	0.1756	Congenital disorder of glycosylation with defective fucosylation 1	OMIM:618005
5665	0.1756	Maturity-onset diabetes of the young, type VIII	OMIM:609812
5665	0.1756	Shashi-Pena syndrome	OMIM:617190
5665	0.1756	Orthostatic hypotension 2	OMIM:618182
5665	0.1756	Maturity-onset diabetes of the young, type 10	OMIM:613370
5665	0.1756	SHORT syndrome	OMIM:269880
5665	0.1756	Diabetes mellitus, transient neonatal 1	OMIM:601410
5665	0.1756	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	OMIM:201910
5665	0.1756	Pyridoxine-dependent epilepsy	ORPHA:3006
5686	0.1754	Combined oxidative phosphorylation defect type 23	ORPHA:444013
5686	0.1754	Combined oxidative phosphorylation deficiency 35	OMIM:617873
5686	0.1754	?Combined oxidative phosphorylation deficiency 46	OMIM:618952
5689	0.1753	Frasier syndrome	ORPHA:347
5690	0.1752	Tyrosinemia, type II	OMIM:276600
5690	0.1752	Hawkinsinuria	OMIM:140350
5690	0.1752	Tyrosinemia, type III	OMIM:276710
5693	0.175	Ovarian dysgenesis 4	OMIM:616185
5693	0.175	?Premature ovarian failure 16	OMIM:618723
5693	0.175	Premature ovarian failure 21	OMIM:620311
5696	0.1748	Wiskott-Aldrich syndrome	ORPHA:906
5696	0.1748	Wiskott-Aldrich syndrome	ORPHA:906
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Infantile myofibromatosis	ORPHA:2591
5698	0.1746	Hartsfield syndrome	OMIM:615465
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Pheochromocytoma	OMIM:171300
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Andersen syndrome	OMIM:170390
5698	0.1746	Pheochromocytoma	OMIM:171300
5698	0.1746	Pheochromocytoma, susceptibility to	OMIM:171300
5698	0.1746	?Hypomagnesemia 4, renal	OMIM:611718
5698	0.1746	Infantile myofibromatosis	ORPHA:2591
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Pheochromocytoma	OMIM:171300
5698	0.1746	Pheochromocytoma	OMIM:171300
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Nephrogenic diabetes insipidus	ORPHA:223
5698	0.1746	Diabetes insipidus, nephrogenic, 2	OMIM:125800
5698	0.1746	Pheochromocytoma, susceptibility to	OMIM:171300
5698	0.1746	Familial pseudohyperkalemia	ORPHA:90044
5698	0.1746	Parathyroid carcinoma	OMIM:608266
5698	0.1746	Hyperparathyroidism, familial primary	OMIM:145000
5698	0.1746	Parathyroid adenoma with cystic changes	OMIM:145001
5698	0.1746	Distal renal tubular acidosis 3, with or without sensorineural hearing loss	OMIM:602722
5698	0.1746	Distal renal tubular acidosis 4 with hemolytic anemia	OMIM:611590
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5698	0.1746	Hyperparathyroidism 4	OMIM:617343
5698	0.1746	Velocardiofacial syndrome	OMIM:192430
5698	0.1746	Hypomagnesemia, seizures, and impaired intellectual development 1	OMIM:616418
5698	0.1746	Diabetes insipidus, nephrogenic, 1	OMIM:304800
5698	0.1746	Nephrogenic diabetes insipidus	ORPHA:223
5698	0.1746	Vascular Ehlers-Danlos syndrome	ORPHA:286
5698	0.1746	Rabin-Pappas syndrome	OMIM:620155
5698	0.1746	Intellectual developmental disorder, autosomal dominant 70	OMIM:620157
5698	0.1746	Gracile bone dysplasia	OMIM:602361
5698	0.1746	Romano-Ward syndrome	ORPHA:101016
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Immunodeficiency 46	OMIM:616740
5746	0.1745	Encephalopathy, acute, infection-induced, 3, susceptibility to	OMIM:608033
5746	0.1745	Immunodeficiency 52	OMIM:617514
5746	0.1745	?Immunodeficiency 37	OMIM:616098
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Cernunnos-XLF deficiency	ORPHA:169079
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Common variable immunodeficiency	ORPHA:1572
5746	0.1745	Dyskeratosis congenita, autosomal dominant 4	OMIM:615190
5764	0.1744	?Cholestasis, progressive familial intrahepatic, 11	OMIM:619874
5765	0.1743	Gastrointestinal ulceration, recurrent, with dysfunctional platelets	OMIM:618372
5766	0.1741	Immunodeficiency, common variable, 12	OMIM:616576
5766	0.1741	Immunodeficiency, common variable, 13	OMIM:616873
5768	0.1737	Immunoskeletal dysplasia with neurodevelopmental abnormalities	OMIM:617425
5769	0.1734	Lung disease, immunodeficiency, and chromosome breakage syndrome	OMIM:617241
5770	0.1733	Gyrate atrophy of choroid and retina	ORPHA:414
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Immunodeficiency 56	OMIM:615207
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5771	0.1729	Autosomal agammaglobulinemia	ORPHA:33110
5782	0.1727	Immunodeficiency, common variable, 6	OMIM:613496
5783	0.1726	Monocarboxylate transporter 1 deficiency	OMIM:616095
5783	0.1726	Increased responsiveness to growth hormone	OMIM:604271
5783	0.1726	Laron dwarfism	OMIM:262500
5783	0.1726	Hypothyroidism, congenital, nongoitrous, 1	OMIM:275200
5783	0.1726	Renal agenesis, bilateral	ORPHA:1848
5783	0.1726	Thyroid hormone resistance, selective pituitary	OMIM:145650
5783	0.1726	Premature aging syndrome, Penttinen type	OMIM:601812
5783	0.1726	Renal agenesis, bilateral	ORPHA:1848
5783	0.1726	Insulin-like growth factor I, resistance to	OMIM:270450
5783	0.1726	Diabetes insipidus, neurohypophyseal	OMIM:125700
5783	0.1726	Persistent Mullerian duct syndrome, type I	OMIM:261550
5783	0.1726	Renal agenesis, bilateral	ORPHA:1848
5783	0.1726	Persistent Mullerian duct syndrome, type II	OMIM:261550
5783	0.1726	Hypothyroidism, central, and testicular enlargement	OMIM:300888
5783	0.1726	Isolated sedoheptulokinase deficiency	ORPHA:440713
5783	0.1726	Short stature due to primary acid-labile subunit deficiency	ORPHA:140941
5783	0.1726	Renal agenesis, bilateral	ORPHA:1848
5783	0.1726	Dicarboxylic aminoaciduria	OMIM:222730
5783	0.1726	Renal agenesis, bilateral	ORPHA:1848
5783	0.1726	X-linked dominant chondrodysplasia punctata	ORPHA:35173
5783	0.1726	Renal agenesis, bilateral	ORPHA:1848
5804	0.1724	Mitochondrial complex I deficiency, nuclear type 25	OMIM:618246
5805	0.1722	SCID, autosomal recessive, T-negative/B-positive type	OMIM:600802
5805	0.1722	Severe combined immunodeficiency, B cell-negative	OMIM:601457
5805	0.1722	Severe combined immunodeficiency, B cell-negative	OMIM:601457
5808	0.1721	D-2-hydroxyglutaric aciduria 2	OMIM:613657
5809	0.1719	Lactase persistence/nonpersistence	OMIM:223100
5809	0.1719	Lactase deficiency, congenital	OMIM:223000
5811	0.1715	Immunodeficiency 35	OMIM:611521
5811	0.1715	FILS syndrome	OMIM:615139
5811	0.1715	Immunodeficiency 63 with lymphoproliferation and autoimmunity	OMIM:618495
5811	0.1715	Immunodeficiency 67	OMIM:607676
5811	0.1715	Immunodeficiency due to defect in MAPBP-interacting protein	OMIM:610798
5811	0.1715	Hepatic venoocclusive disease with immunodeficiency	OMIM:235550
5817	0.1714	Hyperphenylalaninemia, BH4-deficient, C	OMIM:261630
5817	0.1714	Growth delay-intellectual disability-hepatopathy syndrome	ORPHA:541423
5817	0.1714	Zinc deficiency, transient neonatal	OMIM:608118
5817	0.1714	Hyperprolinemia, type II	OMIM:239510
5817	0.1714	IRIDA syndrome	ORPHA:209981
5817	0.1714	Schizophrenia, susceptibility to, 4	OMIM:600850
5817	0.1714	Hyperprolinemia type 1	ORPHA:419
5824	0.1712	Agammaglobulinemia 1	OMIM:601495
5825	0.1711	Combined cellular and humoral immune defects with granulomas	OMIM:233650
5825	0.1711	Combined immunodeficiency, X-linked, moderate	OMIM:312863
5825	0.1711	Combined cellular and humoral immune defects with granulomas	OMIM:233650
5828	0.171	Immunodeficiency 58	OMIM:618131
5828	0.171	?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias	OMIM:619846
5830	0.1707	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	ORPHA:169160
5830	0.1707	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	ORPHA:169160
5830	0.1707	T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta	ORPHA:169160
5833	0.1706	Immunodeficiency 57 with autoinflammation	OMIM:618108
5833	0.1706	Lymphoproliferative syndrome 3	OMIM:618261
5835	0.1703	Anemia, hemolytic, due to UMPH1 deficiency	OMIM:266120
5836	0.1698	Retinitis pigmentosa and erythrocytic microcytosis	OMIM:616959
5836	0.1698	Rhizomelic chondrodysplasia punctata, type 2	OMIM:222765
5836	0.1698	Anemia, hypochromic microcytic, with iron overload 1	OMIM:206100
5839	0.1695	Autosomal dominant popliteal pterygium syndrome	ORPHA:1300
5839	0.1695	?Combined oxidative phosphorylation deficiency 25	OMIM:616430
5839	0.1695	?Developmental and epileptic encephalopathy 88	OMIM:618959
5839	0.1695	Glycine N-methyltransferase deficiency	OMIM:606664
5839	0.1695	Glycine encephalopathy 2	OMIM:620398
5839	0.1695	Oocyte/zygote/embryo maturation arrest 8	OMIM:619009
5845	0.1694	Immunodeficiency 93 and hypertrophic cardiomyopathy	OMIM:619705
5845	0.1694	Agammaglobulinemia 2	OMIM:613500
5847	0.1692	Agammaglobulinemia 3	OMIM:613501
5848	0.1683	Paroxysmal nocturnal hemoglobinuria, somatic	OMIM:300818
5848	0.1683	?Immunodeficiency, common variable, 5	OMIM:613495
5848	0.1683	?Paroxysmal nocturnal hemoglobinuria 2	OMIM:615399
5851	0.1679	Dyskeratosis congenita, digenic	OMIM:620040
5851	0.1679	Immunodeficiency 96	OMIM:619774
5851	0.1679	Autoimmune lymphoproliferative syndrome, type IB	OMIM:601859
5851	0.1679	Immunodeficiency 14B, autosomal recessive	OMIM:619281
5851	0.1679	Hyper-IgE recurrent infection syndrome, autosomal recessive	OMIM:243700
5851	0.1679	Autoimmune lymphoproliferative syndrome, type II	OMIM:603909
5851	0.1679	Autoimmune lymphoproliferative syndrome, type IA	OMIM:601859
5851	0.1679	Autoimmune lymphoproliferative syndrome	OMIM:601859
5859	0.1678	T-B+ severe combined immunodeficiency due to JAK3 deficiency	ORPHA:35078
5860	0.1676	Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia	OMIM:618986
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	OMIM:259730
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Osteopetrosis, autosomal dominant 1	OMIM:607634
5861	0.1675	Platelet-activating factor acetylhydrolase deficiency	OMIM:614278
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Barth syndrome	ORPHA:111
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5861	0.1675	Normosmic congenital hypogonadotropic hypogonadism	ORPHA:432
5883	0.1673	Immunodeficiency 17, CD3 gamma deficient	OMIM:615607
5883	0.1673	Immunodeficiency 12	OMIM:615468
5885	0.1669	?Ondontochondrodysplasia 2 with hearing loss and diabetes	OMIM:619269
5886	0.1665	Pallister-Hall syndrome	OMIM:146510
5886	0.1665	?Immunodeficiency 81	OMIM:619374
5888	0.1651	Fanconi anemia, complementation group A	OMIM:227650
5888	0.1651	Fanconi anemia, complementation group C	OMIM:227645
5888	0.1651	Fanconi anemia, complementation group E	OMIM:600901
5891	0.1648	Autosomal erythropoietic protoporphyria	ORPHA:79278
5891	0.1648	Infantile dystonia-parkinsonism	ORPHA:238455
5891	0.1648	Lipodystrophy, partial, acquired, susceptibility to	OMIM:608709
5891	0.1648	UV-sensitive syndrome 2	OMIM:614621
5891	0.1648	Hepatoerythropoietic porphyria	ORPHA:95159
5896	0.1646	Myopathy, mitochondrial progressive, with congenital cataract and developmental delay	OMIM:613076
5896	0.1646	Mitochondrial phosphate carrier deficiency	OMIM:610773
5896	0.1646	Ovarian hyperstimulation syndrome	ORPHA:64739
5899	0.1638	McCune-Albright syndrome, somatic, mosaic	OMIM:174800
5900	0.1633	Congenital muscular dystrophy, Fukuyama type	ORPHA:272
5900	0.1633	Bardet-Biedl syndrome 20	OMIM:619471
5900	0.1633	Galloway-Mowat syndrome 7	OMIM:618348
5900	0.1633	Low phospholipid-associated cholelithiasis	ORPHA:69663
5900	0.1633	?Pancreatic lipase deficiency	OMIM:614338
5900	0.1633	Temple syndrome due to maternal uniparental disomy of chromosome 14	ORPHA:96184
5900	0.1633	Temple syndrome due to maternal uniparental disomy of chromosome 14	ORPHA:96184
5900	0.1633	Coronary artery disease, autosomal dominant, 1	OMIM:608320
5908	0.1629	CHILD syndrome	OMIM:308050
5908	0.1629	MEND syndrome	ORPHA:401973
5910	0.162	Mitochondrial complex I deficiency, nuclear type 34	OMIM:618776
5910	0.162	?Mitochondrial complex I deficiency, nuclear type 30	OMIM:301021
5910	0.162	Cardiomyopathy, dilated, 1GG	OMIM:613642
5910	0.162	Mitochondrial complex IV deficiency, nuclear type 13	OMIM:616501
5910	0.162	?Mitochondrial complex I deficiency, nuclear type 39	OMIM:620135
5910	0.162	Mitochondrial complex I deficiency, nuclear type 13	OMIM:618235
5910	0.162	?Mitochondrial complex IV, deficiency, nuclear type 9	OMIM:616500
5910	0.162	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	OMIM:614053
5910	0.162	Combined oxidative phosphorylation deficiency 17	OMIM:615440
5919	0.1616	Fanconi anemia, complementation group I	OMIM:609053
5919	0.1616	Fanconi anemia, complementation group F	OMIM:603467
5921	0.1614	Immunodeficiency-centromeric instability-facial anomalies syndrome 3	OMIM:616910
5921	0.1614	Immunodeficiency-centromeric instability-facial anomalies syndrome 4	OMIM:616911
5923	0.1613	Cholestasis, progressive familial intrahepatic 3	OMIM:602347
5923	0.1613	Hypercholanemia, familial 1	OMIM:607748
5923	0.1613	?Bile acid malabsorption, primary, 2	OMIM:619481
5926	0.1612	Activated PI3K-delta syndrome	ORPHA:397596
5926	0.1612	Activated PI3K-delta syndrome	ORPHA:397596
5926	0.1612	Congenital disorder of glycosylation, type IIb	OMIM:606056
5926	0.1612	WHIM syndrome 1	OMIM:193670
5926	0.1612	Activated PI3K-delta syndrome	ORPHA:397596
5926	0.1612	Netherton syndrome	ORPHA:634
5932	0.1611	X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability	ORPHA:480880
5932	0.1611	Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	OMIM:300853
5934	0.1605	Bleeding disorder, platelet-type, 15	OMIM:615193
5935	0.1602	Wolfram syndrome 2	OMIM:604928
5936	0.1599	Bare lymphocyte syndrome, type II, complementation group A	OMIM:209920
5936	0.1599	Bare lymphocyte syndrome, type II, complementation group C	OMIM:209920
5936	0.1599	Bare lymphocyte syndrome, type II, complementation group B	OMIM:209920
5936	0.1599	Bare lymphocyte syndrome, type II, complementation group D	OMIM:209920
5936	0.1599	?Agammaglobulinemia 7, autosomal recessive	OMIM:615214
5941	0.1594	Cholestasis, intrahepatic, of pregnancy, 3	OMIM:614972
5941	0.1594	Cholestasis, intrahepatic, of pregnancy, 1	OMIM:147480
5943	0.1586	Spermatogenic failure 44	OMIM:619044
5944	0.1585	Epilepsy, pyridoxine-dependent	OMIM:266100
5944	0.1585	Hyperbiliverdinemia	OMIM:614156
5944	0.1585	Porphyria, congenital erythropoietic	OMIM:263700
5947	0.1582	Thrombocytopenia, X-linked, intermittent	OMIM:313900
5947	0.1582	Autoinflammation, antibody deficiency, and immune dysregulation syndrome	OMIM:614878
5947	0.1582	Inflammatory bowel disease, immunodeficiency, and encephalopathy	OMIM:618213
5947	0.1582	?Immunodeficiency, common variable, 11	OMIM:615767
5947	0.1582	Neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia	OMIM:620210
5947	0.1582	Severe combined immunodeficiency due to DCLRE1C deficiency	ORPHA:275
5947	0.1582	?Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia	OMIM:618987
5947	0.1582	Immunodeficiency 72 with autoinflammation	OMIM:618982
5947	0.1582	Immunodeficiency 78 with autoimmunity and developmental delay	OMIM:619220
5947	0.1582	Immunodeficiency 11B with atopic dermatitis	OMIM:617638
5947	0.1582	Hyper-IgD syndrome	OMIM:260920
5947	0.1582	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	OMIM:618282
5947	0.1582	Netherton syndrome	OMIM:256500
5960	0.1578	Androgen insensitivity	OMIM:300068
5960	0.1578	Acromesomelic dysplasia 3	OMIM:609441
5960	0.1578	46XY sex reversal 3	OMIM:612965
5960	0.1578	Premature ovarian failure 7	OMIM:612964
5960	0.1578	Perrault syndrome 3	OMIM:614129
5960	0.1578	46XX sex reversal 1	OMIM:400045
5960	0.1578	46XY sex reversal 1	OMIM:400044
5960	0.1578	?Premature ovarian failure 2A	OMIM:300511
5960	0.1578	Premature ovarian failure 20	OMIM:619938
5960	0.1578	Ovarian dysgenesis 3	OMIM:614324
5960	0.1578	?Precocious puberty, central, 1	OMIM:176400
5960	0.1578	Premature ovarian failure 9	OMIM:615724
5960	0.1578	Premature ovarian failure 6	OMIM:612310
5960	0.1578	?Premature ovarian failure 10	OMIM:612885
5960	0.1578	Myoectodermal gonadal dysgenesis syndrome	OMIM:618419
5975	0.1575	?Glucocorticoid deficiency 5	OMIM:617825
5976	0.1573	Thrombocythemia, somatic	OMIM:187950
5976	0.1573	Thrombocythemia 1	OMIM:187950
5976	0.1573	Thrombocythemia, somatic	OMIM:187950
5979	0.1569	Isolated growth hormone deficiency, type III, with agammaglobulinemia	OMIM:307200
5980	0.1561	Thyroid dyshormonogenesis 3	OMIM:274700
5980	0.1561	Thyroid dyshormonogenesis 2A	OMIM:274500
5980	0.1561	Hypothyroidism, congenital, nongoitrous, 7	OMIM:618573
5983	0.1559	Macroglobulinemia, Waldenstrom, somatic	OMIM:153600
5983	0.1559	IMAGE-I syndrome	OMIM:618336
5985	0.1557	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	OMIM:163200
5985	0.1557	Arterial calcification, generalized, of infancy, 1	OMIM:208000
5985	0.1557	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	OMIM:163200
5985	0.1557	Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	OMIM:163200
5985	0.1557	?Protoporphyria, erythropoietic, 2	OMIM:618015
5985	0.1557	?[Fructosuria, essential]	OMIM:229800
5985	0.1557	Protoporphyria, erythropoietic, X-linked	OMIM:300752
5985	0.1557	Classic homocystinuria	ORPHA:394
5985	0.1557	Arterial calcification, generalized, of infancy, 2	OMIM:614473
5994	0.1551	Immunodeficiency 95	OMIM:619773
5995	0.1547	Immunodeficiency 54	OMIM:609981
5995	0.1547	Fanconi anemia, complementation group Q	OMIM:615272
5995	0.1547	Fanconi anemia, complementation group O	OMIM:613390
5995	0.1547	Bone marrow failure syndrome 3	OMIM:617052
5999	0.1542	Farber lipogranulomatosis	OMIM:228000
6000	0.153	CK syndrome	ORPHA:251383
6001	0.1524	Fanconi anemia, complementation group R	OMIM:617244
6001	0.1524	Neutropenia, severe congenital, 8, autosomal dominant	OMIM:618752
6001	0.1524	Fanconi anemia, complementation group D1	OMIM:605724
6001	0.1524	Xeroderma pigmentosum, group C	OMIM:278720
6001	0.1524	Fanconi anemia, complementation group J	OMIM:609054
6001	0.1524	Xeroderma pigmentosum, group E, DDB-negative subtype	OMIM:278740
6001	0.1524	Fanconi anemia, complementation group P	OMIM:613951
6001	0.1524	Fanconi anemia, complementation group N	OMIM:610832
6001	0.1524	Kappa light chain deficiency	OMIM:614102
6010	0.1523	Müllerian aplasia and hyperandrogenism	ORPHA:247768
6010	0.1523	46XX sex reversal 5	OMIM:618901
6012	0.1497	Bleeding disorder, platelet-type, 21	OMIM:617443
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Premature ovarian failure 1	OMIM:311360
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Beta-thalassemia-X-linked thrombocytopenia syndrome	ORPHA:231393
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Ovarian dysgenesis 1	OMIM:233300
6013	0.1495	Leydig cell hypoplasia with pseudohermaphroditism	OMIM:238320
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6013	0.1495	Male infertility with azoospermia or oligozoospermia due to single gene mutation	ORPHA:399805
6051	0.1492	Mowat-Wilson syndrome due to monosomy 2q22	ORPHA:261537
6051	0.1492	RAS-associated autoimmune leukoproliferative disorder	OMIM:614470
6051	0.1492	Bone marrow failure syndrome 5	OMIM:618165
6051	0.1492	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6	OMIM:619767
6051	0.1492	Immunodeficiency 50	OMIM:300988
6051	0.1492	Cowden syndrome 1	OMIM:158350
6051	0.1492	Gaucher disease type 1	ORPHA:77259
6051	0.1492	Bone marrow failure syndrome 4	OMIM:618116
6051	0.1492	?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic	OMIM:614470
6051	0.1492	Sarcoidosis, susceptibility to, 1	OMIM:181000
6051	0.1492	PAPA syndrome	ORPHA:69126
6051	0.1492	Neutropenia, severe congenital, 5, autosomal recessive	OMIM:615285
6051	0.1492	Neuronal intestinal pseudoobstruction	ORPHA:99811
6051	0.1492	Neutropenia, severe congenital 1, autosomal dominant	OMIM:202700
6051	0.1492	Lymphoproliferative syndrome 2	OMIM:615122
6051	0.1492	Gaucher disease type 1	ORPHA:77259
6051	0.1492	Caffey disease	ORPHA:1310
6051	0.1492	Congenital disorder of glycosylation, type IIr	OMIM:301045
6051	0.1492	Prolidase deficiency	OMIM:170100
6051	0.1492	Autoimmune disease, multisystem, infantile-onset, 1	OMIM:615952
6051	0.1492	Pulmonary fibrosis, idiopathic, susceptibility to	OMIM:178500
6051	0.1492	Interstitial lung disease 2	OMIM:178500
6051	0.1492	Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia	OMIM:618042
6074	0.1491	Peroxisome biogenesis disorder 2B	OMIM:202370
6075	0.1482	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	OMIM:155100
6075	0.1482	?Bleeding disorder, platelet-type, 18	OMIM:615888
6075	0.1482	Bleeding disorder, platelet-type, 17	OMIM:187900
6078	0.148	Peroxisome biogenesis disorder 4A (Zellweger)	OMIM:614862
6078	0.148	MEDNIK syndrome	OMIM:609313
6078	0.148	CADDS	ORPHA:369942
6078	0.148	Leiomyomatosis and renal cell cancer	OMIM:150800
6078	0.148	CADDS	ORPHA:369942
6083	0.1477	Autoimmune disease, multisystem, infantile-onset, 2	OMIM:617006
6084	0.1476	Nijmegen breakage syndrome	OMIM:251260
6084	0.1476	Multiple myeloma, resistance to	OMIM:254500
6084	0.1476	Immunodeficiency 48	OMIM:269840
6084	0.1476	Agammaglobulinemia 8A, autosomal dominant	OMIM:616941
6084	0.1476	?Agammaglobulinemia 5	OMIM:613506
6084	0.1476	Multiple myeloma, susceptibility to	OMIM:254500
6084	0.1476	Agammaglobulinemia 9, autosomal recessive	OMIM:619693
6084	0.1476	Hepatic veno-occlusive disease-immunodeficiency syndrome	ORPHA:79124
6092	0.1475	Moyamoya disease with early-onset achalasia	ORPHA:401945
6093	0.1467	Premature ovarian failure 11	OMIM:616946
6093	0.1467	Premature ovarian failure 11	OMIM:616946
6093	0.1467	?Premature ovarian failure 13	OMIM:617442
6093	0.1467	Spermatogenic failure 75	OMIM:619949
6097	0.1461	Atopy, susceptibility to	OMIM:147050
6097	0.1461	Dystrophic epidermolysis bullosa pruriginosa	ORPHA:89843
6097	0.1461	Autosomal dominant hyper-IgE syndrome	ORPHA:2314
6097	0.1461	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	OMIM:304790
6097	0.1461	Hypotrichosis simplex of the scalp	ORPHA:90368
6097	0.1461	Autoimmune disease, multisystem, with facial dysmorphism	OMIM:613385
6097	0.1461	?Inflammatory skin and bowel disease, neonatal, 1	OMIM:614328
6097	0.1461	Spondyloepimetaphyseal dysplasia, sponastrime type	OMIM:271510
6097	0.1461	Atopy, susceptibility to	OMIM:147050
6097	0.1461	Immunoglobulin A deficiency 2	OMIM:609529
6097	0.1461	Combined immunodeficiency due to DOCK8 deficiency	ORPHA:217390
6097	0.1461	Severe combined immunodeficiency due to adenosine deaminase deficiency	ORPHA:277
6097	0.1461	Periodic fever, menstrual cycle dependent	OMIM:614674
6097	0.1461	Trichothiodystrophy 3, photosensitive	OMIM:616395
6097	0.1461	Immunodeficiency 98 with autoinflammation, X-linked	OMIM:301078
6097	0.1461	Atopy, susceptibility to	OMIM:147050
6097	0.1461	Pigmented nodular adrenocortical disease, primary, 3	OMIM:614190
6097	0.1461	Palmoplantar keratoderma, epidermolytic, 1	OMIM:144200
6097	0.1461	Hyper-IgE recurrent infection syndrome	OMIM:147060
6097	0.1461	Autosomal dominant hyper-IgE syndrome	ORPHA:2314
6097	0.1461	?Inflammatory skin and bowel disease, neonatal, 2	OMIM:616069
6097	0.1461	Hypotrichosis simplex of the scalp	ORPHA:90368
6097	0.1461	Peeling skin syndrome 1	OMIM:270300
6120	0.1456	?Leukoencephalopathy with dystonia and motor neuropathy	OMIM:613724
6121	0.1446	Rhizomelic chondrodysplasia punctata, type 1	OMIM:215100
6121	0.1446	Hodgkin lymphoma, susceptibility to	OMIM:236000
6123	0.1435	Combined immunodeficiency-enteropathy spectrum	ORPHA:436252
6123	0.1435	Combined immunodeficiency due to partial RAG1 deficiency	ORPHA:231154
6123	0.1435	LIG4 syndrome	ORPHA:99812
6123	0.1435	LIG4 syndrome	ORPHA:99812
6123	0.1435	Combined immunodeficiency-enteropathy spectrum	ORPHA:436252
6128	0.1434	Leukotriene C4 synthase deficiency	OMIM:614037
6129	0.1432	Chronic granulomatous disease 1, autosomal recessive	OMIM:233700
6129	0.1432	Chronic granulomatous disease 4, autosomal recessive	OMIM:233690
6129	0.1432	Chronic granulomatous disease, X-linked	OMIM:306400
6129	0.1432	Chronic granulomatous disease 2, autosomal recessive	OMIM:233710
6133	0.1431	?Ciliary dyskinesia, primary, 6	OMIM:610852
6134	0.142	Spondyloenchondrodysplasia with immune dysregulation	OMIM:607944
6135	0.1419	Hyperaldosteronism, familial, type IV	OMIM:617027
6135	0.1419	Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	OMIM:613743
6137	0.1412	Ciliary dyskinesia, primary, 14	OMIM:613807
6138	0.1385	Immunodeficiency 40	OMIM:616433
6139	0.1384	Bleeding disorder, platelet-type, 16, autosomal dominant	OMIM:187800
6139	0.1384	Deafness, autosomal dominant 1, with or without thrombocytopenia	OMIM:124900
6139	0.1384	?Bleeding disorder, platelet-type, 22	OMIM:618462
6139	0.1384	Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	OMIM:300835
6139	0.1384	Macrothrombocytopenia, isolated, 1, autosomal dominant	OMIM:613112
6139	0.1384	Platelet disorder, familial, with associated myeloid malignancy	OMIM:601399
6145	0.1376	Ciliary dyskinesia, primary, 13	OMIM:613193
6145	0.1376	Ciliary dyskinesia, primary, 18	OMIM:614874
6147	0.1368	Bleeding disorder, platelet-type, 13, susceptibility to	OMIM:614009
6147	0.1368	Quebec platelet disorder	OMIM:601709
6147	0.1368	Bleeding disorder, platelet-type, 8	OMIM:609821
6150	0.1347	Arthrogryposis multiplex congenita 6	OMIM:619334
6150	0.1347	Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism	OMIM:616549
6152	0.1328	Monosomy 22q13.3	ORPHA:48652
6152	0.1328	Immunodeficiency 20	OMIM:615707
6152	0.1328	Long QT syndrome 8	OMIM:618447
6152	0.1328	Bacterial susceptibility due to TLR signaling pathway deficiency	ORPHA:183713
6152	0.1328	Immunodeficiency 32A, mycobacteriosis, autosomal dominant	OMIM:614893
6152	0.1328	15q14 microdeletion syndrome	ORPHA:261190
6152	0.1328	Immunodeficiency 38	OMIM:616126
6152	0.1328	Immunodeficiency 29, mycobacteriosis	OMIM:614890
6152	0.1328	Acquired partial lipodystrophy	ORPHA:79087
6152	0.1328	Severe combined immunodeficiency due to FOXN1 deficiency	ORPHA:169095
6152	0.1328	?Immunodeficiency 39	OMIM:616345
6152	0.1328	Immunodeficiency 30	OMIM:614891
6152	0.1328	Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency	ORPHA:319552
6152	0.1328	Immunodeficiency 27B, mycobacteriosis, AD	OMIM:615978
6152	0.1328	Immunodeficiency 28, mycobacteriosis	OMIM:614889
6152	0.1328	Immunodeficiency 21	OMIM:614172
6152	0.1328	Neutrophil immunodeficiency syndrome	ORPHA:183707
6152	0.1328	Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency	ORPHA:70592
6152	0.1328	?Immunodeficiency 16	OMIM:615593
6152	0.1328	Immunodeficiency 18	OMIM:615615
6152	0.1328	T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	OMIM:614868
6152	0.1328	Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection	OMIM:619986
6152	0.1328	?Immunodeficiency 13	OMIM:615518
6152	0.1328	Griscelli syndrome, type 3	OMIM:609227
6152	0.1328	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome	ORPHA:391487
6152	0.1328	Pilarowski-Bjornsson syndrome	OMIM:617682
6152	0.1328	Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome	ORPHA:529965
6152	0.1328	Primary immunodeficiency syndrome due to LAMTOR2 deficiency	ORPHA:90023
6152	0.1328	Alpha-thalassemia-myelodysplastic syndrome	ORPHA:231401
6152	0.1328	Burkitt lymphoma, somatic	OMIM:113970
6152	0.1328	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome	ORPHA:391487
6152	0.1328	Immunodeficiency 31A, mycobacteriosis, autosomal dominant	OMIM:614892
6152	0.1328	Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome	ORPHA:487796
6152	0.1328	X-linked intellectual disability, Cabezas type	ORPHA:85293
6152	0.1328	Hatipoglu immunodeficiency syndrome	OMIM:620331
6187	0.1327	Ciliary dyskinesia, primary, 10	OMIM:612518
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Dyskeratosis congenita	ORPHA:1775
6188	0.1311	Reticular dysgenesis	OMIM:267500
6188	0.1311	Reticular dysgenesis	OMIM:267500
6202	0.1307	Ciliary dyskinesia, primary, 12	OMIM:612650
6202	0.1307	Ciliary dyskinesia, primary, 11	OMIM:612649
6202	0.1307	Ciliary dyskinesia, primary, 48, without situs inversus	OMIM:620032
6202	0.1307	Ciliary dyskinesia, primary, 7, with or without situs inversus	OMIM:611884
6202	0.1307	Ciliary dyskinesia, primary, 15	OMIM:613808
6202	0.1307	Ciliary dyskinesia, primary, 34	OMIM:617091
6202	0.1307	Ciliary dyskinesia, primary, 28	OMIM:615505
6202	0.1307	Ciliary dyskinesia, primary, 32	OMIM:616481
6202	0.1307	Spermatogenic failure 38	OMIM:618433
6202	0.1307	Ciliary dyskinesia, primary, 17	OMIM:614679
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Immunodeficiency 19, severe combined	OMIM:615617
6212	0.1294	T-cell immunodeficiency, congenital alopecia, and nail dystrophy	OMIM:601705
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Immunodeficiency 49, severe combined	OMIM:617237
6212	0.1294	Fraser syndrome 1	OMIM:219000
6212	0.1294	Immunodeficiency 104, severe combined	OMIM:608971
6212	0.1294	Omenn syndrome	ORPHA:39041
6212	0.1294	Immunodeficiency 26, with or without neurologic abnormalities	OMIM:615966
6226	0.127	Ciliary dyskinesia, primary, 1, with or without situs inversus	OMIM:244400
6226	0.127	Ciliary dyskinesia, primary, 9, with or without situs inversus	OMIM:612444
6226	0.127	Ciliary dyskinesia, primary, 20	OMIM:615067
6226	0.127	Ciliary dyskinesia, primary, 40	OMIM:618300
6226	0.127	Ciliary dyskinesia, primary, 30	OMIM:616037
6226	0.127	Ciliary dyskinesia, primary, 16	OMIM:614017
6226	0.127	Ciliary dyskinesia, primary, 26	OMIM:615500
6226	0.127	Ciliary dyskinesia, primary, 50	OMIM:620356
6234	0.1269	Hyperprolactinemia	OMIM:615555
6235	0.1266	Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis	OMIM:608203
6235	0.1266	Chronic granulomatous disease 5, autosomal recessive	OMIM:618935
6237	0.1244	Carney complex, type 1	OMIM:160980
6237	0.1244	Multiple endocrine neoplasia, type IV	OMIM:610755
6237	0.1244	Pachydermoperiostosis	ORPHA:2796
6237	0.1244	Pachydermoperiostosis	ORPHA:2796
6237	0.1244	Pituitary adenoma 2, GH-secreting	OMIM:300943
6242	0.1236	Ciliary dyskinesia, primary, 2	OMIM:606763
6242	0.1236	Ciliary dyskinesia, primary, 45	OMIM:618801
6242	0.1236	Ciliary dyskinesia, primary, 22	OMIM:615444
6242	0.1236	Ciliary dyskinesia, primary, 19	OMIM:614935
6242	0.1236	Ciliary dyskinesia, primary, 38	OMIM:618063
6247	0.121	Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome	ORPHA:231720
6247	0.121	Pituitary hormone deficiency, combined, 3	OMIM:221750
6247	0.121	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	OMIM:617260
6247	0.121	Single median maxillary central incisor	OMIM:147250
6247	0.121	Holoprosencephaly 9	OMIM:610829
6247	0.121	Obesity, morbid, due to leptin receptor deficiency	OMIM:614963
6247	0.121	Growth hormone insensitivity with immune dysregulation 1, autosomal recessive	OMIM:245590
6247	0.121	Axenfeld-Rieger syndrome, type 1	OMIM:180500
6247	0.121	Meier-Gorlin syndrome 6	OMIM:616835
6247	0.121	Intellectual developmental disorder, X-linked, with isolated growth hormone deficiency	OMIM:300123
6247	0.121	Noonan syndrome 12	OMIM:618624
6247	0.121	Growth hormone deficiency, isolated partial	OMIM:615925
6247	0.121	Juberg-Hayward syndrome	OMIM:216100
6247	0.121	Mosaic variegated aneuploidy syndrome 2	OMIM:614114
6247	0.121	Spondyloenchondrodysplasia	ORPHA:1855
6247	0.121	Pituitary hormone deficiency, combined, 5	OMIM:182230
6247	0.121	?Fanconi anemia, complementation group W	OMIM:617784
6247	0.121	Ritscher-Schinzel syndrome 1	OMIM:220210
6247	0.121	Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism	OMIM:615866
6247	0.121	Pituitary hormone deficiency, combined or isolated, 7	OMIM:618160
6247	0.121	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies	OMIM:615286
6247	0.121	EEC syndrome	ORPHA:1896
6247	0.121	Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	OMIM:604292
6247	0.121	Histiocytosis-lymphadenopathy plus syndrome	OMIM:602782
6247	0.121	Cohen syndrome	OMIM:216550
6247	0.121	Boomerang dysplasia	ORPHA:1263
6273	0.1199	Pallister-Hall syndrome	ORPHA:672
6274	0.1124	ALG2-CDG	ORPHA:79326
6274	0.1124	Developmental and epileptic encephalopathy 71	OMIM:618328
6274	0.1124	Sjogren-Larsson syndrome	OMIM:270200
6274	0.1124	Developmental and epileptic encephalopathy 4	OMIM:612164
6274	0.1124	Deafness, dystonia, and cerebral hypomyelination	OMIM:300475
6274	0.1124	Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	ORPHA:369939
6274	0.1124	Hypomyelination-congenital cataract syndrome	ORPHA:85163
6274	0.1124	?Slowed nerve conduction velocity, AD	OMIM:608236
6274	0.1124	Hereditary methemoglobinemia	ORPHA:621
6274	0.1124	Leukodystrophy, hypomyelinating, 12	OMIM:616683
6274	0.1124	Hereditary methemoglobinemia	ORPHA:621
